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 “Hip fracture: a complex illness among complex patients... 
In many respects, hip fracture is the quintessential geriatric illness.” 
Hung WW. Ann Internal Med 2011; 267–268. 
“And he [Samson] smote them hip and thigh with a great slaughter...” 
Old Testament, Judges 15:8. 
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Glossary 
Name Description 
 
Admission The period between initial entry into hospital and the final discharge.  
May include multiple episodes for different aspects of hospital care, 
in more than one hospital. Sometimes described as ‘episode string.’ 
Episode A defined period of hospital care for a single service or period of 
care. If change of location within or between hospital(s) is required 
to meet a change in clinical need, the patient is separated from the 
existing episode and a new episode commences.  
 
Separation The end point of a hospital  admission or episode.   
Acute phase Hospital treatment in a ward or service unit designated as acute care. 
In the context of this paper the episode of care carries one of the 
principal diagnosis codes for hip fracture 
 
Hip fracture Fracture of the upper femur between the head (ball) and the upper 5 
cm of the femoral shaft. Fracture of the acetabulum (socket) is not 
included in this definition. 
 
Comorbidity The presence of medical diagnoses, recognised at or before the 
admission or event under consideration, which are deemed to have 
significance for the current health or prognosis of the patient. 
 
Administrative 
database 
Centralised collection of personal and clinical data items extracted 
from medical and hospital records following an admission or 
episode of service provision.  
 
Orthogeriatric Process of care delivery in which orthopaedic and aged care and/or 
rehabilitation clinical teams combine resources for hospital care of 
elderly or frail patients with major fractures. Particularly developed 
for management of hip fracture.  
 
Treatment 
population 
Department of Veterans’ Affairs clients who are eligible for health 
services at departmental expense. Holders of DVA treatment 
eligibility cards. 
 
Residential aged 
care 
Facility accredited under the Aged Care Act 1997 to provide High 
Care (“nursing home”) or Low Care (“hostel”) accommodation for 
persons with specified levels of disability as assessed by an Aged 
Care Assessment Team 
 
Veterans’ Home 
Care 
Package of services provided by DVA to eligible clients. Includes 
personal care, domestic assistance and respite care. 
 
Community 
patient 
RAC patient       
Person not identified as living within residential aged care at given 
point in time. 
Person living in residential aged care facility at given point in time. 
Inclusive of High Care, Low Care and Respite classifications 
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I (2): Abstract 
Background 
Hip fracture is an injury which requires complex and expensive treatment and 
which has equally complex and burdensome consequences. As the most serious 
complication of osteoporosis, hip fracture mostly occurs in persons who are 
already elderly and have other indicators of frailty. International experience is that 
one quarter of all victims will not survive one year and more than one third of all 
survivors will have permanent limitations of physical function and loss of 
independence. Multi-specialty hospital treatment, a wide range of ongoing 
medical and supportive services and long-term institutional care for many 
patients result in a high cost burden, and a severe personal impost for patients and 
families. 
When the work of this Thesis was commenced in 2011, many important details 
of the treatment, ongoing care and patient outcomes for hip fracture in Australia 
were unknown or incompletely documented at a national level. [1] In large part 
this was due to inability to link data for the individual patient both within and 
between the diverse services required for care of this complex condition. Access 
to comprehensive patient-linked databases for both hospital and community 
health services for Department of Veterans' Affairs clients created the possibility 
of addressing many of these questions. 
Objectives 
The initial aim was to document the complete hospital admission — its duration, 
component episodes, costs and both interval and final outcomes. In so doing it 
was apparent that predictive factors for hospital length of stay (LOS) could also 
be identified by data linkages within hospital data and by linkages with other 
datasets. 
A detailed examination of mortality rates beyond the initial episode of hospital 
care was the next objective. Although post-hospital deaths had been described for 
some localised  Australian populations, mortality rates at final hospital discharge, 
at intervals up to four years thereafter, and also the associated risk factors for 
mortality were sought. 
The question of a relationship between resource expenditure and patient 
outcomes was then examined. Access to a nation-wide sample allowed 
comparisons of hospital service elements, length of stay and costs between the 
Australian states. Rates for mortality, aged care residency and levels of 
community services both short-term and at one year post-fracture were to be 
compared. 
3 
 
High rates of hospital episodes for rehabilitation had been identified as a major 
component of hospital stay and cost. The next objective was an analysis of factors 
associated with referral to rehabilitation, with shorter or longer stay in 
rehabilitation units and then a comparison of one-year outcomes for patients with 
and without hospital rehabilitation. 
Finally a context was sought for the findings from these studies by describing the 
national age-specific prevalence and incidence of hip fracture over the past 
twenty years and projected caseloads to the middle of this century. 
An ongoing objective of the work for this Thesis has been to demonstrate the 
value of database linkage in the analysis of services and outcomes for complex 
conditions. 
Patients and Methods 
Patients were identified from the Department of Veterans’ Affairs (DVA) 
Treatment Population (TPOP) which included all DVA clients entitled to receive 
all or selected health services at Departmental expense. In December 2008, 92 
per cent of TPOP were Gold Card holders with access to all recognised Medical 
Benefits Schedule health services. In the study year TPOP included 20.5 per cent 
of all Australians aged 80 years or older (males 26 per cent, females 17.0 per 
cent). The study year was selected (in 2010) to ensure completeness of the dataset 
and to provide an adequate period of post-fracture follow-up. 
All TPOP beneficiaries hospitalised for hip fracture between I July 2008 and 30 
June 2009 were selected. Admissions for a second fracture in the study year were 
excluded but patients with multiple injuries or malignancy were not.  
Data Collection 
This is a retrospective cohort study derived from administrative databases. Data 
describing episodes of service in public and private hospitals, Residential Aged 
Care (RAC) admissions and date of death were obtained in the first instance. Data 
for community nursing and Veterans’ Home Care (VHC) occasions of service and 
for hospital readmissions were subsequently added. Patient-level linkage within 
and between datasets was enabled by the unique identification number assigned 
by DVA and attached to the record of every health service. 
The following variables were included in the dataset: age, sex, fracture type, 
hospital separation status, surgery, intensive care and rehabilitation episodes, 
comorbidities and complications. ICD-10-AM codes were used to identify 
fracture type, rehabilitation episodes, comorbidities and complications. Intensive 
care was identified by a service item descriptor. Codes for fracture type, 
procedures, rehabilitation, intensive care and complications were accepted for 
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analysis if they appeared within the episode string for the index admission. 
Comorbid conditions were identified from primary or secondary diagnoses for all 
hospital episodes in the study year, up to and including the episode string of the 
index admission. Complications were identified only from episodes within the 
index admission. 
Data analyses 
Student’s t-test and Pearson’s Chi-squared test were used to assess differences 
between groups for continuous and binary outcomes respectively. Linear, logistic 
and negative binomial regression models were employed as appropriate with 
checking for high correlation or interaction between variables. Mortality was 
assessed with Kaplan-Meyer survival curves and log-rank testing, and Cox 
Proportional Hazards regression models. 
Formulae were derived for the age-sex standardisation of mortality rates between 
populations with different demographic profiles, for distinguishing between high 
and low risk sub-groups for relevant outcomes and for defining levels of 
dependency following discharge from the index hospital admission. 
Results 
The study population numbered 2552. The mean age was 86.6 years (range 54-
100 years), 37.6 per cent of patients were men and 27.7 per cent of patients were 
living in residential aged care (RAC) at the time of admission. 
Mean length of acute phase care was 13.4 days and of total hospital stay was 30.8 
days. 43 per cent of all days were in acute care, 37 per cent in rehabilitation and 
the remaining 20 per cent was for management of comorbid conditions, 
complications or subacute care awaiting discharge. The main factors influencing 
hospital stay were prior aged care residency and referral to rehabilitation. 
Complications arising in hospital, especially sepsis, were associated with longer 
stay whereas individual comorbid conditions had limited effect. 
Mortality in this elderly sample was 11 per cent at 30 days, 34 per cent at one 
year and 47 per cent at two years. Prior RAC residence was the strongest 
determinant for mortality. Males from RAC had one-year mortality of 72 per cent 
while for females from the community the rate was 19 per cent. Cancer, cardiac 
failure, stroke and renal failure were associated with 20 per cent to 60 per cent 
increased mortality risk during the first year. Hip fracture patients had mortality 
rates in excess of those for a reference population for at least four years. 
Despite lack of significant difference in patient characteristics between the 
Australian States, there were substantial and significant differences in hospital 
utilisation profiles for hip fracture management. Acute phase LOS ranged from 
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9.4 to 14.6 days and total LOS was between 25 and 36 days. The highest mean 
total cost was 51 per cent greater than the lowest value. One year after the index 
fracture there were no significant differences in rates for mortality, RAC 
residence or living at home without defined community services. 
Among 1724 community patients with similar demographics and comorbidity 
profiles, patients who received hospital-based rehabilitation had lower one-year 
and two-year mortality. There were no significant differences in post-fracture 
residential status or receipt of community services attributable to rehabilitation in 
adjusted models. Number and costs of hospital admissions in the year following 
the index fracture were not different. Older age, subtrochanteric fractures, and 
dementia were associated with lower rates of rehabilitation referral while patients 
treated surgically and those with complicating anaemia, urinary or wound 
infection were more frequently referred. Rehabilitation added more than 14 days 
to total hospital stay and over $14,000 to hospital costs in this sample. 
The age-standardised incidence of hip fracture for the general Australian 
population peaked just before 2000 and had fallen by 16 per cent for women and 
8 per cent for men by 2012–13. The greatest rates of decline in age-specific 
incidence were in the age range 75–84 years for both men and women. Despite 
declining incidence the estimated total number of hip fractures had increased 
from 11,400 to 18,600 in the period between 1993–94 and 2012–13, when 50 per 
cent of hip fractures were in persons aged 85 years or older. 
By 2051, a 50 per cent increase in the Australian population to 38 million, of 
which 4.2 per cent would be aged 85 years or older would see hip fracture 
numbers increase to approximately 44,000 if the fall in incidence over the past 15 
years were replicated. Patients aged 85 years or older would contribute 60 per 
cent of the total. 
Conclusions 
New information has been provided on hospital utilisation, costs and long-term 
patient outcomes for hip fracture in a large national sample. 
Predictors for these outcomes have been examined in multivariable models. 
Patients from RAC had significantly shorter total hospital stay and higher 
mortality than community patients. Mortality rates at intervals up to four years 
have been calculated and the principal predictors have been demonstrated. Across 
Australia, hospital utilisation differed between states, but with no resultant 
differences in patient outcomes for mortality or restored independence. In-
hospital rehabilitation was associated with increased hospital LOS and costs, and 
with lower immediate and one-year mortality, but not with improved markers for 
independence. Numbers of hip fractures are projected to continue increasing 
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sharply due to the expansion and ageing of the population despite falling age-
specific incidence. 
Changing processes of care delivery in hospitals are likely to mitigate the cost 
burden. Full understanding of the care of this complex condition requires linkage 
of information from multiple data sources. 
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Section II. The context of hip fracture 
II (1). Definition, significance, epidemiology, history 
1(i): Definition 
Hip fracture describes any fracture of the femoral head, neck or trochanters, and 
the upper femoral shaft immediately distal to the greater trochanter. Fractures of 
the acetabulum are classified as pelvic fractures. Hip fractures are usually 
classified as cervical, trochanteric (or intra-trochanteric) and subtrochanteric. 
Cervical fractures, involving the head and neck of the femur, lie within the 
capsule of the hip joint and are also described as intracapsular fractures. Fractures 
of the greater or lesser trochanter and the sub-trochanteric femoral shaft are 
extracapsular. These classifications are illustrated below in Figure II-1. [2] 
The great majority of hip fractures in the elderly are the result of low impact 
trauma events, almost exclusively due to falls, in persons with pre-existing 
osteoporosis. The term “minimal trauma fracture” is sometimes used. 
 
Figure II-1. Classification of hip fractures. Fractures in the blue area are 
intracapsular and those in the red and orange areas are extracapsular. 
Copyright 2006 © BMJ Publishing Ltd 
1(ii): Significance 
At a personal level hip fracture is regarded as one of the most serious 
consequences of increasing age and frailty and osteoporosis in particular. It 
results in increased risk of death, with 25 to 30 per cent mortality within 12 
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months of injury, and functional limitation for the great majority of survivors, at 
least one-quarter of which require transfer into supported accommodation. [2,3,4] 
The number of hip fractures worldwide was approximately 1.6 million in 2000, 
with an anticipated increase to perhaps four times this number by the middle of 
this century. [5] Loss of disability adjusted life years in Europe alone exceeds 2 
million, a greater burden than that of every individual cancer diagnosis except for 
carcinoma of the lung. [6]  
At a community level, the management of hip fracture involves high cost hospital 
care and prolonged post-hospital care in most cases. Total one-year health costs 
have been assessed at over $50,000 in Canada (2010 $CAD) and more than 
$US70,000 for US veterans with about three-quarters of these costs directly 
attributable to the hip fracture. [7,8] 
1(iii): Epidemiology 
The personal risk factors for hip fracture have been well understood for two 
centuries. Female gender and increasing age in the presence of osteoporosis are 
the dominant causative factors to the extent that this injury has been named “the 
widows’ disease”. In most large series females outnumber males by at least 2.5:1 
and the incidence for persons aged 85 years or older exceeds that of persons aged 
70–74 years by a factor of 10. Family history of osteopenia, reduced oestrogen 
levels, vitamin D deficiency and low calcium intake increase fracture risk as do 
physical inactivity and low body weight in the elderly. [9] At a population level, 
the incidence of hip fracture increases with increasing distance from the equator 
and is higher in more affluent societies. [10] Denmark has the highest (age-
standardised) fracture incidence, Australia is in the lower 40 per cent and South 
Africa the lowest of nations excepting Nigeria. [10] 
1(iv): History 
In his 1823 publication “A treatise on dislocations and fractures of the joints” 
British surgeon Sir Astley Cooper [11] provided detailed clinical and pathological 
descriptions of the three main types of hip fracture (cervical, trochanteric, and 
sub-trochanteric) as recognised today. He emphasised the important differences 
for bone union of fractures within or external to the joint capsule, recognising the 
significance of interrupted vascular supply to the femoral head for subsequent 
healing and function. He also described “...how bones sometimes become soft 
from age and disease and from the absorption of their phosphate of lime...” and 
the increased prevalence of this condition in females, and with age and 
immobility. Although providing this exquisite description of osteoporosis, a term 
which already existed in French literature, it was not seen in English usage before 
the 20th century. [12] 
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Fractures of the femoral neck or trochanter have been identified in archaeological 
specimens from late Neolithic times. The existence of osseous reaction at the 
fracture sites testified to some instances of prolonged survival. [13] The first 
death of a known person as a result of hip fracture was that of Charles IV, King 
of Bohemia in 1378. The skeleton showed a recent intracapsular fracture and 
contemporary records attributed death to a “mischievous fever” — probably 
hypostatic pneumonia. [14] The first clinical description of femoral neck fracture 
was recorded by Ambroise Paré in 1575. [15] 
1(v): History of treatment 
The first successful internal fixation of a femoral neck fracture was performed by 
König in 1875, by aseptic percutaneous insertion of a gimlet. [16] Prior to this 
date von Langenbeck had performed a similar procedure. The patient eventually 
died from sepsis, but healing of an extracapsular fracture was found at autopsy. 
An alternative surgical treatment was excision of the proximal fragment, 
practised by Theodor Kocher with occasional long-term successful healing.[16] 
Joint excision was in common practice for patients with severe arthritis in the 
latter half of the 19th century.[17] This period and the early years of the 20th 
century saw attempts at internal fixation of cervical fractures with pegs of bone, 
ivory or wood. Non-surgical treatment by manipulation and immobilisation in 
plaster achieved bony union in about one-quarter of patients.[18] 
The year 1925 saw the introduction of fixation with a flanged nail by a team lead 
by Smith-Petersen, who reported six years’ experience in 1931[19] with a 
majority of the 20 patients achieving bony union. Results remained poor, with 
only 1:3 patients in a large American centre achieving “bony union and a cure” 
after a prolonged time in hospital. This situation apparently led some surgeons to 
declare that such patients should not be admitted to hospital.[20] Avascular 
necrosis of the femoral head was then being experienced by one-quarter to one-
third of treated patients.[18] 
Modifications of equipment and techniques over the next 25 years saw healing 
rates as high as 97 per cent claimed, though from small series. Although this was 
a major advance, conventional practice of the time required patients to be non-
weight-bearing until X-ray evidence of bony union was achieved. This meant 
many weeks or up to nine months at bed rest [21] with attendant risks to 
subsequent function and survival. 
In 1959, a surgical team from the National Orthopaedic Hospital, London 
commenced partial weight-bearing “as soon as the pain from the operation wound 
has subsided”, this being at 10 -19 days. Consequently patients were ready for 
discharge in no more than 6 weeks, and with rates of fracture healing closely 
approximating to other contemporary reports. [21] 
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The intervening half-century has seen numerous advances in surgical technique, 
with total hip prostheses and methacrylate cementing being introduced and 
developed by Charnley in the 1950s.[22] Among the numerous fixation devices 
required for trochanteric and subtrochanteric fractures (and some cervical 
fractures) none has yet emerged as clearly superior. [2] 
In a large series of hip fractures, reported in 1979, [23] hemiarthroplasty was 
performed on 44 per cent of cervical fractures while 29 per cent were treated by 
internal fixation and 27 per cent were managed without operation. Hospital LOS, 
three-month and one-year mortality rates from this series were competitive with 
current results.[24]  
Protocols describing current best practice are now available with respect to 
immediate resuscitation, pain management, prophylaxis against infection and 
thrombo-embolism, prompt surgery (for the great majority), anaesthesia and early 
ambulation and other elements of acute hospital care.[25,26] Increasing attention 
has also turned to programs of post-acute care and the promotion of primary and 
secondary prevention. [26,27] 
Despite the extensive advances in equipment, technique and patient management 
over the past half century, and the undisputed improvements in outcomes, 
complications or imperfect results after surgery for hip fracture remain common. 
In a large series of cervical (intracapsular) fractures reported in 2009, avascular 
necrosis of the femoral head occurred in 11.4 per cent of displaced fractures and 
4.9 per cent of undisplaced fractures. [28] In another series of 1133 patients 
reported in 2012,[29] non-union occurred in 20 per cent of all cases, 8.5 per cent 
in undisplaced fractures and 32 per cent in displaced fractures. Hip fracture 
remains a serious injury with a high rate of ongoing problems. 
II (2). Incidence and Prevalence 
2(i): Measuring hip fracture incidence 
It is now accepted that, for practical purposes, hospital admission data best 
identify the hip fracture population. The earliest calculations of incidence were 
made in locations such as Dundee, Scotland and Rochester, New York where the 
population was definable and stable and hospital care was provided almost 
exclusively by a single facility. [30,31,32] Information from radiology reports or 
personal clinic records are alternate data sources in closed study 
populations,[33,34,35] but calculations of national incidence were derived from 
centralised data collections for hospital admissions.[36,37] It has long been 
recognised however that most of these regional or national data collections 
identify episodes of hospital care, not individual patients.[38,39] Hip fracture 
patients are likely to have more than one treatment episode within their initial 
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hospital admission, [38,40] hence some degree of double counting is probable. 
Unadjusted hospital episode data for hip fracture appeared to overstate the true 
number of fracture patients by approximately 20 per cent. [38,40] A number of 
processes aimed at reducing this error, such as including only emergency 
admissions or excluding admissions through transfer from another hospital, or 
requiring that the diagnosis of hip fracture be accompanied by a relevant 
procedure code, were applied to population-based data. The extent of over-
reporting could not be accurately determined but may have been 20-25 per cent. 
[39] 
Hospital admission databases which included a patient identifier were established 
at national level in Finland and Denmark and at County level in Sweden in the 
latter decades of the 20th century. [23,37,41] These provided much more accurate 
incidence data. Accuracy of coded diagnoses for hip fracture proved to be high 
when checked against radiology findings. [35]  
2(ii): Incidence of hip fracture prior to 1984: the “orthopaedic epidemic” 
A sharp increase in hip fracture incidence with increasing age has been recognised 
for two centuries. [11] In the middle decades of the last century two converging 
factors were producing a rapid and accelerating increase in the number of hip 
fracture patients. Not only was the population ageing rapidly, but the age-specific 
incidence of hip fractures was also on the increase. [31,32,38,39] Predictions of 
a doubling or even trebling of the number of hospital admissions in the first 20 
years of this century were made in several countries. [39,42,43,44]  
Prior to the advent of national data sets, these projections were based upon small 
numbers of patients in discrete communities served by a limited number of 
hospitals. Rochester, Minnesota serviced almost exclusively by the Mayo Clinic 
[31] reported rising incidence for men and women between 1928 and 1952, but 
acknowledged incomplete case finding in the early years. After 1953 incidence 
did not change significantly: there were only 1355 patients recorded in 50 years 
to 1977. 
In Göteberg, Sweden 104 fractures were recorded in 1940, 443 in 1965 and 928 
in 1983. Between 1965 and 1983 the annual incidence increased by nearly 70 per 
cent for females and 100 per cent for males; although mean patient age increased 
by 8.5 years for females (to 81.7 years) and by 5.3 years for males (74.8 years) 
this demographic shift was estimated to explain only 20 per cent of the increased 
incidence. [43] 
The Hospital In-Patient Enquiry dataset for England and Wales showed that 
hospital admissions increased by a factor of 2.7 between 1959 and 1977, with 
evident increases for all age-groups over 45 years.[38] Again less than 30 per cent 
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of the increase was attributable to demographic shift towards older age. An 
additional 16,000 admissions and 600,000 bed-days were required in 1977 
compared with 1959. 
Data collected in Nottingham, England showed that the rate of increase in 
admissions for hip fracture accelerated further to 10 per cent per annum between 
1977 and 1981, while population grew at 2 per cent. Females aged >75 years 
showed by far the greatest relative and absolute increases in this period. [39] Data 
were scrutinised to minimise double counting due to inter-hospital transfers. In 
discussing possible causes of the rising age-specific incidence the author 
speculated on the possibility of a cohort effect in a group which may have 
undergone dietary deprivations during and after World War II plus lack of 
physical activity in old age as ‘labour-saving devices’ made their appearance. [39] 
2(iii): Hip fracture incidence after 1984: an epidemic averted 
By the early 1990s, evidence was emerging that, while the proportion of persons 
aged over 80 years was continuing to increase, the rise in age-specific incidence 
was being replaced by progressive decline, especially for women. In Rochester, 
a decline in hip fracture incidence for women was found in the period 1973-1992; 
rates for men continued to increase until 1982 but then showed small 
declines.[45] Between 1985 and 2000 in Ostergötland, Sweden the rates of both 
cervical and trochanteric fractures declined for women but rose by higher margins 
for men.  [36] The data of the Scottish Hip Fracture Audit demonstrated a fall of 
approximately 10 per cent in the population aged 50 years and over between 1999 
and 2004. [42] English data for the period 1989–1998 showed that total hospital 
admissions and age-specific admission rates for hip fracture had increased but 
that all of this increase had occurred in the first five years after which rates were 
steady or slightly declining. Total hospital admissions were stable for all patients 
aged under 85 years. [46] In Stockholm County, Sweden between 1998 and 2007 
the population aged 65 years and older increased by almost 20,000, but the 
combined incidence of hip fractures fell from 16.5 to below 14 per 10,000 
persons. [37] In contrast to Scottish projections of increasing actual numbers of 
fractures, [42] hospital admissions for hip fracture fell by 8 per cent across the 
decade. The fall was evident for men and women aged 65–84 years but not in the 
youngest and oldest people. The differential rates of change between the oldest 
patients and younger age-groups was suggestive of a possible cohort effect as had 
been speculated as early as 1983. [39] 
A New Zealand study has demonstrated a strong cohort effect in parallel with the 
period of rising incidence, and the subsequent decline. [47] The passing of cohorts 
born before the end of the 19th century could, in keeping with the improving 
health and fitness of older people, explain some of the current downward trends. 
The described cohort effect is now minimal within this population. [47] 
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Section III. Hip fracture in Australia: incidence, prevalence, hospital 
utilisation data and caseload projection 
The material presented in Section III examines the current and projected caseload 
for hip fracture in the general Australian population. The incidence and 
prevalence of hip fracture by age and sex, and the changes in these measurements 
over the 20 years to 2012-13 are described. A calculation of the projected hip 
fracture population in 2051 is presented. While seeking to acknowledge findings 
of other Australian original research, the descriptions and calculations in this 
Section were derived after cross-referencing and collation within national 
databases in the public domain. The data sources were the relevant editions of 
Australian Demographic Statistics (Australian Bureau of Statistics ABS 3101.0) 
and the National Hospital Morbidity Database (Australian Institute of Health and 
Welfare). Comprehensive data in the NHMD was first available for 1993-94. 
These data also provide a context for the specific findings of resource demands 
and benefits or burdens for DVA patients which are presented in the five research 
studies which form the major elements of this Thesis (Section V).  
III (1). Data sources 
There are currently no precise data to identify the annual number of hip fractures 
in Australia and therefore no precise calculations of incidence. Studies on 
localised populations have high levels of completeness and accuracy, but accurate 
extrapolation to the diverse national population cannot be assumed, on account 
of demographic differences and the likelihood of wide confidence limits. 
[33,34,48]  
Administrative databases of hospital admissions are generally not the correct 
vehicle for calculation of incidence rates for any particular diagnosis. Hip fracture 
is accepted as being an exception, as very few cases will not be admitted to 
hospital and the diagnostic coding for this condition is accepted to be sufficiently 
accurate to support research studies. [49,50,51] A systematic review found 
sensitivity within the range of 69-97 per cent, or 83-97 per cent with positive 
predictive value of 86-98 per cent when the principal diagnosis code was coupled 
with a relevant procedure code. [51]  
Interactive data cubes of the National Hospital Morbidity Database (NHMD) [52] 
report episodes from every public and private hospital except for a small number 
of private day-only facilities. Episodes are classified by principal diagnosis up to 
5-digit ICD-10-AM, by year and by age-group and sex of the patient. Same-day 
and other episodes can be separated. These rich data resources have been 
available since 1993–94. The consistency of trend lines for demographic and 
secular variables across two decades testifies to high levels of accuracy and 
completeness.  
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However, databases record episodes of hospital care rather than individual 
patients, and it is universally recognised that hip fracture patients frequently have 
more than one episode of care during their initial (index) 
hospitalisation.[34,39,40,50] The extent of this excess counting is not precisely 
known but is probably in excess of 20 per cent. [38,40] A number of corrective 
processes are applied to such databases, both in Australia and 
elsewhere.[35,39,40,53,54] These include exclusion of episodes whose coding 
indicates inward transfer from another acute hospital, or limiting ascertainment 
to emergency admissions or with associated codes for low-impact falls or for a 
procedure relevant to hip fracture repair or some combination of the above. 
Individual studies may also exclude pathological hip fractures, and those 
associated with major trauma or multiple injuries.  
While seeking to reduce the over-counting inherent in administrative data, some 
adjustments may fail to identify legitimate cases.  The addition of procedure 
codes to the algorithm results in under-reporting through exclusion of patients 
treated conservatively and also those who have died in hospital before operation. 
[50] The level of heterogeneity between diagnostic algorithms was such that 
meta-analysis was declared to be impractical. [51]  
An additional difficulty is the inconsistency of demographic criteria for hip 
fracture studies. In recent Australian studies, the lower limit for patient age ranges 
from zero to 65 years and age intervals are set between 5 and 15 years. 
[33,34,44,55] Despite the well- recognised rapid increase in numbers of the oldest 
old, such that patients aged 85 years or older now comprise at least 40 per cent of 
all hip fractures, [53] most studies including the NHMD reports, do not further 
separate this group by age. [33,34,54,55] 
III (2). Estimates of hip fracture incidence and caseload 
2(i): Studies of regional populations 
There appears to be no information on fracture rates in Australia prior to 1979. 
Data based upon acute hospital admissions in NSW [56] showed that admissions 
for hip fracture increased for women but not men up to 1986 and then remained 
static: a further study using similar data suggested modest falls in hospital 
separation rates between 1986 and 1991. [57] Between 1989 and 1996, in South 
Australia, age-standardised rates for patients treated surgically initially fell 
slightly then stabilised for women while rates for men were essentially constant.  
[58] A later report from South Australia, covering the years 2002-03 to 2007-08, 
showed significant increases in incidence for men, and no significant reduction 
for women. Total numbers of hip fractures increased by almost 20 per cent across 
this latter interval, while the proportion of males increased from 24 per cent to 30 
per cent.  [59] In Victoria, age-standardised incidence fell from 600 to 467 per 
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100,000 in the decade to 2008-09, with significant reductions for men and women 
in all age groups over 65 years. [60] 
Two longitudinal studies in Dubbo (NSW) and Geelong (Victoria) commenced in 
1989 and 1993 respectively. In the former, conducted with a small and relatively 
young population, annual incidence of all osteoporotic fractures fell by 4 per cent  
for women  and 6 per cent for men across the 12 years from 1989 to 2000. There 
was however no discernible change in respect of hip fracture. In 2000 the age-
standardised hip fracture incidence was 7.6 per 1000 for women and 3.3 per 1000 
for men. [33] 
The Geelong study was drawn from a population of 222,000 in 1996 which had 
increased by 17 per cent in 2006-07. There was an increase of 80 per cent in the 
number of persons for persons aged 85 years or older. As in the Dubbo study, hip 
fractures were identified from radiological reports. Across 10 years, the total 
number of hip fractures increased by 53 per cent for men but only by 4.4 per cent 
for women. There were no significant changes in age-standardised fracture rates 
for men, while rates for women declined by 30 per cent. The age standardised 
incidence in 2006-07 was 4.4 per 1000 for women and 2.3 per 1000 for men. [34] 
In the Australian Capital Territory (ACT) age-specific hip fracture rates were 
assessed from hospital discharge data. Patient ID numbers and scrutiny of 
personal data and admission/discharge dates were used to prevent double 
counting. For both men and women hip fracture rates in 1999-2001 were 
increased relative to data from 1994–98, then fell significantly for women, but 
not for men across the next four years. [55] 
In a comparatively young population (only 14 per cent aged 60 years or older in 
2006) the overall incidence was 6.8 per 1000 for women and 3.4 per 1000 for 
men. [54] Later data from the ACT showed a resurgent increase in incidence for 
women, coinciding with a sharp reduction in bisphosphonate dispensing, itself 
apparently triggered by reports linking this medication with osteonecrosis of the 
jaw. After three years hip fracture incidence has resumed a decline. [61] 
2(ii): Estimates from national databases 
As outlined in Section III-1, a variety of inclusion and exclusion factors have 
been applied to these data to adjust for double counting. Estimates of hip fracture 
prevalence in Australia for 2006-07 were 16152 and 18176 [53,54] and 17003 
and 18676 for 2008-09, [54,62] a spread of 10-12 per cent. An earlier analysis in 
2002-03 excluded episodes coded as incoming transfers but included cases where 
hip fracture was coded as a secondary diagnosis and found 18,616 hip fracture 
cases. [40] The calculated numbers of hip fractures in Australia has therefore 
varied substantially depending upon the method of ascertainment.  
16 
 
 
III (3). Hip fracture in Australia: more accurate estimates? 
The various adjustments to NHMD and other databases would be unnecessary if 
all records within databases carried a secure patient identification code as do the 
DVA databases which support the studies in this Thesis. Such identifiers are no 
longer unique and indeed, the Finnish Health Care Register and its antecedents 
have included these since 1968. [50] This is the Gold Standard which can 
minimise uncertainty in the identification of patient numbers, resource burdens 
and outcomes of hospital care, across multiple services and jurisdictions. 
Through the linkage capacity of the DVA databases, accurate assessment of the 
relationship between hospital episodes and individual patients was possible (see 
Section V, research study no.1). Of 2552 identified DVA patients, 555 (21.7 per 
cent) had multiple and connected acute episodes. The total of 3177 such episodes 
represented a ratio of 1.25 (95% CI 1.22-1.27) episodes per patient. This ratio 
was the same for men and women and there were no significant differences on 
account of patient age. A large series of hip fracture patients from NSW was found 
to have 1.28 acute episodes per patient (Lee Taylor, Epidemiology and Evidence, 
NSW Health Ministry, personal communication, 2013). The DVA adjustment 
factor of 1.25 has been applied to the national NHMD data to determine age-
specific patient numbers and incidence in Tables III-1 and III-2. 
The calculations for these Tables still include assumptions and estimates. The 
95% confidence limits for the episode: patient ratio (1.22-1.27) include a range 
of 16743-17430 about the estimate of 17012, a spread of 4 per cent. The episode: 
patient ratio, based upon DVA data is assumed to hold for the rest of Australia, an 
assumption which could be readily tested. 
III (4). Trends in national incidence and caseload 1993–94 to 2012–13 
4(i): Hip fracture prevalence 
In the two decades since 1993-94 the calculated hip fracture caseload has 
increased from 11378 to 18607 (Table III-1). In this time the proportion of men 
has risen from 23.5 per cent to 28.9 per cent and the proportion of patients aged 
85 years or older has increased from 37.1 per cent to 49.8 per cent. These 
demographic shifts within the overall increasing caseload are illustrated in Figure 
III-1. It is also evident from Table III-1 and Figure III-1 that hip fracture numbers 
for women aged below 85 years have been essentially static since 2003-04 and 
have actually fallen among women aged 75-84 years. [52]  
The age-specific incidence rates for men remained static or slightly increased 
between 1993-94 and 2003-04. In the last nine years, there were substantial 
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decreases for men aged 75 years and older, and a fall of 8 per cent in the age-
standardised incidence. For women rates fell steadily after 1998-99 for all age-
groups except for women aged 65-69 years. In this period the age-standardised 
incidence for women reduced by 16 per cent. The greatest proportional declines 
in incidence since 1998-99 have been in the age range 75-84 years for both men 
and women (Table III-3). 
 
Table III-1. Numbers of hip fractures by age and sex: Australia 
1993–94 to 2012–13 
       Year Age group  
 65–69 70–74 75–79 80–84 ≥ 85 TOTAL  
 Males  
 Episodes 1  
1993–94 354 489 694 787 1021 3345  
1998–99 321 598 841 1072 1378 4210  
2003–04 345 536 1016 1371 1994 5262  
2008–09 376 573 1026 1490 2350 5815  
2012–13 521 706 979 1593 2917 6716  
 Persons 2  
1993–94 283 391 555 630 817 2676  
1998–99 257 478 673 858 1102 3368  
2003–04 276 429 813 1097 1592 4167  
2008–09 301 458 821 1192 1880 4652  
2012–13 417 565 783 1274 2334 5373  
 Females  
Episodes  
1993–94 610 1197 2008 2792 4270 10877  
1998–99 601 1218 2402 3217 5691 13129  
2003–04 607 1191 2478 3803 7034 15113  
2008–09 654 1113 2135 3676 7873 15451  
2012–13 847 1249 2082 3703 8661 16582  
 Persons  
1993–94 488 958 1606 2334 3416 8702  
1998–99 481 974 1922 2574 4553 10504  
2003–04 486 953 1982 3042 5627 12090  
2008–09 523 890 1708 2941 6298 12360  
2012–13 678 999 1666 2962 6929 13234  
1 Episode data: National Hospital Morbidity Dataset (AIHW)                                                    
2 Persons = episodes / 1.25 (see text). 
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Figure III-1 Trends in distribution of hip fracture episodes 
(From NHMD Data cubes by principal diagnosis: AIHW) 
4 (ii): Trends in hip fracture incidence 
Between 1993-94 and 2012-13 the Australian population grew from 17.7 million 
to 22.9 million. [63] The number of Australians aged 65 years or older increased 
by 57 per cent from 2.08 million to 3.27 million (14 per cent of the total) and the 
proportion of men increased from 43 to 46 per cent of this age-group. Persons 
aged 85 years or older increased from 212,000 to 432,000 (1.2 per cent to 1.9 per 
cent of total population) with the proportion of men rising from 24 per cent to 35 
per cent. 
Within this context, the age-specific incidence rates among men remained static 
or slightly decreased between 1993-94 and 2003-04, after which there were 
substantial decreases. (Table III-2) Among women, rates fell steadily after 1998-
99 for all age-groups except 65-69 years. After 1998-99 the age-standardised 
incidence for men fell by 8 per cent and for women by 16 per cent. The largest 
proportional decreases in incidence since 1998-99 have been in the age-range 75-
84 years for both men and women. (Table III-2) 
There is however a suggestion in these data that the decline in incidence rates has 
been slowing in the four years to 2012-13. This would be in accord with a report 
of little or no ongoing increases in age-specific incidence after 2005-06. [64] 
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Table III-2. Hip fracture incidence by sex and age-group, Australia 
1993–94 to 2012–13 
      
Year 
 
Age group 
 
 65–69 70–74 75–79 80–84 ≥ 85 Standard 1  
 Males  
1993–94 0.85 2 1.52 3.37 6.62 15.81 3.53  
1998–99 0.77 1.66 3.26 7.76 15.61 3.65  
2003–04 0.76 1.43 3.34 7.26 17.13 3.66  
2008–09 0.71 1.41 3.21 6.59 14.76 3.34  
2012–13 0.80 1.51 2.89 6.61 15.28 3.36  
 Females  
1993–94 1.36 3.09 6.94 13.88 27.55 8.07  
1998–99 1.38 2.96 6.99 14.35 28.37 8.82  
2003–04 1.31 2.91 6.61 13.45 27.99 8.48  
2008–09 1.22 2.55 5.78 11.94 25.46 7.60  
2012–13 1.28 2.56 5.40 11.88 24.84 7.44  
1 Australian population 2003–04 is reference population (ABS3101.0)  
2 Hip fractures per 1000 persons per year 
In combination, the Australian data of Tables III-1 and III-2 closely reflect 
hospital admission trends for periods around the turn of the century in Sweden, 
the United States and England where numbers have been static or reducing for all 
but the oldest patients [37,65, 66] although in populations with lower growth rates 
than Australia. 
III (5). Hospital utilisation for hip fracture: a large efficiency gain 
In 1993-94 the mean length of hospital episodes (LOS) coded for hip fracture was 
17.3 days for both males and females aged 65 years and older. (Table III-3) By 
1998-99 these values had reduced to 12.0 days (males 12.6 days, females 11.8 
days) and by 2012-13 mean LOS had further reduced to 9.8 days (males 10.2 
days, females 9.6 days). If this reduction in LOS had not occurred, approximately 
140,000 additional bed-days or some 450 additional acute hospital beds would 
have been required for the 2012-13 caseload. [52] 
Full examination of the reasons for these large reductions in hospital stay, and 
particularly the major change between 1993-94 and 1998-99 is outside the scope 
of this Thesis. They are almost certainly multifactorial and complex. Evolving 
awareness of best-practice guidelines for hospital care of frail patients has 
possibly contributed. Numerous studies report that orthogeriatric programs, 
however delivered, can reduce acute hospital stay for hip fracture. [27,67] 
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Table III-3. Mean LOS for unlinked acute hospital episodes for hip 
fracture: Australia 1993-94 to 2012-13 
Year Age group  
 65–69 70–74 75–79 80–84 ≥ 85 All  
Males        
1993–94 17.4 1 16.2 18.3 18.9 15.8 17.3  
1998–99 12.5 12.1 12.5 13.1 12.4 12.6  
2003–04 11.0 10.5 12.1 12.4 12.1 11.9  
2008–09 9.7 11.2 11.7 11.7 11.7 11.5  
2012–13 9.2 8.9 10.6 10.9 10.2 10.2  
Females   
1993–94 13.9 15.5 15.7 16.8 19.2 17.3  
1998–99 10.6 11.7 11.4 11.8 12.1 11.8  
2003–04 10.5 10.2 10.9 11.2 11.2 11.1  
2008–09 9.6 10.4 10.8 10.8 11.4 11.0  
2012–13 7.7 8.6 9.2 9.9 9.7 9.6  
1  Mean length of stay in days                                                                                                        
Data source : NHMD Data Cubes (AIHW) 
Rehabilitation is a major element in the hospital management of hip fracture, with 
almost 50 per cent of patients being referred to hospital based units in Europe [68, 
69] and up to 90 per cent being referred for rehabilitation in hospital units or in 
skilled nursing facilities in the United States. [70] Table III-4 shows that, in 
Australia between 1998 and 2013, there has been an increase in the numbers of 
rehabilitation episodes, disproportionate to the population increases. The age-
standardised rates for rehabilitation episodes (all causes) have risen from 18.3 
episodes per 1000 persons in 1998-99 to 31.6 per 1000 persons in 2012-13 and 
length of stay in rehabilitation units has also fallen sharply during the same 
period. 
Whether hip fracture patients share in the shorter rehabilitation LOS is not exactly 
clear, but whatever this interaction, strong efficiency gains in both acute and 
subacute hospital care, of relevance to hip fracture, are apparent. At a time when 
hospital costs, especially for the elderly are under increasing scrutiny, the 
progressively efficient use of expensive resources by hospital clinicians and 
managers should perhaps receive greater recognition, and the reasons for these 
gains be better understood. 
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Table III-4. All hospital episodes for rehabilitation, Australia 
1998–9 to 2012–3 
       Year Age group  
 65–69 70–74 75–79 80–84 ≥ 85 All  
 Number of episodes 
 
 
1998–99 4194 1 7084 9501 9391 9792 39962  
2003–04 5195 8870 13710 15355 16355 59485  
2008–09 7904 10592 15215 19010 23536 76257  
2012–13 12818 15440 19042 23005 32904 103209 
 
 
 Mean LOS of rehabilitation episodes 
 
 
1998–99 21.9 2 21.7 21.5 22.3 22.6 22.0  
2003–04 22.3 19.3 19.4 20.9 21.9 20.7  
2008–09 17.5 17.3 18.1 18.4 19.7 18.5  
2012–13 16.1 15.5 16.2 16.7 17.8 16.7  
1 Numbers of episodes 
2 Hospital stay in days                                                                                                            
Data source: NHMD Data Cubes (AIHW) 
III (6). Hip fracture projections for Australia, the unaverted epidemic? 
Projections based upon data from the Geelong Osteoporosis Study in the last 
decades of last century estimated hip fracture numbers in 2051 to reach 
approximately 60,000, or four times the estimated caseload for 1996.[44] At this 
time age-specific and age-standardised incidence rates were static for women and 
rising slowly for men, and the projected estimate was based upon continuation of 
existing rates. The mid-range projection for the Australian population in 2051 was 
of the order of 25 million, [70] with 5.1 per cent being aged 85 years or older as 
shown in Table III-5. 
Since this estimation there have been substantial changes to both population 
projections and age-related incidence of hip fracture for Australia. The latest 
available projection (2012) is for a total population of 38 million in 2051, with 8 
million persons being 65 years or older and 1.6 million (920 000 women and 670 
000 men) aged 85 years or older. The proportion of the ‘oldest old’ is estimated 
to increase from 1.9 per cent at present to 4.2 per cent by mid-century. The overall 
proportions of men and women are expected to remain essentially constant over 
this time. [71] 
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Table III-5. Estimated Australian population in 20511 
 
Age group 
 
1999 estimate 
 
2005 estimate 
 
2012 estimate 
 
 Males Females Males Females Males Females  
65–69 755 2 766 814 810 984 1013  
70–74 691 719 725 744 810 855  
75–79 631 691 661 719 708 781  
80–84 494 587 550 636 577 676  
≥ 85 532 761 678 942 667 920 
 
 
All ages 12626 12783 17104 17109 18886 19070 
 
 
Totals 25.4 million 34.2 million 38.0 million  
1 Data: ABS Population Projections 1997-2051, 3222.0, ABS 2013, Canberra  
2 Mid-range projection, thousands 
Should age-related incidence rates for hip fracture remain unchanged from those 
of the 1990s, the faster expanding and ageing population would have yielded 
more than 90,000 hip fracture cases by 2051. However, from the middle 1990s, 
rates have been falling steadily, especially for women. [34,53,55] Should the 
trend lines for age-specific incidence be projected unaltered from the data in Table 
III-2, the resulting caseload in 2051 would be 43,800 hip fractures of which 37 
per cent would be men and 63 per cent would be aged 85 years or older. If the 
rate by which incidence declined were halved beyond 2013, the total caseload 
would be 52,000 with 34 per cent men and 59 per cent aged 85 years or above, as 
shown in Table III-6. 
 
Table III-6. Estimated hip fracture prevalence, Australia 20511 
Age group Males Females  
 N (000’s) Rate 2 Hip fractures N (000’s) Rate Hip fractures  
65–69 984  0.7 690 1013 1.3 1320  
70–74 810  1.3 1050 855 2.1 1800  
75–79 708  2.7 1910 781 4.3 3360  
80–84 577  6.4 4270 676 10.0 6760  
≥ 85 667  14.8 9870 920 22.9 21070 
 
 
Totals 3 746  4.7 17 790 4 245 8.1 34 310  
1 ABS mid-range population projections 1997-2051, 3222.0, ABS 2013 
2 Incidence decline for 2013-2051 = 50 per cent of rate from 1993-94 to 2012-13 
A long-range projection for any health-related situation involves a complex 
interplay of assumptions. Future demography may be impacted by economic, 
political, environmental, health technology and numerous other factors, often 
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unforeseen at present. It will be interesting to observe whether the reported, and 
counter-intuitive, stabilisation in the proportions of the very elderly is confirmed 
and whether tentative evidence for a cohort shift towards less fracture-prone 
individuals is realised. 
Improvement in preventative measures for both osteoporosis and the other 
recognised risk factors for hip fractures can only be surmised but history suggests 
that many such advances will emerge. Even if case numbers continue to rise 
steeply, the burden upon hospitals, and community resources may be less than 
forecast. Current reductions in hospital LOS may continue. Some aspects of 
hospital-based management may be partially or wholly replaced with less costly 
community-based programs. Community resources would also be greatly 
increased should current trends towards both population growth and later 
retirement from the workforce are continued. 
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Section IV: Introduction to research studies 
IV-1. Aims and objectives 
When this work was commenced in 2011, there was no national information on 
the complete duration, cost or outcome of hospitalisation for hip fracture in 
Australia. An extensive report by AIHW in 2010 [1] had presented a great deal of 
numerical data on these subjects, but only in respect of acute hospital episodes 
with a principal diagnosis of hip fracture. In doing so, AIHW acknowledged that 
there were important limitations to the findings. Over half of the identified 
episodes of hospital care ended with transfer to further hospital care, but without 
capacity for data linkage at a patient level, the location and content of this care 
remained unknown. For the same reasons, data describing hospital readmissions, 
community supportive services, entry into residential aged care and post-hospital 
mortality were not available. The same limitations also applied to, and were 
recognised by several other Australian studies based in individual hospital or 
regional populations. [72,73] The available data in all these instances identified 
hospital episodes and not the complete experience of individual patients. 
Given the changes in locations and clinical situations implied by these findings, 
it was unlikely that even treating clinicians understood the full hospital 
experience of hip fracture patients. The absence of capacity to link hospital and 
other health databases on a national scale also left unanswered the questions of 
what happened after final hospital discharge. Rates of readmission, placement 
into supported accommodation and death in the ensuing months or years could 
not be calculated on a population basis. 
With access to linkable databases provided by the Department of Veterans’ 
Affairs, this study commenced with the aim of describing the total length of 
hospital stay, the contributing episodes, the outcomes (as identified by separation 
codes) at final discharge and the costs of complete hospital care for a large 
national cohort. 
The extensive range of clinical and administrative variables within these data, 
provided the opportunity to identify factors associated with longer or shorter 
hospital stay, and diverse outcomes. The linkage of hospital data with information 
on post-hospital RAC, community based services and mortality, permitted 
examination of rates of and determinant factors for longer term patient outcomes. 
This Thesis describes a number of aspects of hip fracture management and the 
patient outcomes of these processes. The principal intention has been to provide 
more comprehensive analytical detail than has been previously published in 
respect of a large sample of Australian patients. Beyond this, there is no single 
objective, hypothesis or research question. 
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Objectives 
The major objectives of these extended database analyses were therefore: 
1. To describe the length of hospital stay, for acute care, for rehabilitation and for 
management of other contingent issues: in particular to identify the full burden of 
the initial hospital stay following hip fracture for a substantial sample of elderly 
Australians. 
2. To identify the outcomes at the conclusion of the total hospital stay. 
3. To identify the personal and clinical factors associated with longer or shorter 
hospital stay and hence costs. 
4. To estimate mortality rates following hip fracture, their major predictors and 
the extent of excess mortality above predicted rates for a reference population 
adjusted for age and sex. 
5. To examine hospital resources expended for initial hip fracture management in 
the different Australian states and the relationship, if any, between resource 
burden and medium to long-term patient outcomes. 
6. To examine the resource burden of hospital-based rehabilitation and the 
associations with long-term outcomes for mortality and independent living. 
7. To describe recent trends in incidence and prevalence of hip fracture in the 
general Australian population, and to calculate a projected caseload to 2051. This 
objective has already been identified and addressed in Section III. 
8. To demonstrate the importance of database linkage in describing and analysing 
the management of a complex clinical condition. To show the additional 
information released when outputs from database linkage are applied to national 
datasets in the public domain. 
 
Issues not addressed 
It is recognised that many subjects of relevance to the study of hip fracture are 
not addressed in this Thesis. These include the prevention and treatment of 
osteoporosis, reduction in risk for and consequences of falling and the respective 
merits of different surgical techniques. In respect of these issues data provided in 
linked databases may not always be the ideal vehicle for comprehensive 
assessment. Other research opportunities and priorities are indicated at the 
conclusion of this document in Section VI (4). 
26 
 
IV (2). Patients and methods 
2(i): The DVA Treatment Population (TPOP) 
The study population was drawn from the DVA Treatment Population (TPOP) 
which includes all DVA beneficiaries entitled to health services at Departmental 
expense as holders of a Gold Card (treatment for all conditions) or White Card 
(treatment for cancer, tuberculosis, post-traumatic stress disorder, anxiety, 
depression or any condition(s) accepted as due to military service). Gold Card 
status is provided to either veterans or their surviving spouses and in December 
2008, included 92 per cent of TPOP members aged 65 or older (85 per cent of 
males, 98 per cent of females).[74] 
In the study year of 2008-09 the TPOP numbered 275,037 of which 209, 322 
(103,332 males and 105,990 females) were aged 65 years or older.[74] This 
represented 20.5 per cent of Australians aged 80 years or older (males 26.1 per 
cent, females 17.0 per cent). The data are illustrated in Figure IV-1. The very high 
proportion of young men, and at least 50,000 young women, who volunteered for 
military service in World War II is reflected in these data, which now include an 
increasing proportion of their bereaved spouses as war widows or widowers. 
 
Figure IV-1. DVA TPOP as a percentage of Australian population.              
Data sources: DVA Treatment Population Statistics and Australian Demography, ABS 3101.0 
2 (ii): The study population 
All TPOP members hospitalised for the first time on account of hip fracture (ICD-
10-AM S72.0 to S72.2 inclusive) between 1 July 2008 and 30 June 2009 were 
included. 
Patients with multiple injuries or malignancy were included but second hospital 
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admissions within the study year were excluded. The comparative demographics 
of the study population and those of other Australian hip fracture patients are 
shown in Figure IV-2. The much higher proportion of DVA patients aged 85 years 
or older was more pronounced in men than for women. 
 
Figure IV-2. Age-distribution of hip fracture: DVA and non-DVA 1 patients. 
1 Data source: National Hospital morbidity Database (AIHW)  
2 (iii): Data items 
The DVA databases accessed and linked for these studies were routinely 
generated by the Department essentially for billing purposes. The databases for 
public and private hospital services were provided to DVA by the health 
administrations in the various states and territories. There are no items in the 
datasets exclusive to DVA patients with the exception of services from Veterans' 
Home Care, a variant of the Home and Community Care (HACC) program.   
The following variables were included in the dataset: age, sex, fracture type, 
hospital separation status, surgery, intensive care and rehabilitation episodes, 
comorbidities and complications. ICD-10-AM codes in the hospital datasets were 
used to identify fracture type, surgical procedures, rehabilitation episodes, 
comorbidities and complications. Intensive care was identified by a service item 
descriptor. Surgical codes were accepted if they were accompanied by one of the 
codes for hip fracture. Rehabilitation codes were accepted whether treatment 
required transfer to another hospital or phase change within the same hospital. 
Codes for fracture type, procedures, rehabilitation, intensive care and 
complications were accepted for analysis if they appeared within the episode 
string for the index admission. Comorbid conditions from the 1999 revision of 
the Charlson Index [75,76] were identified from primary or secondary diagnoses 
for all hospital episodes in the study year, up to and including the episode string 
of the index admission. Itemised costs were provided for each hospital episode. 
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Fracture type was classified as cervical, trochanteric, subtrochanteric and ‘other’. 
Surgical procedures were grouped as internal fixation, hemiarthroplasty, total hip 
replacement and ‘other’. Comorbidities with significant impacts on LOS or 
patient mortality included dementia, renal failure, cardiac failure, ischaemic 
heart, renal, chronic respiratory and cerebrovascular diseases, diabetes and 
malignancy. Complications were skin (pressure) ulceration, delirium, post-
haemorrhagic or unspecified anaemia, plus urinary, lower respiratory and surgical 
site infections. The ICD-10-AM codes for all clinical variables are listed at Table 
V3-A in Section V(3). The data compilations and calculations for Objective 7 and 
Section III were sourced from AIHW and ABS tables in the public domain. 
(iv): Data linkage  
The DVA-specific linkage key was used to match relevant records at patient and 
episode level (“line-by-line” data). The process of record linkage involved firstly 
concatenation of hospital episodes for each patient to describe the total 
continuous hospital stay for hip fracture. Criteria for episode linkage were (a) the 
admission date of a subsequent episode was one day or less after the prior 
separation date, or (b) separation was to another hospital and the interval to the 
next recorded admission was seven days or less. For reasons of patient or hospital 
choice, hospital episodes may not always be billed to DVA, and such episodes do 
not appear in the DVA databases. 
Determination of episode strings and calculation of the length of the total hospital 
stay for each patient was performed by inspection of the primary database, which 
contained 9846 records. While DVA possessed an algorithm for identifying 
‘clusters’ of continuous episodes, these sometimes included hospital days for 
unrelated conditions prior to and continuous with the defined index admission 
date. Merging of data in different datasets was performed in SAS 9.2 or 9.3. [77] 
2 (v): Compilation of Master File 
Data items from the primary dataset were re-formatted to meet the requirements 
for SAS analysis. To the listed items from the hospital datasets were added, as 
binary variables: identification of pre-fracture RAC status, classification of 
fracture type, surgical procedure classification and intensive care episode, date of 
death, RAC occupancy and provision of community nursing and Veterans’ Home 
Care services (90 days, one year and two years after the index admission date), 
individual comorbid and complicating diagnoses and state of treating hospital. 
Concatenated LOS for acute, rehabilitation, other component episodes and for 
total LOS, comorbidity scores, [75, 76] and costs of hospital treatment were 
entered as continuous variables. Data for readmissions within the first year 
following the index admission and patient-specific hospital costs were included. 
The completed Excel spreadsheet contained more than 100 individual data items. 
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Section V: Research Studies 
V (1): Research Study No. 1 
Total length of stay, costs and outcomes at final discharge for admitted 
patients with hip fracture: linked episode data for Australian veterans and 
war widows 
A W Ireland and PJ Kelly 
Internal Medicine Journal 2013; 43(12): 1280–1286 
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Abstract 
Objective: To identify the total duration of hospital stay, total hospital costs and 
outcomes at final discharge for a series of Australian patients with hip fracture. 
Methods: The study was a retrospective cohort study using episode linkage 
within and between administrative databases. Study population was 2552 
Australian veterans and war widows with primary diagnosis of hip fracture 
(ICD10, 72.00–72.2) and hospital separation dates between 1 July 2008 and 30 
June 2009. The Unique Identifying Number (UIN) within Department of 
Veterans’ Affairs health service databases was used to link records for relevant 
hospital episodes as defined. Additional linkages were made with data for 
residential care admissions and date of death. 
Results: Mean length of stay (LOS) for unlinked acute episodes was 11.1 days 
and cost of hospitalisation was $A13095. Fifty-one per cent of these episodes 
ended with transfer to ongoing hospital care, 9.5 per cent were discharged to 
residential care (RAC), in-hospital mortality was 6.5 per cent and 23 per cent 
were discharged to “usual residence”. When data for all continuous episodes 
following hip fracture were combined mean LOS was 30.8 days, costs were 
$A26023 and in-hospital mortality was 11.1 per cent. Additional linkage with 
RAC records identified 38 per cent of final discharges were to RAC facilities with 
44 per cent of patients returning to independent living. 
Conclusion: For complex conditions such as hip fracture, a process of patient-
specific episode linkage is required to accurately identify hospital LOS, costs and 
patient outcomes. 
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Introduction 
The hospital management of hip fracture is a complex process for patients with 
complex clinical issues. [1] Multiple episodes of hospital care are the norm rather 
than the exception to address care needs between initial admission and eventual 
discharge. [1,2,3] 
Reports of hospital performance in respect of hip fracture which do not include 
information from all relevant hospital episodes provide an incomplete picture in 
respect of hospital resources and patient outcomes. The 2010 report on hip 
fracture by the Australian Institute of Health and Welfare noted that it could not 
track individual patients through the “hospital system” and therefore true 
outcomes could not be described. [4] The most recent Australian study which 
identifies length of stay (LOS) and hospital mortality for hip fracture patients 
describes only the acute episode of care. [5]. 
Western Australia was the first Australian jurisdiction to practice systematic 
linkage of health databases [6,7] but to date has not reported patient-based 
linkages within hospital data. The true values for LOS, cost and outcomes of 
treatment for hip fracture and other complex clinical conditions in Australian 
hospitals remain unknown. [4] Wide disparities in international reports of hospital 
performance in respect of hip fracture arise mostly from differing capacity to link 
the relevant episodes in the hospital care process. Systems which provide patient-
linked reporting include the Stockholm County Patient Care Register [8] and the 
Hospital Episodes Statistics (HES) database for the English NHS. [9] While 
reporting total LOS of 17 and 23 days respectively both reports ascribe less than 
half of the total hospital days to acute (surgical) episodes. Systems which report 
only acute episode data show median values of 5–9 days [5,10] while systems 
which incorporate rehabilitation have mean LOS of up to 44 days. [10,11] There 
are commensurate differences in hospital outcome profiles. [5,11,12,13] 
This study will demonstrate, for a cohort of elderly Australian patients, the very 
wide differences in LOS, hospital costs and patient outcome profiles between 
values derived through linkage of all relevant hospital episodes and those based 
upon unlinked data. 
Methods 
The study population was drawn from veterans, war widows and other 
beneficiaries of the Department of Veterans’ Affairs (DVA)-funded health 
services. In the study year this comprises 185985 persons (87678 males and 
98317 females) aged ≥ 75 years, being 14 per cent of this Australian demographic 
at that time. 
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Study data were drawn from DVA databases for episodes of admitted care in 
public and private hospitals. All hospital separations between 1 July 2008 and 30 
June 2009 with principal diagnosis of hip fracture (ICD10 codes 72.00–72.2) 
were identified. The following variables were extracted: Unique Identifying 
Number (UIN), age, sex, state and postcode, principal and secondary diagnoses, 
surgical procedure(s), LOS, admission and separation dates, costs and separation 
codes. A patient’s first recorded hip fracture during the study period was classified 
as the index episode. 
Episode linkage was enabled through the UIN, a numeric code assigned to every 
DVA client and attached to all entries in all DVA databases. Patient transfers both 
within and between hospitals were thereby tracked and linked from first 
admission to definitive discharge. 
An additional DVA dataset describing dates of admission to and discharge from 
residential aged care (RAC) was also linked to the hospital data through the UIN. 
Costs for hospital episodes were transcribed directly from the DVA datasets. For 
public hospitals, these costs had been calculated in accord with the National 
Hospital Cost Data Collection. [14] For private hospitals the cost was the sum of 
itemised service costs according to standard DVA schedules, or contracted 
package costs. 
Four different datasets were created: 
Dataset 1: Unlinked episodes with primary diagnosis code for hip fracture 
Dataset 2: Patient-linked episodes with primary diagnosis of hip fracture. Linkage 
was created between episodes with matching UIN, plus hip fracture diagnosis and 
interval of ≤ 1 day between separation date and next admission date. 
Dataset 3: All episodes subsequent to and continuous with the index episode. 
Criteria for linkage were: 
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(i) interval of ≤ 1 day between separation date and next admission date; the 
principal diagnosis for second and subsequent episodes was not censored; 
(ii) separation code from preceding episode identified transfer to another hospital, 
and interval to the subsequent recorded episode ≤ 7 days. 
Dataset 4. As for dataset 3 with additional linkage to the DVA database for 
residential aged care. If admission date to an RAC facility was ≤ 1 day different 
from that of final hospital discharge then the separation code for transfer to RAC 
was recorded. 
The outcomes of interest were LOS, cost and mode of separation. For the linked-
episodes datasets, LOS and cost were the summation of values for the linked 
episodes. The outcome was according to the separation code of the last linked 
episode. 
Exclusions 
At the conclusion of the linkage processes patients with aggregate LOS exceeding 
365 days were excluded. Apparent second fractures for the same patient within 
the study year, identified by time lapse of more than one week between previous 
definitive discharge and next admission coded to hip fracture, were also excluded. 
Statistical Analyses 
Student’s 2-Sample t-tests and Pearson’s Chi-square tests were conducted when 
comparing groups for continuous and categorical outcomes respectively. 
Associations between patient age, LOS and costs were examined by linear 
regression. For comparison between datasets, linear and logistic mixed models 
were used, respectively for continuous and binary outcomes, as data are paired 
according to patient. [15] All calculations were computed in Excel 2003 or 
SAS9.2. 
Ethics approval was granted by the DVA Human Research Ethics Committee in 
December 2010. 
Results 
A total of 3177 episodes coded to hip fracture was identified, representing 2552 
patients. An additional 94 episodes from 45 of these patients were identified as 
probable second fractures. Females comprised 62.4 per cent of patients, with 
mean age of 86.6 years (range 59–100). Mean age for males was also 86.6 years 
(range 54–104). 
Data for the three levels of episode linkage are summarised in Table V1-A and 
Table V1-B. For unlinked data (dataset 1), there was no significant difference 
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between mean LOS for females and males (P= 0.14). LOS increased with 
increasing age for females (P= 0.04) but not for males (P=0.25). For the complete 
study group LOS increased significantly with patient age (P=0.02). Males and 
females had similar values for episode costs (P=0.35). 
LOS and Costs 
The linked data of dataset 2 describe the acute phase of hospital management for 
hip fracture; 86 per cent of patients were treated surgically. Of the 2552 patients, 
1997 had a single acute episode coded to hip fracture, and 555 (21.7 per cent) 
shared an additional 1180 episodes, with eight patients having four linked acute 
episodes coded to hip fracture. The episode : patient ratio was 1.25 for females 
and 1.24 for males (P = 0.93). 
As before, mean values for females and males did not significantly differ in 
respect of LOS (P= 0.06) or cost (P= 0.22). The mean LOS value for all patients 
was 2.3 days greater than for unlinked episodes (95% CI 0.8–3.9, P < 0.0001) and 
the mean cost was higher by $1804 (95% CI $1372-$2236, P <0.0001). 
The complete linkage process (dataset 3) identified 5228 individual episodes for 
2552 patients of whom 1514 (59.3 per cent) shared 4190 episodes, 2051 being 
for principal diagnoses other than hip fracture. The mean episode: patient ratio of 
2.05 in this dataset was almost identical for females (2.06) and males (2.04). The 
most complex hospitalisations involved up to eight continuous episodes in up to 
five different hospitals. 
There were 1172 patients (45.9 per cent) referred for rehabilitation, for a total of 
1307 episodes. The average time in admitted care for rehabilitation was 25 days 
per patient. 
The complete process of episode linkage for the 2552 patients (dataset 3) in this 
study identified a very wide range of values (Range 1–310 days) for LOS about 
the mean of 30.8 days. 175 patients had a hospital stay of 10 weeks or more. Total 
hospital costs ranged from $680 to $194282 about the mean of $26023; 190 
patients accrued more than $50000 of hospital costs. 
The key results for all levels of episode linkage are summarised in Table V1-C. 
Hospital outcomes 
The distributions of coded outcomes for all levels of linkage are shown in Table 
V1-D. For unlinked episodes, more than half the episodes were “incomplete”, 
being transferred for further hospital care either in another hospital (43.5 per cent) 
or in another unit within the same hospital (7.4 per cent). The linkage of episodes 
coded to hip fracture (dataset 2) significantly reduced the reported rate of inter-
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hospital transfers to 35 per cent (P <0.001). The increase in identified rate of 
transfer to Aged Care was also significant (P = 0.02) as was the increased in-
hospital mortality rate (P= 0.04). 
The differences between reported values for patient outcomes in dataset 2 and 
dataset 3 were all highly significant (P< 0.0001). Essentially, when incomplete 
episodes were followed to their eventual discharge, transfers for further care were 
superseded by codes for discharge to “usual residence” or residential aged care. 
The linkage process also showed that in-hospital mortality rate for hip fracture 
was 72 per cent higher than the rate identified in unlinked data (Table V1-D). 
Linkage with Aged Care databases showed that 701 patients (27.4 per cent) had 
been RAC residents at the time of hospital admission for hip fracture. Of these 
patients, 96.6 per cent who survived hospital returned to residential care. For the 
other 1851 non-RAC patients in this study, 393 (21 %) were found to have 
transferred to RAC upon hospital discharge: 14 transfers were for short-term 
respite. 
Discussion 
Patient-based episode linkage has revealed that for this population of hip fracture 
patients the total hospital stay, total costs and short-term outcomes all differed 
widely from values based upon unlinked episodes. There is ample Australian data 
describing both acute phase care [4,5,15] for hip fracture and related rehabilitation 
episodes [16,17]. The process of transfer between these two elements has also 
been well described [18]. However patient-identified data for both elements have 
not previously been linked for a substantial, national sample in this country. 
The creation of cross-linkages between institutional databases is now not 
uncommon [19, 20]. The additional process of this study- identifying and linking 
patient-specific hospital episodes with non-hospital data- is less frequently 
attempted in population-based reports. 
This study employs data drawn from DVA administrative databases, the primary 
function of which is for reconciliation of billing. Patient identification is 
systematically matched within DVA against other Departmental datasets. These 
features, and the study criteria for defining populations and data items, meet 
published principles for minimising bias in studies using such databases [21]. 
The presence of some coding inaccuracies within administrative databases is 
endemic but the rates of such errors are no longer seen as barriers to the valid use 
of databases for either human research or policy support [22]. Recent reviews of 
Australian hospital databases have confirmed their comparatively very high 
levels of coding accuracy [23]. The level of accuracy is further enhanced in the 
process of data linkage [24] as employed in this study. 
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In the study year the DVA Treatment Population represented 13.8 per cent of 
Australians aged 75 years or older in the study year. Males comprise 37.6 per cent 
of the 2552 patients in this study, significantly higher than 27.4 per cent (P=0.004) 
of hip fracture episodes attributed to males in Australian data [4] . Mean age of 
DVA patients with hip fracture in 2008–9 was 86.6 years, compared with 83 years 
for Australian females and 81 years for males in 2006–7 [4]. Females aged 85 
years or older accounted for 79 per cent of DVA episodes compared with 62 per 
cent of non- DVA episodes (P < 0.001). Equivalent values for males aged 85 years 
or over were 28 per cent and 8 per cent respectively [15-derived]. The absolute 
values reported by this study for LOS, costs and outcome rates must be interpreted 
in the context of these demographics. 
However, it is the dimensions of the differences between results from unlinked 
and patient-linked data which this study primarily addresses. These relativities 
would appear to be generally applicable, given the similarities between matchable 
data from this study and nationally reported datasets as described below. 
For unlinked episodes in patients aged 75 years and over, LOS in this study- 10.9 
days for females and 11.4 days for males — closely matched values of 11.2 and 
11.8 days respectively for non-DVA patients.[15-derived] Costs for unlinked 
episodes in this study ($13095) compared favourably with the mean cost of 
$13012 calculated from the AIHW data for 2006–7. [4] The mean duration of 
rehabilitation in this study, 23.0 days was almost identical with the Australian 
benchmark for “orthopaedic fractures” (22.6 days) in 2009. [16] 
The average number of episodes per patient in dataset 2 was 1.25, while the 
equivalent ratio in a large series of hip fracture patients from New South Wales 
was 1.28 (Taylor, NSW Health Ministry, personal communication). The lack of 
significant age or gender gradients in the DVA ratios would minimise any 
potential distortions due to demographic differences. 
For dataset 3 no attempt was made to censor the principal diagnoses for episodes 
continuous with the index episode. The wide spectrum of clinical conditions — 
post-acute care, complications or co-morbidities — contribute to a diversity of 
hospital care for hip fracture. [1,3] The allowed interval of ≤ 7 days between an 
episode ending in transfer to another hospital and a subsequent episode reflects 
the uncommon occurrence of episodes not billed to DVA and thus not recorded 
in DVA databases. 
The management of hip fracture frequently involves an emergency hospital 
admission in which diagnosis is established, with prompt transfer to another 
episode for definitive (usually surgical) treatment. In this study, 439 of 506 
episodes (87 per cent) with LOS ≤ 2 days and separation codes other than death, 
were transferred to another hospital. 
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Comparative international reports of LOS for hip fracture vary widely. The 
Stockholm County Patient Care Register for 2007 identified total LOS of 17.3 
days, comprising 7.0 days for acute phase care and 10.3 days for rehabilitation. 
[8] Another Swedish study reported 11.3 days for acute phase care and 27.9 days 
for ‘‘total hospitalisation”. [25]. French data for 2005–6 identified 16.2 days in 
acute phase care followed by 27.8 days in rehabilitation. [11] The Hospital 
Episodes Statistics (HES) for English NHS reports hospital “spells” of linked 
episodes under different consultants. These data describe LOS of 23.0 days for 
hip fracture in 2008–9, a value which appears to include inpatient rehabilitation, 
as such episodes are not separately reported in any numbers. Data for private 
hospitals were “mostly excluded” from this report. [8] A Japanese study reports 
LOS of 34 days and notes a marked contrast with the median of only 5 days 
reported from the United States. Hospital stay in Japan was inclusive of post-
acute care, whereas the American data related purely to acute surgical treatment. 
[10] Scottish data from 2006 reported a mean of 25 days for total LOS, linking 
orthopaedic, rehabilitation and ‘other’ episodes, but this calculation excluded ‘‘at 
least a quarter’’ of patients who were still in hospital at 42 days. [26] 
Recently reported in-hospital mortality rates are similarly diverse. In Australia 
the national data presented by AIHW for 2006–7 reports 6 per cent, [4] while a 
series from a Sydney teaching hospital shows 4.9 per cent for 2003–7. [5] The 
French Hospital National Data identifies deaths for only 2.8 per cent of patients 
aged 40+ years in 2008. [11] These figures all relate to data which describe 
unlinked episodes for acute treatment. Hospital mortality reported in the HES for 
the period 2006–8 was 13.7 per cent based upon linked episodes. [22] 
The differences in profiles of hospital separations between unlinked and episode-
linked datasets are substantial. Overall in-hospital mortality increased to 11.1 per 
cent from 6.5 per cent in unlinked data and the very high proportion of inter-
hospital transfers in unlinked data is almost entirely replaced by discharges to 
“home” or residential aged care in fully linked results. The additional linkages 
with Aged Care data produced, in this elderly cohort, substantial revision of 
separation codes with transfers to Aged Care increasing from 20.0 to 37.8 per 
cent. 
In an elderly and medically complex patient cohort, extra days in hospital are 
associated with additional untoward outcomes. Quoted rates for hospital 
mortality and other outcomes for hip fracture may be more dependent upon the 
definition of “separation from hospital” than upon standards of practice within a 
given hospital system. 
Conclusion 
A process of patient-based episode linkage to identify the total hospital stay and 
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definitive outcomes in respect of hip fractures is presented. Two-thirds of the 
study population experienced transfer from acute phase episodes for ongoing 
admitted care., with 46 per cent of all patients referred for rehabilitation. Total 
LOS was 30.8 days, almost three times the value for unlinked data (11.1 days). 
Hospital costs were almost double the values identified in unlinked data. In-
hospital mortality was shown to be higher by over 70 per cent, and transfer to 
RAC was four times more frequent than the values obtained from conventional 
reports based upon unlinked data. One in nine of these elderly patients did not 
survive hospital and more than 40 per cent of survivors were transferred to Aged 
Care facilities. 
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Table V1-A. Length-of-stay (LOS) for patients with hip fracture 
2008–09 
 
Dataset 1 
Unlinked Episodes 
Dataset 2 
Linked acute episodes 
Dataset 3 
All Linked Episodes 
 
Age N LOS1 N LOS N LOS 
 
Females 
 
< 75 27 10.0 20 11.9 20 24.3  
75–79 115 10.2 89 13.0 89 27.0  
80–84 523 10.6 415 12.8 415 33.1  
85–89 812 10.9 644 13.5 644 32.0  
≥ 90  506 11.5 424 13.0 424 28.2  
TOTAL 1983 10.9 1592 13.1 1592 30.9 
 
Males 
 
< 75 34 9.3 28 11.4 28 23.7  
75–79 25 10.3 21 12.3 21 25.2  
80–84 242 10.7 191 13.5 191 31.2  
85–89 595 12.0 470 14.7 470 32.5  
≥ 90  298 11.1 250 12.9 250 27.5  
TOTAL 1194 11.4 960 13.9 960 30.5 
 
ALL 3177 11.1 2552 13.4 2552 30.8 
 
1 Mean LOS in days 
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Table V1-B. Hospital Costs for patients with hip fracture 2008–09 
 
Dataset 1 
Unlinked episodes 
Dataset 2 
Linked acute episodes 
Dataset 3 
All linked episodes 
 
Age N $AUD N $AUD N $AUD 
 
Females 
 
< 75  27 12354 20 13568 20 22521  
75–79 115 12938 89 15698 89 25660  
80–84 523 12916 415 14804 415 27045  
85–89 812 12948 644 14826 644 26593  
≥ 90  506 13411 424 14613 424 24303  
TOTAL 1983 13049 1592 14797 1592 25998 
 
Males 
 
< 75 34 12237 28 14223 28 21018  
75–79 25 12653 21 15545 21 22511  
80–84 242 12287 191 13928 191 26037  
85–89 595 13515 470 15446 470 27326  
≥ 90 298 13362 250 15289 250 24581  
TOTAL 1194 13174 960 15068 960 26065 
 
ALL 3177 13095 2552 14899 2552 26023 
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Table V1-C. Summary of LOS and hospital costs for linked and 
unlinked datasets 
Dataset Females (95 % CI) Males (95 % CI) All (95 % CI) 
 
Mean Length of stay (days) 
 
Unlinked 10.9 10.5–11.4 11.4 10.7–12.0 11.1 10.7–11.5  
Acute episodes1 13.1 12.6–13.7 13.8 13.1–14.6 13.4 12.9–13.8  
Total episodes 30.9 29.6–32.2 30.5 28.9–32.2 30.8 29.8–31.8  
Hospital costs ($AUD) 
 
Unlinked 13047 12687–13407 13174 12652–13696 13095 12797–13393  
Acute episodes1 14797 14431–15163 15068 14424–15612 14899 14592–15206  
Total episodes 25998 25195–26801 26085 24996–27134 26023 25381–26665  
1 Linked acute episodes, Dataset 2 
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Table V1-D. Distribution of separation codes: unlinked and linked 
data for patients with hip fracture 2008–09 
Separation mode 
Dataset 1 
Unlinked 
Dataset 2 
acute episodes1 
Dataset 3 
All episodes 
Dataset 4 
Linked to 
RAC 
 
Females n=1983 n=1592 n=1592 n=1592 
 
Transfer other hospital  46.22 38.4 5.9 3.1  
Transfer within hospital 6.9 7.0 1.4 1.2  
Transfer to Aged Care 9.9 11.6 21.4 39.6  
Death 4.3 5.3 7.7 7.6  
Home discharge 23.2 26.5 59.5 45.0  
Other 9.5 11.2 4.2 2.6  
Males N=1184 n=960 n=960 n=960 
 
Transfer other hospital  39.2 29.6 4.1 2.1  
Transfer within hospital  8.2 8.4 0.2 0.3  
Transfer to Aged Care 8.8 10.5 17.8 34.8  
Death 10.2 12.7 17.2 16.9  
Home discharge 22.6 25.5 56.5 42.3  
Other 11.0 13.3 4.3 3.7  
All n=3177 n=2552 n=2552 n=2552 
 
Transfer other hospital  43.5 35.0 5.2 2.7  
Transfer within hospital 7.4 7.6 0.9 0.9  
Transfer to Aged Care 9.5 11.2 20.0 37.8  
Death 6.5 8.1 11.2 11.1  
Home discharge 23.0 26.1 58.4 44.0  
Other 10.1 12.0 4.2 3.5  
1 Linked acute episodes, Dataset 2 
2 All values are percentages of total separations 
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Abstract 
Background: Hospital treatment for hip fracture is complex, often involving 
sequential episodes for acute orthopaedics, rehabilitation and care of contingent 
conditions. Most reports of hospital length of stay (LOS) address only the acute 
phase of care. This study identifies the frequency and mean duration of the 
component episodes within total hospital stay, and measures the impacts of 
patient-level and clinical service variables upon both acute phase and total LOS. 
Methods: Administrative datasets for 2552 subjects hospitalised between 1 July 
2008 and 30 June 2009 were linked. Associations between LOS, pre-fracture 
accommodation status, age, sex, fracture type, hospital separation codes, selected 
comorbidities and complications were examined in regression models for acute 
phase and total LOS for patients from residential aged care (RAC) and from the 
community. 
Results: Mean total LOS was 30.8 days, with 43 per cent attributable to acute 
fracture management, 37 per cent to rehabilitation and 20 per cent to management 
of contingent conditions. Community patients had unadjusted total LOS of 35.4 
days compared with 18.8 days for RAC patients (p <0.001). The proportion of 
transfers into rehabilitation (57 per cent vs 17 per cent, p <0.001) was the major 
determinant for this difference. In multivariate analyses, new RAC placement, 
discharge to other facilities, and complications of pressure ulcer, urinary or 
surgical site infections increased LOS by at least four days in one or more phases 
of hospital stay. 
Conclusion: Pre-fracture residence, selection for rehabilitation, discharge 
destination and specific complications are key determinants for acute phase and 
total LOS. Calculating the dimensions of specific determinants for LOS may 
identify potential efficiencies from targeted interventions such as orthogeriatric 
care models. 
Keywords: hip fracture, length of stay, complications, residential aged care, 
rehabilitation 
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Introduction 
The hospital treatment of hip fractures is a complex process involving multiple 
services [1,2]. Following initial assessment, acute phase treatment is usually 
surgical, sometimes in a different hospital. Definitive discharge from the acute 
unit to the patient’s previous accommodation is the exception [2,3,4]. Transfer to 
another service for rehabilitation occurs in almost half of all cases [4,5] and 
transfers between hospital units for other reasons are not uncommon [4,6]. 
The traditional pattern of acute orthopaedic care followed by selective referral to 
rehabilitation or other aftercare is now frequently replaced by a variety of shared 
care models, with involvement of specialist geriatric and/or rehabilitation teams 
in the acute phase, or accelerated transit from the surgical ward to rehabilitation 
services [3,7,8]. Despite these developments, most reports of hospital stay for hip 
fracture describe only the acute surgical phase of treatment. This phase has a wide 
range of reported LOS from two days to more than two weeks [8,9]. In the few 
studies which report total LOS, mean values lie between 17 days and six weeks 
[3,9,10,11]. Total LOS for the current study has been previously reported at 30.8 
days [4]. 
A wide variety of factors, including patient age [12], fracture type [3], 
preoperative delay [13] and specific comorbid conditions and complications[14] 
have been shown to impact the length of either acute phase or total LOS. 
However, the actual increase or decrease in LOS attributable to patient-level 
factors is rarely calculated, and then only for the acute phase of care [14]. 
The significance of residence in aged care institutions for risk factors and 
outcomes of hip fracture has been well described [15,16]. Less well documented 
is the impact of prior living status upon the duration and composition of hospital 
stay. 
This study has two aims. First, to identify the proportion of total hospital stay due 
to acute phase treatment, rehabilitation and the management of contingent 
problems. Second, to identify and quantify the patient-related and clinical service 
factors associated acute phase and total LOS. For both aims, pre-fracture 
residential status is a major consideration. 
Methods 
Episode-based datasets were obtained from the Australian Department of 
Veterans’ Affairs (DVA) for all veterans and war widows hospitalised for hip 
fracture (ICD-10-AM S72.0-S72.2) between 1 July 2008 and 30 June 2009. The 
Unique Identification Number (UIN) attached to every DVA record permitted 
linkage of continuous hospital episodes for individual patients, as well as linkage 
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with RAC datasets and mortality records. Additional details of the data linkage 
process have been described previously. [4] 
Subjects were identified as community-dwelling or as residents of RAC facilities 
at the time of fracture and hospital admission. In Australia, defined reductions in 
capacity for activities of daily living and/or cognitive functionality, are statutory 
criteria for admission to RAC facilities, which include nursing homes.[17] 
Data Collection 
Hospital episodes contributing to total LOS were classified into three components 
— acute, rehabilitation and “other”. The acute phase included all episodes 
continuous with the index admission date with a primary diagnosis of hip fracture 
(ICD10-AM: S72.0-S72.2). The rehabilitation phase was the sum of all episodes 
coded (Z50.8-Z50.9) which were part of a continuous sequence of episodes 
following the index episode. The third component included all other episodes 
which were likewise in a continuous sequence following the index episode. These 
included care for comorbidities and complications or hospital time awaiting 
placement elsewhere. Every patient had an acute phase, but may or may not have 
had a rehabilitation or other phase. 
The following variables were included in the dataset: pre-admission residential 
status (RAC or community), age, sex, fracture type, separation status (for each 
phase), clinical services (rehabilitation, intensive care, surgery), comorbidity and 
complications. Fracture type was classified as cervical (S72.01-72.04), 
trochanteric (S72.05, S72.10-72.11), subtrochanteric (S72.2) and ‘other’ (S72.00, 
S72.08). The dataset also included the comorbidities listed in the Charlson Index 
as modified for ICD-10-AM [18].This information was extracted from all hospital 
episodes in the study year, up to and including the episode(s) comprising total 
LOS for the index hip fracture. Complications of skin ulceration (L89, L97), 
delirium (F05), anaemia (D62, D64.9), and urinary (N39), lower respiratory (J13-
J15, J18, J20-22) and surgical wound (T81.4, T84.5-7) infections were also 
identified, due to associations with either LOS or unwanted outcomes following 
hip fracture. [2,13,19] Complications were identified only from those episodes 
comprising total LOS for the index fracture. 
Hospital separation Code 9 — “separation to usual residence” or “other” — was 
interpreted as transfer to RAC if the patient had been in such care immediately 
prior to the index hospital admission. If hospital discharge and subsequent RAC 
admission dates were continuous, then transfer was also assumed regardless of 
the separation code. Details of the level of care provided within RAC for a given 
patient were not consistently available and were not analysed. 
Since patients admitted from RAC or similar forms of supported living have 
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different hospital trajectories from those who admitted from the community, [12, 
20, 21] data are tabulated and analysed separately for these two groups. 
Statistical analyses 
Student’s t-test and Pearson’s Chi-squared test were used to assess differences in 
groups for continuous and categorical outcomes respectively. Total LOS, acute 
phase, rehabilitation phase and other phase LOS were tabulated for both RAC 
and community patients. Negative binomial regression models were then used to 
identify variables which significantly altered the length of acute phase and total 
LOS. Variables entered the model if univariate P <0.25 and, using backward 
elimination, remained in the final model if P<0.05. For each variable in a final 
model, the average number of days greater or less than the baseline value (mean 
LOS when all predictor variables are zero or the referent group within a class 
variable) was calculated. All analyses were performed using SAS 9.3 (SAS 
Institute Inc; Cary, NC) or Excel 2010 (Microsoft Corporation, Redmond, WA). 
Ethics approval was granted by the DVA Ethics Committee in December 2010. 
Results 
There were 2552 patients hospitalised for hip fracture between 1 July 2008 and 
30 June 2009. Linkage with RAC databases identified 27.7 per cent of patients as 
aged care residents at the time of hospital admission. Table V2-A summarises the 
patient characteristics of the two sub-populations. There was a higher proportion 
of RAC patients aged 90 years or older (37 per cent vs 22 per cent, p < 0.001). 
The proportions of females, the distributions of fracture types and the proportions 
treated surgically were not significantly different. A greater proportion of 
community patients was admitted to Intensive Care (7.4 per cent vs 5.1 per cent, 
p = 0.035). Comorbidities and complications were similarly distributed apart 
from dementia (43.1 per cent vs 14.6 per cent, p < 0.001) and respiratory infection 
(12.3 per cent vs 9.1 per cent, P=0.015). The proportion of transfers to 
rehabilitation was more than three times greater among community patients (57 
per cent vs 17 per cent, p < 0.001). 
Components of LOS 
For the total study population, 43 per cent of total LOS was attributable to acute 
fracture management, 37 per cent to rehabilitation and 20 per cent to other causes. 
Mean LOS values for the various components are shown in Table V2-B. There 
were 29012 hospital days for rehabilitation (1172 patients) and 15415 hospital 
days for “other” episodes (652 patients) out of the grand total of 78592 days. 
The acute phase of care was significantly longer (14.1 days vs 11.6 days, p < 
0.001) for community patients than for RAC patients. Both the proportion of 
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patients transferred to rehabilitation and the total time in rehabilitation phase 
(25.1 vs 21.3 days) were significantly higher for community patients. The 
resulting per capita contribution to total LOS was (1050* 25.1/1844) =14.3 days 
for community patients and (122*21.3/708) = 3.7 days for patients from RAC 
(data in Table V2-B). 
Linked hospital episodes attributed to neither acute fracture care nor 
rehabilitation occurred in 652 patients (26 per cent) and again in a higher 
proportion of community patients (28 % vs 19 %, p < 0.001). Total stay in “other” 
episodes was also longer for community patients, especially among those not 
transferred to rehabilitation. 
Factors which impact upon LOS 
The factors which significantly affected the acute phase of hospital stay are shown 
in Table 3. The length of the acute phase was not significantly affected by patient 
age, sex or fracture type within either sub-group, but age had a minor effect in the 
combined population. For RAC patients the acute phase was substantially 
increased by surgical treatment, admission to intensive care and by complications 
of skin ulceration and infections, particularly in the fourteen patients with surgical 
site sepsis. No listed comorbid condition had any significant impact in this group. 
For community patients, direct transfer to RAC extended the acute phase by six 
days. Cardiac failure, skin ulceration, respiratory and urinary infections were all 
associated with increases of at least 20 per cent of the baseline value, and diabetes, 
stroke and delirium by significant but lesser amounts. Community patients who 
died or were transferred to rehabilitation or other units had shorter acute phases 
(Table V2-C). 
The baseline value of total LOS for RAC patients was more than doubled for 
patients who received rehabilitation and by separation to a hospital or other 
facility (Table V2-D). Intensive care admission, and surgical site sepsis were also 
associated with increases exceeding 50 per cent of baseline value while increases 
of 20 per cent or more were associated with surgery, skin ulceration and urinary 
infection. Neither sex, age, fracture type nor any specific comorbidity impacted 
total LOS for RAC patients. 
Among community patients, those aged between 80 and 89 years had longer stay 
than both younger and older patients (Table V2-D). Patients with intracapsular 
fractures had shorter total stay than those with other injuries. The increase 
associated with rehabilitation was over 60 per cent of the baseline value. 
Discharge to RAC or to other facilities, Parkinsonism, skin ulceration and 
surgical site sepsis were all associated with increases of at least 30 per cent. 
Community patients who died had a shorter total LOS. In the complete sample 
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patients with dementia had a small reduction in total LOS but this was not evident 
within either sub-population (Table V2-D). 
There were 763 episodes for management of conditions not coded to hip fracture 
or rehabilitation (652 patients). Sex, age and fracture type were not substantial 
determinants of LOS in this category. Diabetes, chronic respiratory disease, 
Parkinson’s disease, anaemia and “awaiting accommodation in another facility” 
(ICD10 -AM, Z751) were the most frequently identified reasons for episodes in 
this category (data not tabulated). 
The impact of multiple LOS determinants is compound: a community patient 
aged 85 – 89 years, with subtrochanteric fracture, complications of leg ulcer and 
wound infection, transferred to rehabilitation and eventually discharged to RAC 
would have a calculated total LOS of 92 days. 
Discussion 
This study has employed data linkage to identify three key findings for hospital 
management of hip fracture. First, the majority of hospital days (57 per cent) 
occurred after the acute phase, as observed in other studies. [3, 13] Secondly, total 
LOS for patients admitted from RAC was approximately half that of those 
admitted from the community. Thirdly, referral to hospital-based rehabilitation 
effectively doubles the total LOS. 
Factors impacting LOS 
The value of assessing the complete hospital experience is evident in the differing 
profiles of determinant factors for LOS for acute phase and total stay. Age and 
fracture type do not influence acute LOS but are significant factors for total stay. 
Transfers to other treating facilities, including rehabilitation, facilitate separation 
from the acute phase but result in substantially longer total LOS. Parkinsonism, 
diabetes and anaemia have no significant impacts on acute stay but are associated 
with longer total LOS. The reverse situation is seen in respect of cardiac failure. 
These variations are mostly due to differing rates of transfer to rehabilitation, and 
hospital episodes due to “other” causes. Surgery prolonged the acute phase as in 
English data, [22] however a prolonged total stay was seen only among RAC 
patients. 
The shorter stay for patients aged under 80 years reflected the findings of other 
studies,[23] but unlike Scottish findings, patients aged over 90 years did not stay 
longer than octogenarians.[12] Fewer transfers to rehabilitation among the oldest 
patients was again the probable reason. Additional post-acute days and longer 
total stay for patients with trochanteric and subtrochanteric, compared with 
intracapsular fractures, reflect data from the Finnish Health Care Register. [3] 
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It is customary in Australia for rehabilitation after hip fracture to involve transfer 
to a dedicated hospital unit or hospital, removed from the acute facility. [23] 
These transfers, while including some days of inappropriate acute care, [23] still 
resulted in reduced LOS in acute units, as do transfers to other facilities. Surgery 
prolonged the acute phase as in English data, [24] however a prolonged total stay 
was seen only among RAC patients. Admission into intensive care extended both 
acute phase and total LOS by more than 60 per cent for RAC patients but had no 
impact for community patients. 
Of the selected comorbidities, cardiac failure and stroke in respect of acute phase 
and Parkinsonism and diabetes for total LOS were the only associations with 
substantially longer stay. The complications listed in Tables 3 and 4 were more 
potent in extending hospital time, particularly skin (pressure) ulceration and 
surgical site (wound) infections, both responsible for >30 per cent increase in 
acute and total LOS. 
Both these conditions have been associated with considerable increases in LOS 
in other studies [25, 26] but not examined in comprehensive multivariate models. 
Systems of co-managed (orthogeriatric) care, [7] resourced to promptly recognise 
and manage comorbidity and complications have been shown to reduce acute 
phase LOS, costs and the incidence of unwanted outcomes. [7,8,20] In 
quantifying the impact of LOS determinants at specific phases of the hospital 
experience, this study gives dimensions to potential benefits in both costs and 
reduced morbidity through timely interventions. 
Pre-fracture residence 
Residential status prior to hip fracture is variously defined and variably reported. 
[13,20,21] Some studies exclusively address RAC patients, [27] others exclude 
them [23,28] and many do not identify pre-fracture residence.[10,24] The 
findings of this study suggest that knowledge of pre-fracture residential status is 
vital to the understanding of the hospital trajectory for hip fracture. While other 
studies have previously noted a comparatively short LOS for RAC patients in the 
acute phase [13, 20, 29) and similarly for “total institutional days”, [13, 27] LOS 
in all phases of hospital stay were shorter for these patients in this study. 
The difference in the acute phase was greatest (11.7 to 17.0 days, p <0.001) for 
patients who did not transfer to rehabilitation. Immediate access to post-hospital 
accommodation for RAC patients was the probable reason. [28] Hospital episodes 
for “other” reasons (comorbidities or complications) were fewer and shorter for 
RAC patients. Most of the difference in total LOS between RAC and community 
patients was attributable to the greater than threefold difference in rates of 
hospital-based rehabilitation. This large difference parallels findings from the 
Scottish Hip Fracture Audit. [29] 
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The linkage of hospital and RAC datasets is regarded as vital to the accurate 
interpretation of separation codes and hence LOS data for hip fracture patients. 
In this study 14.4 per cent of all discharges were re-classified as transfers to RAC 
after examining linked data [4]. RAC patients returning to institutional care have 
low hospital stay [29] whereas community patients requiring new RAC 
placements have shown significantly longer stays than those who return to non-
institutional living. Lower LOS values for patients with dementia in a large 
Australian study [30] possibly reflect the high proportion of institutional patients 
in the dementia group, who do not transfer to rehabilitation but have expedited 
discharges back to RAC. 
Strengths and weaknesses 
Administrative databases have intrinsic strengths and weaknesses for studies of 
this nature. Large patient numbers and a comprehensive list of data items are 
major assets. Current levels of coding and transcription errors are now regarded 
as acceptable for meaningful analyses of diagnostic and procedural data, with 
reported accuracy rates as high as 96 per cent. [31] The evidence of this study 
suggests that separation codes in Australian hospital databases require further 
scrutiny. [4] The linkage facility of DVA records enabled measurement of total 
LOS, a wide search field for comorbidities, accurate matching of RAC status with 
fracture events and alignment of specific variables with components of LOS. 
The principal disadvantages include the lack of information regarding disease 
severity, pre-fracture functional status and preoperative waiting time. Australian 
admission criteria make pre-fracture RAC residency at least a partial surrogate 
for poor functionality [17] and pre-operative delay is partly due to medical 
complexity [32] as reflected in comorbidity profiles. 
The mean age of hip fracture patients in this study was up to 6 years greater than 
elsewhere reported. [3,10,24] The proportion of males was 37.6 per cent, 
compared with 25- 30 per cent in other population-based studies. [3,10,30] These 
differences were reflected in a higher proportion of patients from RAC than 
reported from a large Scottish sample (27.7 per cent vs 21.3 per cent). [29] DVA 
patients did not appear to use hospital services differently from other Australians 
of comparable age. [4] The distribution of fracture type was unremarkable [3, 5] 
after 380 “unspecified or unknown” fractures (S72.00, S72.08) were 
proportionally reclassified. 
With respect to comorbidities, this study identified higher rates for diabetes, 
cardiac and respiratory conditions than those drawn from the English Hospital 
Episode Statistics. [24] 
A large database study from New South Wales, Australia found dementia in 35.9 
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per cent of hip fracture patients aged ≥ 85 years. [30] In this study the comparable 
prevalence was 31.8 per cent (p =0.03), based upon less extensive data 
surveillance. We acknowledge that there were substantial levels of false negatives 
for some other key diagnoses. Targeted studies of clinical records reported 
delirium in between 29 and 50 per cent of hip fracture patients [33,34] and 
pressure ulcers in more than one third [35], both approximately three times the 
rates found in this study. However, comorbidity capture from linked episode data 
is substantially superior to that derived from acute episodes alone. [36] 
It is also recognised that the characteristics of individual hospitals or groupings 
of hospitals may contribute to differences in LOS. In this study 476 different 
treating hospitals were identified by code, but no information as to hospital 
characteristics was provided. More than half of all patients were treated in more 
than one hospital, with nine per cent treated in three or more hospitals. Identifying 
hospital-level determinants for LOS was therefore not attempted. 
Conclusion 
Hip fracture patients admitted from residential care or from the community have 
widely different component and total LOS, for which the threefold difference in 
rates of transfer to rehabilitation is the major determinant. New transfer to RAC, 
other inter-facility transfers, Parkinsonism, pressure ulcers, and urinary and 
wound infections all increased LOS by at least 4 days or 25 per cent of baseline 
values at some phase of the hospital stay. Multiple factors associated with 
increased LOS had an exponential effect. These data give dimensions to potential 
resource efficiencies and reduced patient morbidities through targeted 
intervention, and emphasise the importance of specialist medical care during the 
acute surgical management of hip fracture patients. The additional insights 
provided by data linkage in studies of complex conditions are also evident. 
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Table V2-A. Characteristics of study cohort by pre-fracture 
residential status 
 Community patients 
(N=1844) 
RAC patients 
(N=708) 
All patients 
(N=2552) 
 N % N % N % 
Females 1148 62.3 444 62.7 1592 62.4 
Age group 
< 80 138 7.5 20 2.8 158 6.2 
80–84 465 25.2 141 19.9 606 23.7 
85–89 832 45.1 282 39.8 1114 43.7 
90 + 409 22.2 265 37.4 674 26.8 
Fracture type 
Cervical 712 38.6 269 38.0 981 38.4 
Trochanteric 781 42.4 300 42.4 1081 42.4 
Subtrochanteric 86 4.7 24 3.4 110 4.3 
Other, unspecified 265 14.4 115 16.2 380 14.9 
Rehabilitation 1050 56.9 122 17.2 1172 45.9 
Surgical treatment 1543 83.7 611 86.3 2154 84.2 
Intensive care 137 7.4 36 5.1 173 6.8 
Comorbidities 
Dementia 269 14.6 305 43.1 574 22.5 
Renal failure 253 13.7 96 13.6 349 13.7 
Cardiac failure 231 12.5 104 14.7 335 13.1 
Cardiac ischaemia 191 10.4 70 9.9 261 10.2 
Diabetes 178 9.7 69 9.7 247 9.7 
Respiratory disease 156 8.5 60 8.5 216 8.5 
Stroke 108 5.9 53 7.5 161 6.3 
Malignancy 131 7.1 30 4.2 161 6.3 
Parkinson’s Disease 48 2.6 26 3.7 74 2.9 
Complications 
Urinary infection  315 17.1 119 16.8 434 17.0 
Skin ulceration 268 14.5 99 14.0 367 14.4 
Anaemia 253 13.7 113 16.0 366 14.3 
Chest infection 167 9.1 87 12.3 254 10.0 
Delirium 166 9.0 80 11.3 246 9.6 
Wound infection 49 2.7 14 2.0 63 2.5 
Separation status 
Private dwelling 1106 60.0 14 2.0 1120 44.7 
RAC 391 21.2 575 81.2 966 37.1 
Hospital, other 71 9.3 12 1.7 183 7.0 
Death 176 9.5 107 15.1 283 11.2 
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Table V2-B. Unadjusted mean values for components of total LOS for 
hip fracture. The impact of pre-fracture residential status and 
referral to rehabilitation 
 Community patients RAC Patients All patients 
Phase N 
Mean LOS 
(days) 
N 
Mean LOS 
(days) 
N 
Mean LOS 
(days) 
All admissions 
Acute 1844 14.1 708 11.6 2552 13.4 
Rehabilitation 1050 25.11 122 21.3 1172 24.8 
Other 519 24.91 133 18.6 652 23.6 
Combined phases 1844 35.41 708 18.8 2552 30.8 
Admissions which include rehabilitation 
Acute 1050 11.8 122 10.9 1172 11.7 
Rehabilitation 1050 25.1 122 21.3 172 24.8 
Other 272 20.8 37 16.3 309 20.2 
Combined phases 1050 42.3 122 37.2 1172 41.7 
Admissions without rehabilitation 
Acute 794 17.0 586 11.8 1380 14.8 
Other 247 29.5 96 19.4 343 26.7 
Combined phases 794 26.2 586 14.9 380 21.4 
1 Mean LOS for combined phases (total LOS) = weighted average from each 
 component. For community patients = 
 ((1844 × 14.1) + (1050 × 25.1) + (519 × 24.9)) ÷ 1844 = 35.4 days 
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Table V2-C. Factors associated with acute phase LOS after hip 
fracture 
 Community patients N=1844 Patients from RAC N=708 
 
Added 
days1 
95 % CI P 
Added 
days 
95 % CI P 
Baseline LOS2 12.4   7.3  
Sex 0.9 (0.1–1.8) 0.029  - - 
Separation mode   <0.001   - 
Usual residence  referent   - - 
New RAC 
transfer 
6.0 (3.6–8.7)     
Rehabilitation -3.2 (-3.9, -2.5)     
Other transfer -1.2 (-2.4, 0.0)     
Death -2.0 (-3.3, -0.4)   -  
Surgery 1.3 (0.1–2.5) 0.027 3.0 (1.6–4.6) <0.001 
Intensive care  - - 4.6. (2.3–7.5) <0.001 
Comorbidities       
Cardiac failure 2.8 (1.5–4.3) <0.001  - - 
Diabetes 1.8 (0.4–3.4) 0.009  - - 
Stroke 2.4 (0.6–4.5) 0.006  - - 
Complications       
Delirium 2.2 (0.6–40) 0.006  - - 
Pressure ulcer  5.4 (34–7.5) <0.001 3.2 (1.4–5.3) <0.001 
Chest infection 3.1 (1.2–5.3) 0.001 1.9 (0.6–3.5) 0.003 
Urinary infection 2.9 (1.4–4.4) <0.001 2.8 (1.5–4.4) <0.001 
Wound infection - - - 12.3 (6.0–21.7) <0.001 
1 Mean addition to baseline value 
2 LOS for female <80 years: cervical fracture, no surgery, rehabilitation, 
 intensive care, comorbidity or complications; separated to usual residence 
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Table V2-D. Factors associated with LOS for total hospital stay after 
hip fracture 
 Community patients N=1844 Patients from RAC N=708 
 
Added 
days1 
95 % CI P 
Added 
days 
95 % CI P 
Baseline LOS2  14.8   10.2  
Age-group   0.001  -  
<80  referent   -  
80–84 3.5 (1.4–5.9)   -  
85–89 3.6 (1.6–5.8)   -  
90 + 2.1 (0.1–4.3)    – 
Fracture type   <0.001  -  
Cervical  referent   -  
Unspecified 4.3 (2.7–6.1)   -  
Subtrochanteric 3.1 (0.7–5.8)   -  
Trochanteric 2.0 (0.9–3.1)    <0.001 
Separation mode   <0.001    
Usual residence  referent   referent  
Other transfer 4.7 (2.8–6.9)  18.3 (8.8–32.7)  
New RAC transfer 5.1 (3.7–6.7)  N/A N/A  
Death -2.7 (-4.0, -1.3)  -0.5 (-1.9, 1.1) <0.001 
Rehabilitation 9.9 (8.4–11.4) <0.001 13.9 (10.8–17.4) 0.009 
Surgery – –  2.4 (0.6–4.5) <0.001 
Intensive care – –  7.9 (4.1–12.7)  
Comorbidities       
Parkinson’s disease 5.7 (2.3–9.7) <0.001  –  
Diabetes 2.5 (0.9–4.3) 0.002  –  
Dementia 1.7 (0.0–3.5) 0.04  –  
Complications  –     
Pressure ulcer 5.6 (4.0–7.4)  3.7 (1.7–5.9) <0.001 
Wound infection 4.9 (1.7–8.8) <0.001 5.9 (0.9–13.0) 0.010 
Urinary infection 2.8 (1.5–4.3) 0.001 4.2 (2.4–6.4) <0.001 
Delirium 1.9 (0.4–3.7) <0.001 1.9 (0.1–4.1) 0.04 
Chest infection 2.7 (1.0–4.5) 0.02 – –  
1 Mean addition to baseline value 2 LOS for female <80 years :cervical fracture, no 
 surgery, rehabilitation, intensive care, comorbidity, complications; separated 
 usual. 
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Abstract 
Background and Aims 
One-year mortality after hip fracture may exceed 30 per cent with a very large 
number of reported risk factors. Determinants of mortality beyond one year are 
rarely described. This study employs multiple data linkages to examine mortality 
rates, risk factor profiles and age-specific excess mortality at intervals from 30 
days to four years. 
Method 
Retrospective cohort study of linked administrative datasets describing hospital 
episodes, residential aged care (RAC) admissions and date of death for 2552 
Australian veterans and war widows hospitalised for hip fracture in 2008–09. 
Associations between time to death and patient age, sex, pre-fracture 
accommodation, fracture type, treatment options, selected comorbidities and 
complications were tested in Cox proportional hazards models. 
Results 
In a population with mean age of 86.6 years (range 54–100 years), overall death 
rate was 11 % at 30 days, 34 % at one year, 47 % at two years and 67 % after four 
years. For males hospitalised from RAC one-year mortality was 72 %, contrasting 
with 19 % for females from the community. Cancer, cardiac failure, 
cerebrovascular and renal disease were each associated with increased mortality 
risk of 20–60 %t at one year. Above-expected age-specific mortality was 
sustained for four years except for males ≥ 90 years. 
Conclusion 
Pre-fracture RAC residence was the strongest determinant factor for mortality. 
Patients selected for rehabilitation had lower mortality rates. The profiles of 
explanatory variables for death altered with increasing time from the index 
fracture event. 
Keywords 
Hip fracture, mortality, residential aged care, comorbidity, comparative mortality 
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Introduction 
An increased mortality rate following hip fracture is beyond dispute. [1.2] There 
is however a wide variation in reported mortality rates at 30 days, one-year and 
subsequently. International population based studies report one-year mortality 
rates between 22 and 31 %, [3–6] and higher in some smaller series.[7] Identified 
risk factors for mortality are numerous, but the selection and definition of 
determinant variables are both inconsistent.[8] 
Study datasets are derived from sources as diverse as single hospitals, meta-
analyses and national databases covering multiple years. [2, 9, 10] Exclusion 
criteria, such as minimum age, coincident injuries, pathological fractures, pre-
fracture residential status or non-surgical management are variably defined and 
inconsistently applied. [11–14] Mean age of subjects ranges from 80 to 87 years. 
[11, 15] Studies which identify pre-fracture residence consistently show higher 
mortality in patients from supported living or “nursing homes”. [12–14, 16] 
Differences in classification of residential aged care facilities present difficulties 
for comparing studies.[17] Mortality rate after hip fracture relative to expected 
population death rates is highest in the early months after injury, but may persist 
for at least 10 years. [2] The excess of deaths diminishes with time, more quickly 
for men than for women, and for older survivors. [2, 6] 
This study describes the mortality of a cohort of elderly hip fracture patients over 
periods of up to four years. In addition to the conventional risk factors of age, 
sex, fracture type and comorbid diagnoses, the impacts of pre-fracture residential 
aged care status and selection for surgery, intensive care and rehabilitation during 
the index hospitalisation are also examined. To our knowledge this is the first 
Australian study to report and analyse determinants of hip fracture mortality in a 
substantial national cohort which identifies a large sample of aged care residents. 
Methods 
The Australian Department of Veterans’ Affairs (DVA) maintains patient-specific 
records of all health services funded for its clients. All records carry the unique 
identifying number of the client, which facilitates linkage of datasets. The DVA 
Treatment Population (TPOP) comprises all clients who have received health-
related service during the year in question. For this study, datasets for public and 
private hospital episodes, residential aged care (RAC) admissions, and date of 
death were obtained for all TPOP members who were hospitalised for hip fracture 
(ICD-10-AM S72.0-S72.2 inclusive) between 1 July 2008 and 30 June 2009 (the 
index hospitalisation). Hospital episode records for each patient were first 
concatenated to identify the total continuous hospital stay for the index hip 
fracture. Second and subsequent hospital admissions for hip fracture within the 
study year were excluded from analyses. Pre-fracture RAC residence was 
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identified by matching or overlapping dates of discharge from RAC and hospital 
admission. Patients who were not admitted directly from RAC were thereafter 
described as “community patients”. Time to death was counted from the 
admission date for the index fracture. Further details of the linkage processes are 
described in a previous publication. [18] 
The following variables were included in the dataset: age, sex, fracture type, 
hospital separation status, surgery, intensive care and rehabilitation episodes, 
comorbidities and complications. ICD-10-AM codes in the hospital datasets were 
used to identify fracture type, surgical procedures, rehabilitation episodes, 
comorbidities and complications. Intensive care was identified by a service item 
descriptor. All coding items are listed within Table 1. Surgical codes were 
accepted if they were accompanied by one of the codes for hip fracture. 
Rehabilitation codes were accepted whether treatment required transfer to another 
hospital or phase change within the same hospital. Codes for fracture type, 
procedures, rehabilitation, intensive care and complications were accepted for 
analysis if they appeared within the episode string for the index admission. 
Comorbid conditions from the 1999 revision of the Charlson Index [19, 20] were 
identified from primary or secondary diagnoses for all hospital episodes in the 
study year, up to and including the episode string of the index admission. 
Fracture type was classified as cervical, trochanteric, subtrochanteric and ‘other’. 
Surgical procedures were grouped as internal fixation, hemiarthroplasty, total hip 
replacement and ‘other” Comorbidities with significant impacts on mortality 
included dementia, renal failure, cardiac failure, ischaemic heart, chronic 
respiratory and cerebrovascular diseases, diabetes and malignancy. 
Complications were skin ulceration, delirium, post-haemorrhagic or unspecified 
anaemia, plus urinary, lower respiratory and surgical site infections (Table V3- 1) 
Mortality risk was classified into four groups according to the combined effects 
of age, sex, and prior RAC residence. Males aged ≥ 85 years from RAC were 
assigned the highest risk and females aged < 85 years were the lowest risk group. 
Statistical analyses 
Univariate analyses of study variables were assessed with Kaplan-Meyer survival 
curves and log-rank testing. Cox Proportional Hazards models were then 
constructed for qualifying variables. Sex and age-groups were retained in all 
multivariate models regardless of their significance. Other variables entered a 
given model if univariate P <0.25 and remained in the final model if P <0.05. 
Comparative mortality was calculated by comparing, for males and females, the 
mortality of the aggregated DVA TPOP July 2009 to 30 June 2012 inclusive 
(reference population) with age-standardised mortality rates of the study 
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population in each of four years following fracture. Patients aged < 70 years were 
excluded because of small numbers and inconsistent age ranges in this group. 
Data for annual deaths within the reference population were provided by DVA. 
[21] 
Comparisons of mortality rate (MR) between this and other studies necessitated 
accounting for demographic differences. After adjusting male: female proportions 
to the DVA profile, known sex-specific rates were applied to the new sub-
populations. If these rates were not given a conservative estimate that male MR 
=1.5 female MR was used. [22, 23, 24] The resulting number of total deaths was 
then uplifted by 1.05 [22,24] compounding for every year by which the DVA 
mean age exceeded that of the comparison population. All analyses were 
performed using SAS 9.3 (SAS Institute Inc; Cary, NC) or Excel 2010 (Microsoft 
Corporation, Redmond, WA). 
Ethics approval was granted by the DVA Human Research Ethics Committee in 
December 2010 and renewed in December 2013 (Reference E010/030). 
Results 
The study population was 2552 DVA clients of whom 960 (37.6 %) were males. 
Mean age was 86.6 (Range 54–100 years) with 1788 patients (70.1%) being 85 
years or older (Table V3-A). Multiple comorbidities were identified for 591 
patients (23%) with 44% having none of the listed conditions. Multiple 
complications were found in 6 % of patients with 72 % having no recorded 
complication. There were 708 patients admitted from RAC (27.7% ) and these 
were slightly older than community patients (88.1 years vs. 86.0 years (P<0.001), 
but with the same proportion of males. 
Mortality rates at four time intervals up to two years are shown in Table V3-B. At 
30 days after the index admission date 285 patients (11 %) had died, 222 of these 
without leaving hospital. By the end of one year 864 patients (34%) had died. 
Barely half of all patients (53%) survived to the end of the second year and only 
one-third were alive after four years. At all listed time points the mortality rate 
for males was significantly higher (P<0.001). Younger patients had lower rates 
throughout (Table V3-B) with this trend being more defined for males. At one 
year, 10 of 49 males (20 %) aged < 80 years had died compared to 52 per cent of 
250 males aged 90 years or older (P <0.001).The corresponding rates for females 
were 24% and 36% (P <0.001). 
Determinant factors for mortality 
The spectrum of significant factors for mortality varied across time (Table V3-
C). In the first 30 days, male sex, older age and admission into intensive care were 
all associated with approximately twice the baseline mortality risk, and patients 
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from RAC had a 50 per cent greater risk of dying. Patients selected for surgical 
treatment were much less likely to die in the first 30 days: only 11 of 1172 patients 
selected for rehabilitation died between the 10th and 30th day after admission. 
Cardiac failure, non-AMI ischaemic heart disease and renal disease all increased 
mortality risk by approximately 50 per cent and a diagnosis of urinary infection 
had apparent survival value. 
Between 30 days and one year, the hazard ratios for sex and age were smaller but 
the decline was not significant. Pre-fracture residence in RAC was the strongest 
determinant of mortality risk across this period (Table V3-C and Figure V3A). 
Admission into intensive care, comorbid cardiac failure and renal disease 
continued to impart a higher risk as earlier. Patients with cerebrovascular disease, 
cancer and pressure ulcers prior to or at the time of hip fracture had increased risk 
of death between 30 days and one year after fracture. 
Direct transfer of community patients from hospital to RAC (new RAC transfer) 
was associated with higher mortality after 30 days (Table V3-3). At 90 days, 36 
of 391 such patients (9.2%) had died and at the end of one year 26.1 % had died. 
Corresponding values for patients discharged elsewhere were 2.7 % (P <0.001) 
and 12.1% (P <0.001). 
In the second year following hip fracture, 335 patients died (20% of 12-month 
survivors). Males were 40 % more likely to die, and risk for those aged 90 years 
or older was nearly three times that for persons younger than 80 years. Patients 
from RAC were more than three times more likely to die. Diabetes with 
complications, cardiac failure, cancer and dementia were, in descending order, 
associated with increased mortality, the latter having borderline significance 
(Table V3-3). 
The higher mortality for RAC patients is illustrated in Figure V3A, which shows 
survival curves for four identified risk groups. Females from the community had 
one-year mortality of 19% while 72% of males from RAC had died. The addition 
of extra variables for age and comorbidity further widened this disparity. Of 216 
community females aged 85 years or older with no comorbidities, 21 (10 %) were 
dead at one year, compared with 65 of 73 (89 %) RAC males aged 85 years or 
older with two or more comorbidities. 
Correlation between age-group and RAC status in this atypical cohort was low 
(Pearson coefficient=0.13) and insertion of an interaction variable for age group 
and RAC into the regression model did not alter the results displayed in Table 
V3-3. RAC patients had higher mean comorbidity scores than community 
patients (1.11 vs 0.82, P<0.001) and a higher proportion of patients with multiple 
comorbidities (29 per cent vs 21 per cent, P<0.001). 
69 
 
Time-related differences in impacts upon mortality are illustrated in Figure V3B 
2 in respect of sex, surgical treatment, transfer to intensive care and RAC patients 
in two time periods (before 30 days and 30 days to one year). Patients treated 
surgically had no detectable survival advantage after 30 days in this population 
and increased mortality for patients treated in intensive care not apparent after six 
months. 
Table 4 shows the mortality rates for males and females standardised against the 
DVA treatment population for each of four years following fracture. Comparison 
rates are higher for all four years, being substantially higher in year 1, then 
essentially stable. Males and females have similar ratios. Higher than expected 
mortality was seen for all age groups except for males mortality was sustained 
into the fourth year after fracture for all patients except for males aged 90 years 
or older in year 4. 
Discussion 
The mortality rates at 30 days, 90 days and one year in this study were 11%, 20% 
and 34% respectively. These are higher rates than reported in most other 
Australian and international studies, [6,11,24,25] but demographic factors 
probably account for much of the differences. When adjusted to the age-sex 
distribution of other Australian studies [22,25,26] the calculated one year 
mortality rate for the study population was 29.3 per cent. The factors which 
determine mortality rates following hip fracture are numerous and diverse: only 
the major elements from this study are discussed. 
Patient demographics 
Comparisons between mortality rates in different studies should be drawn with 
care. Adjustment for differences in age and sex distributions, as defined for this 
study, can substantially alter crude rates. The Bureau of Health Information in 
New South Wales reported 30-day mortality of 6.9 % for public hospital patients 
with surgical treatment for hip fracture .[26] Mean age was 82.9 years, with 72.4 
% females. Adjustments for age and sex resulted in a mortality rate of 8.6 %, 
comparable with 9.3 % for surgical patients in the present study (P=0.35). A 
tertiary hospital in Newcastle NSW, reported a series with mean age of 83.5 years 
and 73.7% females.[22] The reported 30-day mortality of 8.2 % equated to 10.3 
% after adjustment to the DVA demographics. 
Register-based studies of large Danish, Swedish and Finnish cohorts with similar 
demographics (mean ages 80.7–81.4 years and females 72–74%) reported one-
year mortality rates of 29.3%, 23.9% and 27.0% respectively. The one-year 
mortality for the present study would not exceed 26 per cent with these 
demographic profiles, assuming equivalence of other risk factors. It is noted for 
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example that patients admitted from RAC were excluded from the Finnish study, 
while not specifically identified in the others. [3,4,24]. 
Residential aged care 
Admission from RAC was the most important single determinant of mortality in 
this study. Other reports have confirmed this, although not in comprehensive 
multivariate analyses. An orthogeriatric service in Norway reported one-year 
mortality of 46% (61%) for 137 patients admitted from nursing homes compared 
with 14 per cent for the remaining 430 patients. [15] A Dutch study, in which 
patients from RAC were older by 5 years, found 45 % and 17% respectively [12] 
An Australian hospital study of 666 hip fracture patients admitted between 2003–
06 found one-year mortality of 40% in patients from RAC with an age-adjusted 
relative risk of 1.8 (95% CI 1.4–2.4): other potential risk factors were not 
identified. [16]. Adjusted HR values for RAC patients of 1.6 at 30 days and 3.2 
at one year, in separate studies [5,15] very closely matched the values in our study. 
It is additionally noted that, hip fracture increases mortality risk even within a 
cohort of exclusively frail, institutionalised persons.[27] 
The higher mortality risk of RAC patients in the context of hip fracture is only 
partially explained by the data of this study. RAC residents in the atypical cohort 
of this study were significantly older, though by only two years and comorbidity 
was significantly higher. Three times more RAC patients have diagnosed 
dementia in these data, but as discussed below this has marginal additional impact 
on mortality in this study. RAC patients have shorter hospital stay, much lower 
rates of transfer for hospital-based rehabilitation and hospital survivors are 
discharged almost exclusively back to RAC.[28] Details of physical functionality 
were not available but it is noted that the Australian criteria for RAC admission 
equate with substantial functional and/or cognitive incapacities. [29] 
Comorbidity 
This study elected to describe the effect of individual comorbid conditions on the 
assumption that clinicians are more likely to identify and respond to a medical 
diagnosis than (even a validated) calculated index. Eight of the twelve diagnoses 
identified in the 1999 modification of the Charlson Index [20]were associated 
with increased mortality for this study population at some time period. Cardiac 
failure, cancer and renal impairment were most consistently associated. 
Comorbidities in hip fracture patients may be identified from coded 
administrative databases, by physician assessment, or from searches within 
clinical records or, [5,14,16] with resulting wide differences in detection rates. 
The reported prevalence of cardiac failure ranges from 3.7% to 17%, [5,30] while 
some studies conceal this diagnosis within ‘cardiovascular disease’ [7,14] or omit 
it . [30,31]. Of the nineteen referenced studies which identify comorbidity, only 
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three examine all eight of the diagnoses listed in this study [4,24,29] while others 
use Charlson scores only. [15,23,32] 
Coincident dementia is reported in rates ranging from 12.3 to 28.8 per cent and is 
cited as contributing to increased 30-day or longer-term mortality.[10,22,32] Our 
study found that dementia, though much more frequent in RAC patients, was not 
an independent risk factor across the first year when pre-fracture RAC residence 
or new RAC transfers were identified in multivariate models. In the second year 
a marginal association between dementia and mortality was identified (Table 3). 
Such inconsistencies in study design compromise the value of comparisons 
between studies and meta-analyses in particular [8] The improving levels of 
compliance with data reporting in the National Hip Fracture Database in the UK 
[34] — and the consequent improvements in outcomes — suggest that 
standardisation of data collection and analytical protocols may be both practical 
and beneficial. At least two algorithms for differentiating risk status for hip 
fracture mortality have been validated. [5,33] These are based upon data items 
which are readily available in the clinical setting. 
Comparative mortality 
An extensive meta-analysis [2] showed that mortality risk was as high as eight 
times that of control populations in the first three months after injury and 
remained above threefold in the second year. Thereafter rates declined slowly but 
remained significant at 10 years. Males had higher relative mortality than 
females. Several studies reported in a 2008 review confirm that this higher 
mortality diminishes in older patients.[8] Although age-standardised death rates 
in this study tended to be higher for men for at least four years, we could not 
confirm that the degree of excess mortality was greater for men. 
Strengths and weaknesses 
This study benefited from the capacity to link different administrative datasets, in 
particular the matching of RAC occupancy with dates of hospital admission and 
discharge. An extensive list of comorbidities and clinical process options was 
available in coded formats. The accuracy of Australian diagnostic coding in such 
datasets is accepted as sufficient to support valid analyses of this nature. [35,36] 
Prevalence of individual comorbidites and complications did not match the 
detection rates obtained from personal medical files in some studies [15]but 
generally exceeded those reported from an Australian tertiary hospital. [29] Other 
studies based on administrative databases found lower rates for key comorbidities 
in most instances. [5,7,10] Information on disease severity and pre-fracture 
functional status was not available to further inform risk status our study. While 
pre-and post-fracture RAC occupancy was accurately identified from our data, 
72 
 
the exact residential status of community patients was not available. The clear 
statistical separation of results for these two residential groups would, if anything, 
have been enhanced if community patients included some with less than ideal 
health and physical capacity. 
This higher age distribution and greater proportion of males in this study has been 
recognised by reporting relevant values by age and sex and by adjusting global 
mortality rates for age and sex. 
Conclusion 
Pre-fracture residential status is the strongest single determinant of mortality after 
hip fracture: patients from RAC have three times the one-year mortality rate of 
those previously living elsewhere in multivariate models. Male sex, increasing 
age, new transfer to RAC and comorbid cardiac failure, cancer, respiratory and 
renal disease are all associated with increased mortality at one and two years, 
while patients selected for rehabilitation have lower rates. The use of data items 
routinely available during initial hospital care can be combined to clearly define 
high and low risk for subsequent mortality. 
Knowledge of pre-fracture residential status is vital to the interpretation of 
mortality rates following hip fracture. Acceptance of a common protocol for 
measuring mortality risk would greatly enhance the value of studies which 
describe outcomes for this complex population. 
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Table V3-A. Definition and distribution of study variables 
Item ICD-10-AM Coding N Per cent 
 
Females  1592 62.4  
Age Group  
< 80  158 6.2  
80–84  606 23.7  
85–89  1114 43.7  
≥ 90   674 26.4  
Admitted from RAC  708 27.7  
Fracture type  
Cervical S720.1-S720.4 981 38.4  
Trochanteric S720.5, S721.0, S721.1 1081 42.4  
Subtrochanteric S722 110 4.3  
Other, unspecified S720.0, S720.8 380 14.9  
Rehabilitation Z50.8, Z50.9 1172 45.9  
Intensive Care  173 6.8  
Surgery   2213 86.8  
Internal fixation 47519 981 38.4  
Hemiarthroplasty 47522 1081 42.4  
Primary hip replacement 49315, 49318  110 4.3  
Other 47528, 49324, 49333, 
49342 
380 14.9  
Comorbidities  
Dementia F01-F03, F05.1, G30.9 574 22.5  
Renal failure N18, N19 349 13.7  
Cardiac failure I50 335 13.1  
Cardiac ischaemia I20-I25 261 10.2  
Diabetes E10–E14 247 9.7  
Respiratory disease J40 -J47 216 8.5  
Cerebrovascular disease I60–I69 161 6.3  
Malignancy  C00–C99 161 6.3  
Complications  
Urinary tract infection N39 434 17.0  
Pressure Ulcer L89, L97 367 14.4  
Anaemia D62, D64.9 366 14.3  
Respiratory infection J13, J15-J18, J20-J22 254 10.0  
Delirium F05 246 9.6  
Surgical site infection T81.4, T84.5, T84.7 63 2.5  
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Table V3-B. Mortality rates following hip fracture: by sex and age 
groups at time intervals to two years 
Age group N 30 days (%) 90 days (%) One year (%) Two years (%) 
Males 
< 85 240 28 (12) 44 (18) 74 (31) 103 (43) 
≥ 85 720 140 (19) 217 (30) 330 (46) 426 (59) 
All males 960 168 (18) 261 (27) 404 (42) 529 (55) 
Females 
< 85 524 27 (5) 57 (11) 123 (23) 174 (33) 
≥ 85 1068 90 (8) 187 (18) 337 (32) 493 (46) 
All females 1592 117 (7) 244 (15) 460 (29) 667 (42) 
All patients 2552 285 (11) 505 (20) 864 (34) 1196 (47) 
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Table V3-C. Determinants of mortality: time intervals to 2 years 
following hip fracture 
 
< 30 days 30–365 days 365–729 days  
HR1 (95% CI) P HR (95% CI) P HR (95% CI) P 
 
Male sex 1.9 (1.5–2.4) <0.001 1.3 (1.1–1.6) 0.001 1.4 (1.1–1.7) 0.006  
Age-group  0.002  0.007  0.004  
< 80 referent  referent  referent   
80–84 2.1 (0.9–4.9)  0.9 (0.6–1.3)  2.0 (1.0–3.9)   
85–89 2.4 (1.0–5.4)  1.0 (0.7–1.5)  2.3 (1.2–4.5)   
≥ 90 3.4 (1.5–7.7)  1.3 (0.9–1.9)  2.9 (1.5–5.8)   
RAC2 1.5 (1.2–1.9) 0.001 3.4 (2.8–4.2) <0.001 3.3 (2.5–4.4) <0.001  
New RAC 
transfer3 0.4 (0.2–0.8) 0.007 1.5 (1.2–1.9) 0.002 1.6 (1.2–2.2) 0.002 
 
Rehabilitation 0.1 (0.0–1.0) <0.001 0.6 (0.5–07) <0.001 0.7 (0.5–0.9) 0.001  
Surgery 0.4 (0.3–0.5) <0.001      
Intensive care 1.9 (1.3–2.7) <0.001 1.6 (1.2–2.1) 0.002    
Comorbidities        
Cancer   1.4 (1.2–1.6) <0.001 1.5 (1.2 -1.8) <0.001  
Cardiac failure 1.6 (1.2–2.1) 0.003 1.6 (1.3–2.0) <0.001 1.8 (1.3–2.4) <0.001  
Ischaemic HD 1.5 (1.1–2.1) 0.017      
Dementia     1.3 (1.0–1.7) 0.054  
Diabetes4     2.0 (1.4–3.1) 0.001  
Renal disease 1.4 (1.2–1.6) <0.001 1.2 (1.1–1.3). 0.003    
Stroke   1.4 (1.0–1.8) 0.049    
Complications        
UTI 0.4 (0.2–0.7) 0.001      
Skin ulceration   1.3 (1.1–1.6) 0.008    
1 HR=Hazard Ratio 
2 RAC = RAC occupancy immediately before fracture 
3 Community patients transferred to RAC 
4 Includes diabetes with complications 
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Table V3-D. Relative mortality rates (MR) following hip fracture in 
2552 DVA clients 
 Number1 Deaths2 Actual MR3 
Expected 
MR4 
Comparative 
MR5 
Males 
Year 1 939 388 0.413 0.125 3.3 (3.0–3.5) 
Year 2 535 121 0.226 0.125 1.8 (1.5–2.1) 
Year 3 411 96 0.234 0.125 1.9 (1.6–2.2) 
Year 4 314 79 0.252 0.125 2.0 (1.6–2.4) 
Females 
Year 1 1583 434 0.274 0.086 3.2 (2.9–3.4) 
Year 2 1125 201 0.179 0.086 2.1 (1.8–2.3) 
Year 3 915 163 0.178 0.086 2.1 (1.8–2.4) 
Year 4 745 149 0.200 0.086 2.3 (2.0–2.6) 
1 Survivors at commencement of year 
2 Values for deaths are age-standardised against DVA Treatment Population 
 July 2009 – June 2012 
3 Mortality Rate for given year 
4 From DVA Treatment Population July 2009- June 2012 
5 Actual MR / expected MR 
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Figure V3-1. Survival for 2 years after hip fracture by risk group 
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Figure V3-2. Survival curves in two time intervals for selected 
determinants of mortality 
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V (4): Research Study no. 4 
State of Origin: Australian States use widely different resources for 
hospital management of hip fracture but achieve similar outcomes. 
Analyses of linked Department of Veterans’ Affairs databases 
Ireland A W, Kelly P J, Cumming R G 
Australian Health Review. Accepted for publication 24 May 2015 
85 
 
Abstract 
Background and objective 
Hospital management of hip fracture varies widely in respect of length of stay, 
delivery of post-surgical care and costs. The present study examines the 
association between hospital resource outlays and patient outcomes in six 
Australian States. 
Study type 
Retrospective cohort study of linked administrative databases for 2530 Australian 
veterans and war widows aged ≥65 years, hospitalised for hip fracture in 2008–
09. 
Methods 
Department of Veterans’ Affairs (DVA) datasets for hospital episodes, residential 
aged care (RAC) admissions and date of death were linked. Patient 
characteristics, hospital utilisation and process data, rates for mortality and 
residential care placement were compared for patients from each of six defined 
jurisdictions. 
Results 
There were no significant differences in fracture incidence, patient demographics 
or fracture type among the States. Adjusted total mean length of hospital stay 
ranged from 24.7 days (95%CI 22.3–27.5 days) to 35.0 days (95%CI 32.6–37.6 
days, P<0.001) and adjusted total hospital cost was between $24792 (95%CI 
$22191-$ 27700) and $35494 (95%CI $32853 -$38343, P<0.001). Rates of 
referral to rehabilitation ranged from 31.7 per cent to 50.4 per cent (P=0.003). At 
one year there were no significant differences between States for key outcome 
determinants of mortality (P=0.71) nor for proportions of patients who retained 
their independent living status (P=0.66). 
Conclusion 
Hospital resources for management of hip fracture differ substantially among the 
Australian States. Key medium-term patient outcomes do not show significant 
differences. A potential for substantial cost efficiencies without increased risk to 
patient welfare is suggested. 
What is known about this topic? Hospital resources deployed in the initial 
management of hip fracture differ widely between countries, regions and 
individual hospitals. Patient outcomes also vary widely, but are inconsistently 
associated with resource outlays. 
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What does this paper add? Description of the differing resource outlays for 
management of hip fracture in six Australian jurisdictions and the absence of 
equivalent differences in medium-term patient outcomes. 
What are the implications for practitioners? The data of this study suggest that 
efficiencies in hospital management of hip fracture may be achieved without 
negative consequences for patient outcomes. 
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Introduction 
The management of hip fracture is complex and costly and patient outcomes for 
both survival and function are less than ideal [1, 2, 3]. Comparisons of duration 
and content of hospital management at national, regional and facility levels show 
wide diversity [1, 4, 5]. Across the world, duration of hospital stay for hip fracture 
ranges from as little as 5 days [6] to more than six weeks [1]. These variations are 
mostly the result of different approaches to provision of post-acute hospital 
services [4, 7, 8]. 
Between 2.7 per cent and 16 per cent of subjects are treated without surgical repair 
[9, 10]. Post-fracture rehabilitation can differ in both overall rate (21 to 67 per 
cent) and manner of delivery across regions [4, 8, 11]. Because of the wide 
differences in duration and content of the primary hospital admission, mortality 
rates at 30 days are mostly accepted to better represent the safety and 
effectiveness of hospital management. Reported values range from 2.7 to 14 per 
cent [12, 13]. 
In the past 20 years a number of management protocols have been created which 
involve various combinations of orthopaedic, geriatric and rehabilitation services. 
These ‘orthogeriatric’ models mostly result in speedier passage through the acute 
wards, reduction of short-term complications and sometimes in lower rates of in-
hospital or 30-day mortality [14, 15, 16]. However, evidence for association 
between orthogeriatric acute care and longer-term benefits is inconsistent [12, 17, 
18]. 
The acute phase of care is coming under particularly close scrutiny in national 
audit programmes which document compliance with recommended process 
elements and report comparative rates of short-term outcomes. Performances are 
compared between health services or more commonly between individual 
hospitals [5, 11]. Repeated feedback of audit results is associated with increased 
compliance with recommended “best practice”, and also results in reduced time 
in hospital, lower costs and improved short-term outcomes [5, 11]. 
The Australia and New Zealand Hip Fracture Registry [19] has commenced 
reporting availability of key service components for a majority of registered 
hospitals but to date has not yet reported patient-level performance data. The 
Registry and other agencies within Australasia have also produced recommended 
care pathways or guidelines for hip fracture management [19, 20]. 
This study describes the variations in hospital utilisation for management of hip 
fractures among six jurisdictions within Australia and their corresponding 
medium-term outcomes. It is the first Australian study to link resource utilisation, 
key process elements and patient outcomes in a national dataset. 
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Methods 
This is a retrospective cohort study. This study comprises all Department of 
Veterans’ Affairs (DVA) treatment beneficiaries aged 65 years or older who were 
hospitalised for hip fracture (ICD10-AM S720-S722) between 1 July 2008 and 
30 June 2009. A Universal Identification Number for each patient allowed linkage 
of all hospital episodes continuous with the index admission, together with 
records of admissions into Residential Aged Care (RAC) facilities and the DVA 
Mortality Index. Data items included patient age, sex, fracture type, pre-fracture 
residential status (as RAC or “community”) up to 16 diagnosis codes, operation 
type, episode separation codes, date of death, hospital type, itemised costs and 
State of treating hospital. Additional details of the record linkage processes have 
been described previously [21]. Dates of service for community nursing and 
Veterans’ Home Care (VHC) services, up to one year following fracture were also 
collected. VHC provides a wide range of personal and domestic supports for 
entitled veterans, war widows and their carers, including institutional or in-home 
respite. 
The outcomes of interest were hip fracture incidence, total length of stay and total 
cost for the index hospitalisation, new RAC admission and deaths within one 
year, total time spent in RAC for hospital survivors and time from index 
admission to death. These outcomes were analysed for each of the six Australian 
States. Data for hospitals in the Australian Capital Territory were reported with 
data from New South Wales and data from the Northern Territory were included 
within data for South Australia. 
For calculation of hip fracture incidence, age and sex distributions in each State 
were standardised to the distributions within the complete study population. The 
hospital period defined as ‘acute phase’ included all episodes coded as hip 
fractures which were continuous with the index admission. Rehabilitation length 
of stay was the total duration of one or more episodes with principal diagnosis of 
rehabilitation (ICD10-AM Z508-Z509) which were included within total 
hospitalisation. Total hospital stay was the concatenated value of all episodes, 
however coded, which were continuous with the index admission. These included 
episodes for management of complication and comorbidities and for subacute and 
non-acute care. Hospital cost was the total of charges for accommodation, theatre 
and prosthesis costs plus fees for medical, allied health, pathology and diagnostic 
imaging services approved and paid by DVA in respect of the total hospitalisation 
period. 
Comorbidity was assessed by Quan scores [22] for patients from the community 
only, this being the relevant group for to all outcome measures applied in the 
study. 
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Several different sub-populations are described and analysed. Post-hospital 
community services can only be provided to patients who have been discharged 
alive and are not in RAC. The denominator for the proportion of persons in RAC 
is the surviving population at the specified time point. Community nursing and 
VHC services can only be provided to persons not in RAC. Patients surviving in 
the community without resource to community nursing or VHC services were 
also identified. 
One-way analysis of variance was used to assess differences between mean 
values for continuous variables, and differences between proportions of 
categorical variables were analysed by Pearson’s chi-square test. To assess 
differences between States, all other risk factors and confounders, as listed above, 
which retained significance of P<0.05 were included in multivariate models. 
Continuous outcomes were analysed using negative binomial regression and 
binary outcomes analysed using logistic regression. 
All analyses were performed using SAS 9.3 (SAS Institute Inc; Cary, NC) or 
Excel 2010 (Microsoft Corporation, Redmond, WA). 
Results 
There were 2530 patients aged ≥ 65 years admitted to hospitals in the study year. 
This was a relatively elderly population with 71 per cent being ≥ 85 years of age. 
The overall incidence of 12.0 per 1000 persons aged ≥ 65 years was reduced to 
5.6 per 1000 when the age-sex distribution was adjusted to that of other Australian 
hip fracture patients. The age-sex adjusted incidence of hip fracture was 9.9 per 
1000 in Tasmania and 13.1 in Queensland, but this difference did not achieve 
significance in this sample (Table V4-A). 
Table 1 shows that there were no significant differences between the States in 
distributions of age, sex or the proportions of patients who had been in residential 
aged care (RAC) prior to fracture. 
Hospital process and utilisation 
The proportions treated surgically were similar between the States but there were 
significant differences in the proportions of patients who received in-hospital 
rehabilitation (χ2 =17.8; df =5; P=0.003), rates being highest in Victoria and New 
South Wales and lowest in Tasmania and Queensland. In the period immediately 
following the index hospitalisation, 231 episodes of same-day rehabilitation (27 
study patients) were additionally identified. All but six of these patients were from 
New South Wales. Rates of transfer into Intensive care were also different but 
numbers were relatively small -172 in the entire sample (6.8 per cent) 
There were significant differences in the length of acute phase care, as shown in 
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Figure V4-1. Mean values for the individual states ranged from 9.4 days in 
Tasmania to 14.6 days in Queensland. Values were similarly diverse for the length 
of total hospital stay with South Australia having the shortest (24.7 days) and 
Western Australia the longest (36.2 days) in adjusted models. The same two States 
had the lower and upper values for the duration of rehabilitation episodes, with 
the highest value being 52 per cent above the lowest (Figure V4-1A,B,C). 
Mean total cost of the index hospitalisation was $31208 inclusive of 
accommodation, operating theatre and prosthesis costs and fees for medical, 
allied health, pathology and diagnostic services provided during the hospital 
period. There were significant differences among States in overall cost per 
occupied bed-day (range $909 to $1149 per day, P<0.001, data not shown). The 
highest State value for total hospital cost exceeded the lowest value by 51 per 
cent (Figure V4-1D). In each of the four utilisation analyses illustrated in Figure 
1, differences in mean values between States were significant and substantial. 
Total cost of hospital services was $79 million. 
Private hospitals in total had lower bed-day charges for both surgical and 
rehabilitation episodes and were less costly overall despite having equal or longer 
LOS. The national mean LOS for surgery was lower in public hospitals, but there 
was no difference in respect of rehabilitation (Table V4-B). The proportions of 
patients having surgical procedures and rehabilitation episodes in private 
hospitals showed State-specific profiles. Overall, 59 per cent of operations to 
repair hip fractures were performed in public hospitals. In New South Wales, 82 
per cent of surgery was in the public sector, but more than two-thirds of operations 
were in private hospitals in Queensland and South Australia (Table V4-B, Figure 
V4-2A). Private hospitals provided 56 per cent of 1272 hospital episodes for 
rehabilitation (1159 patients). This value ranged from 81 per cent in South 
Australia to 32 per cent in Victoria (Table V4-B, Figure V4-2B). 
Significant and substantial differences for total hospital costs persisted, after data 
for each State were standardised for public: private distribution and for bed-day 
costs in respect of surgery and rehabilitation. 
Post-hospital services 
Community nursing services were provided to 613 persons and VHC services to 
666 persons at some time within the year after fracture, and 360 persons received 
both services at some time. There were significant differences between the states 
in unadjusted rates of service provision (Table 1). By one year post-fracture, 444 
of 1076 (41.3 per cent) potentially independent persons were currently receiving 
one or both services but the adjusted State distribution was no longer 
disproportionate (P=0.20). The one-year combined cost of these services was $3.7 
million or $1631 per hospital survivor (untabled data). 
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Hospital readmission within one year occurred for 50.4 per cent of patients. This 
rate varied between 43 per cent (Tasmania) and 58 per cent (South Australia), but 
the results for the other States clustered tightly about the mean and the overall 
distribution did not show significant difference. 
One-year outcomes 
In contrast to the diversities in patterns of service delivery, there were no 
significant differences in unadjusted or adjusted data describing mortality rates 
and occupation of aged care facilities at one year after fracture (Table V4-C). At 
one year, the spread of unadjusted mortality rates was 31 to 41 per cent, but all 
confidence intervals were overlapping (P=0.73), and the multivariate regression 
model showed similar lack of significant difference (P=0.71). The pattern was 
repeated for RAC occupancy among one-year survivors and for the composite 
outcomes of ‘potential independence’ with and without additional supportive 
services. One year after the index admission date, 632 community patients (35 
per cent) were living in non-RAC accommodation without support of nursing or 
VHC services. In the adjusted model there were again no significant differences 
in proportions of these “good outcomes” between the States (p=0.20). Crude and 
adjusted values for all outcome measures suggested that the State with the lowest 
costs (South Australia) achieved equivalent or superior outcomes to those of other 
States. (Table V4-C, FigureV4-1B,C). 
Discussion 
There were substantial and significant differences in hospital utilisation profiles 
among the six States for mean total length of stay (24 to 35 days), rates of referral 
to rehabilitation (32 to 51 per cent) and the aggregate time in rehabilitation (18 to 
27 days). These differences, contributed to the wide range of hospital costs 
between States. Differential rates of private hospital admissions for surgery and 
rehabilitation episodes and cost differences between public and private providers 
may also have been a factor. Costs, especially in the private sector, may have 
reflected differing contract arrangements between DVA and provider 
organisations, but details were not available to the study. 
Equally wide utilisation differences are reported in other contemporary studies, 
in which total hospital stay ranged from 17 to 48 days [1, 23]; rates of referral to 
rehabilitation ranged from 21 to 67 per cent [8, 11] and mean duration of hospital-
based rehabilitation was between one and six weeks [23, 24]. 
A recent Australian study found significant differences between four States in 
LOS for rehabilitation of specific classes of lower limb amputees [25]. 
The outcome parameters accessible to this study were mortality, RAC residency 
and the absence of both, taken as a surrogate for independent living. These 
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elements are widely acknowledged as key indicators of “poor” or “good” longer-
term outcomes in the elderly [26]. An additional level of better functionality was 
possibly indicated by the absence of community nursing or VHC services, 
especially in the longer term, as identified in Table 3. 
Examples of the disconnect between resource deployment and patient outcomes 
following hip fracture are evident at national, regional and individual hospital 
level. A review of Medicare data in the United States for the period 2000–2008 
showed a downward trend for acute phase LOS and a small downward trend for 
mortality [6]. 
In the 2008 report of the Scottish Hip Fracture Audit [11] which compared data 
from 22 hospitals, the four hospitals with the shortest aggregate hospital stay 
(mean 31.5 days) and the four with the longest stay (42.4 days) had 120-day 
mortality rates of 19.5 per cent and 18.9 per cent respectively (P=0.74). The 
proportions of patients from these groups of hospitals in care home 
accommodation at 120 days were likewise equivalent (17.8 per cent and 17.2 per 
cent, P=0.71).In the National Hip Fracture Database of 2012, total hospital stay 
for seven hospitals (with ≥ 100 separations) with the lowest rates of “private home 
to private home” outcome at 30 days and for nine facilities with the highest such 
rates were 20.0 and 19.1 days respectively [5-derived]. In the last three years of 
the NHFD report, the national mean LOS has reduced while hospital mortality 
has remained steady [5]. 
All three of these large nationally-based reports suggest that hospital stay can be 
reduced without detriment to immediate or medium term outcomes. Two smaller 
American studies conversely described lower in-hospital or 6-month mortality 
rates for patients of high cost teaching hospitals albeit with very high cost 
increments relative to modest mortality gains [27, 28]. 
At a regional level, eleven health districts in Tuscany reported an approximately 
eight-fold difference in rates of hospital-based rehabilitation across eleven health 
districts with commensurate cost differentials due to differing referral rates and 
proportions of episodes delivered as admitted care 4. Six- month mortality rates 
were not significantly diverse. For two hospital districts in Finland, with 527 and 
731 hip fractures respectively, one group with a significantly shorter total hospital 
stay reported significantly more patients returned to their homes at 120 days and 
lower mortality at one year [29]. 
At the hospital level, an orthogeriatric service in New Zealand reduced hospital 
stay and increased rate and promptness of transfers to rehabilitation, without 
altering 6-month mortality [17]. The 12-month mortality for community dwelling 
patients was not associated with length of hospital stay in an orthogeriatric unit 
in Oslo [30]. An Australian study over a 10 year period showed reductions in 30-
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day mortality from 12.1 to 8.2 per cent while LOS marginally increased [31]. In 
the latter two studies, an apparent association between longer stay and improved 
survival for the whole study population was attributed to the early discharge of 
frail patients. None of these hospital-based studies identified costs. 
Strengths and weaknesses 
These are essentially the inherent issues presented by the use of administrative 
datasets. Large populations and an extensive range of data items are available. 
The sample reported in this study represented approximately 1:7 of the Australian 
caseload for hip fracture [19]. The level of coding accuracy in Australian hospital 
data has been assessed as adequate for population-based studies of clinical 
subjects [32] and accuracy is further enhanced by data linkage [33]. The database 
linkage capacity permitted a comprehensive description of hospital resources and 
of post-hospital events in specific groups of patients, with an extensive list of 
variables for multivariate analyses. 
Data on Transition Care (TC), while potentially relevant to many patients in this 
study, by providing short-term support to elderly patients discharging from 
hospitals, was not available to this study. This service, jointly provided through 
the Commonwealth and State Health agencies in Australia, is therefore not funded 
nor recorded by DVA. National reports published by the Australian Institute of 
Health and Welfare, showed that the distribution of TC places closely reflected 
state demography in 2008–09, but DVA clients were not identifiable [34]. 
The particular demographics of the DVA population are noted. Patient age and 
sex were not significant determinants of cost in this study, but were major 
determinants of outcomes. As previously reported [21], hospital stays for acute 
phase or rehabilitation episodes show little difference between DVA and non-
DVA populations in comparable data. Appropriate adjustments for demographic 
differences have been made when comparing these data with outcomes of other 
Australian and international studies. There were no significant between-state 
differences in demographics. 
Conclusions 
The data of the present study indicate potentially major cost-efficiencies for 
hospital management of hip fracture. If the second lowest State value for total 
LOS (25.7 days), and the second-lowest bed-day cost ($951) were applied across 
the entire study population the cost for hospital management of hip fracture would 
be reduced by 18 per cent. The lack of association between resource expenditure 
and longer-term outcomes suggests that this could be achieved without detriment 
to patient welfare. 
In the hospital management of hip fracture there are significant and substantial 
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differences among the Australian States with respect to acute and total length of 
stay, rates of rehabilitation referral, public-private service distribution and costs. 
In adjusted models for total hospital stay and cost, the highest values exceed the 
lowest values by more than 40 per cent. With one exception, patient outcomes as 
assessed by rates for mortality and RAC placement and defined independence at 
12 months, do not significantly differ. These findings indicate a potential for 
substantial cost efficiencies in hospital management of hip fracture without 
compromise to patient outcomes. 
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Table V4-A. Patient characteristics, service profiles and hip fracture 
incidence by State for 2530 patients aged ≥ 65 years, admitted to hospital 
2008–09 
 NSW 
(N=904) 
QLD 
(N=526) 
SA 
(N=194) 
TAS 
(N=63) 
VIC 
(N=643) 
WA 
(N=200) 
P 
Incidence 11.71 13.1 11.1 9.9 12.4 12.5 0.09 
Patient characteristics 
Males 36.12 40.1 36.6 39.7 35.9 38.7 0.66 
Age ≥ 85 70.4 69.2 64.9 74.6 72.8 73.9 0.26 
RAC3 29.1 26.8 30.4 34.9 25.8 28.6 0.46 
Quan Score ≥ 34 13.7 12.2 12.6 9.86 16.8 15.4 0.20 
Hospital services 
Surgery 83.6 83.3 88.7 92.1 84.4 82.9 0.24 
Intensive care 5.5 6.1 14.4 0.0 9.3 1.0 <0.001 
Rehabilitation 47.7 40.9 41.8 31.7 50.4 44.0 0.003 
Total LOS (Days) 30.6 35.0 24.7 25.7 31.5 31.6 <0.001 
Total cost ($AUD) 32880 31838 24052 28747 29625 36247 <0.001 
Post-hospital services 
Community 
Nursing5 
29.0 29.6 33.5 26.8 22.8 21.1 0.001 
Veterans’ Home 
Care5 
29.2 25.5 41.9 26.8 29.8 23.4 0.001 
RAC days6 21.3 22.1 17.5 18.8 23.5 18.5 <0.001 
1 Incidence per 1000 of DVA Treatment Population. 
2 Values are percentages 
3 Patients admitted from residential aged care 
4 Community patients only 
5 Proportion of hospital survivors receiving service within 12 months of fracture 
6 Days in RAC as proportion of total survival days within 12 months of fracture 
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Table V4-B. Length of Stay, bed-day costs and total episode costs by 
State and hospital type Australian veterans and war widows 2008–09 
 Private hospitals Public hospitals 
Episodes including surgery: 2303 episodes for 2194 patients 
State N1 LOS $/day2 Cost3 N LOS $/day Cost 
NSW 146 13.6 1563 21313 676 11.8 1934 22731 
VIC 268 14.3 1477 21118 317 11.2 1599 17888 
QLD 346 13.8 1343 18591 128 14.5 1537 22237 
SA 129 11.4 1478 16878 56 14.3 1437 20526 
TAS 14 8.9 1733 15351 45 9.6 1976 18877 
WA 51 20.3 1136 23059 127 9.1 2657 24097 
AUST 954 13.9 1417 19677 1349 11.7 1840 21455 
Episodes including rehabilitation : 1272 episodes for 1159 patients 
 N LOS $/day Cost N LOS $/day Cost 
NSW 269 25.9 578 14971 200 20.8 690 14378 
VIC 134 17.5 584 10207 214 25.0 663 16599 
QLD 195 23.0 584 13444 48 22.3 649 14436 
SA 59 15.7 555 8773 28 19.4 546 10589 
TAS 16 18.6 661 12319 6 26.2 482 12612 
WA 33 26.9 608 16358 70 20.7 706 14597 
AUST 706 22.5 582 13128 566 22.5 668 15044 
1 LOS= length of stay for episode 
2 Cost per occupied bed-day 
3 Cost of hospital episode. All costs in Australian dollars. 
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Table V4-C. Outcomes at one year by State 
A: Mortality 
  
 Unadjusted (P=0.73) Adjusted1 (P=0.71)   
 N Deaths Per cent (95%CI) Odds Ratio 95% CI   
NSW / ACT 904 305 33.7 (30.6–36.8) referent   
QLD 526 176 33.5 (29.5–37.5) 0.99 (0.76–1.29)   
SA / NT 194 61 31.4 (24.9–37.9) 0.79 (0.53–1.18)   
TAS 63 26 41.3 (29.1–53.5) 1.25 (0.68–2.29)   
VIC 643 222 34.5 (30.8–38.2) 1.02 (0.80–1.31)   
WA 200 73 36.5 (29.8–43.2) 1.17 (0.81–1.69)   
AUST 2530 863 34.1 (32.3–35.9) –   
B: RAC residents (12-month survivors) 
  
 Unadjusted (P=0.90) Adjusted (P=0.56)   
 N2 Residents Per cent (95% CI) Odds Ratio 95% CI   
NSW / ACT 599 210 35.1 (31.3–38.9) referent   
QLD 350 123 35.1 (30.1–40.2) 1.13 (0.86–1.48)   
SA / NT 133 42 31.6 (24.3–39.2) 1.12 (0.75–1.68)   
TAS 37 14 37.8 (22.2–53.4) 1.02 (0.53–1.96)   
VIC 421 156 37.1 (32.5–41.7) 1.11 (0.86–1.43)   
WA 127 43 33.9 (25.7–42.1) 0.77 (0.51–1.18 )   
AUST 1667 588 35.3 (33.0–37.6) –   
C: Independent without community support services (community patients only) 
 
 Unadjusted (P=0.59) Adjusted (P= 0.20)  
 N Persons3 Per cent (95% CI) Odds Ratio Per cent (95% CI)  
NSW / ACT 641 212 33.1 (29.5–36.7) referent  
QLD 385 141 36.6 (31.8–41.4) 1.18 (0.83–1.66)  
SA / NT 135 46 34.1 (26.1–42.1) 0.79 (0.49–1.26)  
TAS 41 16 39.0 (24.1–53.9) 2.40 (0.85–7.64)  
VIC 477 160 33.5 (29.3–37.7) 1.22 (0.88–1.68)  
WA 143 57 39.9 (31.9–47.9) 1.39 (0.84–2.29)  
AUST 1822 632 34.7 (32.5–36.9) –  
1 Adjusted for sex, age group, comorbidity score, pre-fracture RAC residence, and 
 rehabilitation, intensive care, community nursing and veterans’ home care services 
2 Survivors at 12 months.  3 Survivors not in RAC at 12 months 
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Figure V4-1: Hospital utilisation by State: 2530 patients 
aged ≥ 65 years, 2008–09 
LOS = length of hospital stay. Y-error bars represent 95 % confidence intervals 
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Figure V4-2. Service distribution by State and hospital type 
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Rehabilitation after hip fracture: association with two-year survival, and 
independent living status. Findings from Department of Veterans’ Affairs 
databases for 1724 community-dwelling patients 
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Abstract 
Objective 
To compare rates of mortality, hospital readmissions and independent living 
status for two years following hip fracture in community-dwelling patients who 
did and did not receive hospital-based rehabilitation. 
Design  
Retrospective cohort study 
Methods 
Administrative datasets were linked for hospital treatment, residential aged care 
admissions, selected community services and date of death for  community-
dwelling hip fracture patients. Mortality, readmissions, residency within aged 
care facilities and independent living status at intervals up to 2 years were 
compared in multivariable logistic regression for patients with and without  
hospital-based rehabilitation 
Results 
Age, sex and comorbidity distributions were similar for 1050 patients who 
received rehabilitation and 674 patients who did not. Rehabilitation added 11 days 
to total hospital stay and $12000 to hospital costs. Mortality at 90 days after hip 
fracture was 4.7 % for rehabilitation patients vs. 10.7 % for others (p <0.001) and 
26.2 % vs 37.2 % (p <0.001) at 2 years. In the year following the index fracture 
the difference in hospital readmission rates for the two groups was of borderline 
significance (60.3% vs 55.6%, p = 0.05). Beyond 90 days there was no significant 
association between receipt of rehabilitation and the proportion of patients 
meeting criteria for independent living. 
Conclusion 
In-hospital rehabilitation substantially increases total hospital costs. It is 
associated with improved early and late survival, but not with the likelihood of 
living independently for up to two years after hip fracture. 
Keywords 
Hip fracture, rehabilitation, hospital costs, mortality, independent living. 
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Introduction 
Hip fracture is a common and frequently devastating event for elderly persons. 
Although age-specific incidence is steadily falling in Australia (1), approximately 
13 in every 1000 women aged 75 or older and about half as many men will be 
affected each year (1, 2, 3). Despite the progress in acute hospital practices in 
recent decades, the one-year mortality following hip fracture remains in the 
region of 25–30 per cent (4, 5). Rates of functional recovery after one year also 
remain poor, with more than one-third of survivors failing to regain pre-fracture 
levels of physical functions, and at least one-quarter being in permanent 
institutional care (5, 6, 7). 
In seeking better patient outcomes, the high rates of comorbid medical conditions 
and peri-operative complications in this frail, elderly population are increasingly 
addressed through advocacy of best-practice guidelines and management by  
multispecialty, ortho-geriatric teams (8, 9, 10, 11). These initiatives have 
produced short-term benefits — reductions in hospital mortality, complication 
rates, time in acute hospital care and functional status at hospital discharge. Long- 
term benefits with regard to survival and independent living status are suggested 
by only a minority of studies (11, 12). 
Attention has therefore turned to post-acute care and rehabilitation (REH) 
programs. The majority of hip fracture patients now receive formal rehabilitation. 
In Ontario Canada, up to 90 per cent of discharges in 2003 were via inpatient 
REH or skilled nursing facilities (13). In the United States in 2008, 85 per cent 
were transferred to skilled nursing or “other hospital” facilities, mostly for REH, 
and fewer than 3 per cent of patients went home without any formal after-care 
program (14).  
While ambulatory, home-based and even telemedicine  models for rehabilitation 
have been trialled (15, 16, 17), the great majority of services are delivered in 
hospital units (13, 14, 18) . Short-term benefits in physical function, especially 
ambulation, and some additional psycho-social advantages are now almost 
universally reported by all programs (19, 20).  
Numerous programs address specific functionalities such as improved balance or 
lower limb strength with a view to improving independence or reducing risk of 
further injury (21, 22). While specific targets  are frequently met in the short term,  
significantly superior rates of independent living at the end of even the first year 
after hip fracture are reported for only a few studies (17, 19, 20). 
A Cochrane Review published in 2009 described controlled trials of a wide 
variety of rehabilitation services, mostly delivered to inpatients. Some programs 
showed a tendency to infer longer-term benefits to patients, but none achieved 
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statistical significance. The concluding comment was that rehabilitation was not 
harmful (23). 
This study compares mortality, hospital readmissions and independent living 
status across the first two years after hip fracture for a cohort of elderly 
community-dwelling patients who received hospital-based rehabilitation and a 
series of similar patients with no documented rehabilitation. 
Methods 
The study population was drawn from a cohort of 2552 Australian veterans and 
war widows hospitalised for a first hip fracture (ICD-10-AM, S72.0-S72.2 
inclusive) between July 2008 and June 2009. The existence of a unique 
identifying number for each patient in Department of Veterans’ Affairs (DVA) 
databases permitted linkage of continuous hospital episodes, residential aged care 
(RAC) admission history, hospital readmissions, delivery of community nursing 
and/or veterans’ home care services, and date of death for each individual subject. 
Details of this cohort have been reported previously (24). 
Subjects who were RAC residents immediately prior to hospital admission for 
hip fracture or who died within the acute surgical phase of hospital care were 
excluded. Patients admitted from RAC have shorter hospital stays, higher hospital 
mortality, and survivors almost exclusively return permanently to RAC (25). 
Since referral to REH presupposes survival to the end of the acute phase episode, 
the exclusion of non-REH patients who died in the acute phase reduces bias in 
mortality comparisons. 
Study data were obtained from DVA administrative databases for care in public 
and private hospitals for all patients. Data items included patient age, gender, 
fracture type, operation type, comorbidities and complications, treatment in 
intensive care, and separation code for each component episode. Fracture type 
was classified from ICD-10-AM codes for principal diagnosis as cervical 
(S72.01–72.04), trochanteric (S72.05, S72.10–72.11), subtrochanteric (S72.2) 
and ‘other’ (S72.00, S72.08). Comorbidity codes were extracted from all hospital 
episodes in the study year, up to and including the episode(s) comprising the 
index hip fracture admission. Comorbidity weight was assessed by the Quan 
modification of the Charlson Comorbidity Index (26).This algorithm, derived 
from hospital data in Alberta Canada and internationally validated, assigns a score 
of 1- 6 for each of 12 conditions. 
 Complications of skin ulceration (L89, L97), delirium (F05), anaemia (D62, 
D64.9), and urinary (N39), lower respiratory (J13–J15, J18, J20–22) and surgical 
site (T81.4, T84.5–7) infections were also identified, due to known associations 
with either length of stay (LOS) or unwanted outcomes following hip fracture (2, 
107 
 
13, 19). Complications were identified only from those episodes comprising the 
index fracture admission. Admitted care for REH was identified if one or more 
episodes with principal diagnosis, coded as ICD-10-AM Z50.9 or Z50.8, was 
included in an episode sequence continuous with the index admission date. No 
additional details of the processes of delivering the various REH services were 
available in the database.  
Acute phase care was defined as those episodes with principal diagnosis of hip 
fracture (S72.0-S72.2 inclusive) which were continuous with the admission date. 
Rehabilitation length of stay (LOS) was the total of all REH episodes between 
the end of the acute phase and final discharge. ‘Other’ care included all episodes 
included within an episode sequence continuous with the index admission date, 
but not defined as acute or REH care. Total length of stay described the duration 
of hospitalisation from the index admission date until final discharge. The total 
cost of hospitalisation included all charges for accommodation, theatre, 
prostheses, and fees for medical, allied health and diagnostic services accepted 
for payment by DVA in respect of the index hospital admission. Hospital 
readmissions, and the LOS and cost of each episode were identified for one year 
dated from the index admission. Costs were expressed in Australian dollars 
($AUD) at 2009 values.  
The three main outcome measures, were mortality, RAC status and “living 
independently” measured since index admission date. Mortality was obtained by 
linkage with the DVA Death Index. RAC status was defined as living in RAC, as 
identified in DVA records, but the denominators only include those patients who 
are alive at the specified time point. “Living independently” was defined as 
neither deceased nor resident within RAC nor receiving community nursing or 
Veterans’ Home Care services at the specified time point. Female subjects, aged 
< 85 years with one or zero coded comorbidities were defined as a “low risk” 
group for mortality at one year.  
Statistical analyses 
Univariable analyses were conducted comparing patients that did and did not 
receive rehabilitation using Student's t-test and Pearson's Chi-square test for 
continuous and categorical variables respectively. A multivariable logistic model 
was also fitted for receiving versus not receiving rehabilitation. Variables were 
included in the regression model if p <0.25 in the univariable analyses and 
remained in the final model if p <0.05 after backwards elimination. For the 
outcomes of mortality, RAC and “independent living” logistic regression models 
were each fitted separately for the specified time points of 90 days, one and two 
years, with rehabilitation as the exposure variable and adjusted for the following 
other factors: sex, age group and comorbidity. Logistic regression was used rather 
than survival analysis as, unlike mortality,   commencement dates for RAC status 
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were not consistently available. These outcomes were also analysed against LOS 
of acute care and REH episodes within the index hospitalisation. 
All analyses were performed using SAS 9.3 (SAS Institute Inc; Cary, NC) or 
Excel 2010 (Microsoft Corporation, Redmond, WA). Ethics approval was 
obtained from the DVA Human Research Ethics Committee in December 2010 
and renewed in December 2013. 
Results 
There were 1050 community patients who were referred to hospital units for REH 
following acute care for hip fracture. An additional 674 community patients who 
survived the acute phase of care did not receive formal rehabilitation. The 
characteristics of these two groups are listed in Table V5-A. This DVA population 
was somewhat older (mean age 86 years) and with a higher proportion of males 
(36.5 per cent) than is customary for series of hip fracture patients (26). The 
proportions of patients meeting the defined criteria for low mortality risk were 
not significantly different (Table V5-A). Patients aged under 80 years and those 
with associated dementia or delirium were under-represented in the REH 
population, while the reverse applied for patients treated surgically (Table V5-A). 
Multivariate models confirmed a two-thirds increase in referral rate for surgical 
patients, and patients with dementia (ICD10-AM, F01-F05.1 inclusive) were 
referred at one-third of the rate of other patients (data not shown).  
REH involved a distinct increase in total LOS for the index hospitalisation and in 
the cost of hospital care as shown in Table V5-B. The mean total time spent in 
REH units — there were 1172 coded episodes for the 1050 patients — had a 
duration of 25 days and a mean cost of almost $AUD15000. Acute phase LOS 
and cost were higher for the non-REH patients who also had more frequent and 
longer hospital episodes for care of complications and comorbid conditions 
(‘other’ episodes). In univariable models mean total LOS was 14 days longer and 
total costs $AUD14000 greater for REH patients, or 11 days and $AUD 12000 in 
models adjusted for sex, age-group and comorbidity. 
Patient outcomes 
Outcomes were assessed at intervals of 90 days, one year and two years from the 
index admission date. In unadjusted data, the 90-day mortality for REH patients 
was less than half that of non-REH patients (4.7 per cent vs 10.7 per cent, 
p<0.001). In the remainder of the first year after fracture the difference was not 
significant (11.1 per cent vs 13.8 per cent. p=0.11) but in the second year, REH 
patients again had lower mortality (12.9 per cent vs 18.5 per cent, p =0.005). At 
the end of all three time periods, mortality rates were substantially and 
significantly lower for REH patients (Table V5-C). 
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RAC residency among all surviving patients at the end of 90 days was higher for 
non-REH subjects: this difference was maintained when the 50 REH and 28 non-
REH subjects still in hospital at 90 days were excluded. At one year and two years 
after hip fracture there were no significant differences in RAC residency rates 
between the groups. 
The proportion of patients who were living independently, as defined, showed no 
significant differences between the groups at the end of any of the three follow-
up periods (Table V5-C). The higher proportion of REH patients accessing 
community services at 90 days (38.5 per cent vs 24.1 per cent, p<0.001) was a 
factor in reducing the rate of independence for REH patients at this time point. 
There were 3912 hospital readmission episodes (for all causes) recorded for 1007 
(58.4 %) patients within one year of the index fracture (Table V5-B). Readmission 
rates were marginally higher for REH patients (60.3% vs 55.6 %, p=0.049). 
However, readmission status was not a significant variable in regression models 
for the three defined outcomes for REH against non-REH patients. Within each 
subgroup, higher two-year mortality for readmitted REH patients (31% vs 18 %, 
P<0.001) was the only instance in which readmission was significantly associated 
with outcomes. For all causes of readmission, occupied bed days and costs per 
capita were not different for REH and non-REH patients (Table V5-B). There 
were 635 readmission episodes coded as rehabilitation within the first year, for 
239 patients. Of these 580 episodes and 199 patients came from the REH group. 
In models adjusted for sex, age group, and comorbidity (Table V5-C) REH 
patients again had significantly lower mortality risk at the end of all follow-up 
periods. There were no differences in probability of RAC residency across the 
two-year period. There was a clear increase in probability of independent status 
at one year for non-REH patients, but the results at 90 days and two years were 
not different in the adjusted models. These profiles persisted when patients with 
defined ‘low-risk’ were separately considered: 12-month mortality was 5 per cent 
for REH and 13 per cent for non-REH patients (p=0.009), but there were no 
differences in RAC occupation. The inclusion of individual comorbid conditions 
rather than Quan scores in multivariable models did not materially change the 
direction or dimension of these results. 
Among 1050 REH patients, the length of the acute care phase prior to REH 
transfer, a close approximate of time delay between fracture and commencement 
of REH, was directly related to the one-year mortality rate in the univariate 
analysis (Table V5-D). Longer acute care was associated with higher rates of 
RAC residency and lower rates of independence at one year. The total time in 
REH was not associated with one-year mortality in either univariate analysis or 
in models adjusted for sex, age-group and comorbidity weight. There was a direct 
association between duration of REH and rate of residence in RAC, and an 
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inverse relationship with the likelihood of independent living, at one year post-
fracture, in both univariable and multivariable analyses (Table V5-D). Similar   
associations were found in respect of acute phase LOS.  
A total of 306 patients (29.1 per cent) who received REH and 212 (31.5 per cent) 
of those without REH became RAC residents at some time within one year of 
fracture. Total time in RAC was 68.3 days per capita for REH patients and 71.5 
days for non-REH patients. Neither of these differences was significant. 
Among community-dwelling survivors at one year, 275 subjects (25.0 per cent) 
were receiving community nursing and/or veterans’ home care services. These 
subjects did not differ from those not receiving services with regard to 
male/female distribution, mean age, or comorbidity scores. It was found that more 
REH patients were referred to community nursing in the first 90 days after 
hospital discharge, but the difference was not significant for later end-points. 
Rates of death or RAC placement between one and two years were not different 
for these patients (data not tabled).  
Discussion 
Admitted care for rehabilitation following hip fracture added almost 2 
weeks to the index hospital stay and at least $AUD 12000 to hospital 
costs. Among patients referred for REH, mortality at one and two years 
post-fracture was lower by 40 percent than for patients not referred. The 
rates of admission into, duration of residence in aged care facilities or 
proportion of patients meeting criteria for independent living were not 
significantly different in multivariable models. Hospital readmission rates 
during the first post-fracture year were not reduced for REH patients. 
The acute hospital management of hip fracture continues to be refined, and 
continues to yield better results with respect to hospital mortality, 
complication rates and hospital costs  (27, 28). The benefits of subsequent 
REH for sustained survival and independent living, whether in hospital 
units or a variety of community-based programs have not been so 
convincing (19, 20, 22). 
The claim that multidisciplinary REH may have both short and longer- term 
benefits is advanced in both systematic review (19) and meta-analysis (20). 
However only a minority of the quoted studies (4 of 9 in the latter report) relating 
to hip fracture continued follow-up to the end of the first post-fracture year. Our 
paper suggests that outcomes in the first 90 days after fracture are not consistently 
predictive of ongoing outcomes. When data from meta-analyses (20) were 
restricted to studies with at least 12-months follow-up, associations between REH 
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and positive 12-month outcomes were significant for Katz scores (two studies 
only) but not significant for RAC admission (RR 0.79, 95% CI 0.51-1.22, p=0.30) 
and borderline for mortality (RR 0.76, 95% CI 0.58 -1.00, p=0.047). 
Analyses of a large sample of Medicare (USA) data for the period 2000–2008 
(14) showed that the proportion of hip fracture patients admitted from RAC (the 
most frail) declined, while providing indirect evidence for an increase in rates of 
transfer to and duration of post-acute REH. Despite these trends, the proportion 
of subjects resident in RAC at one year post-fracture remained essentially 
unchanged at 35 per cent. Providing more institution - based REH for a seemingly 
more robust population did not translate into better outcomes (14). 
In the present study, increased length of in-hospital REH was inversely related to 
independence at one year, with residence in RAC being more than twice as likely 
for patients in REH for 35 days or longer than for patients in REH for less than 3 
weeks. Data from almost 68000 REH episodes for “orthopaedic conditions” (22 
per cent hip fracture) in the United States showed a 42 per cent fall in LOS over 
the period 1994-2001, associated with a slight increase in proportion of patients 
living at home at 180-day follow-up (29). An earlier American study found that 
longer stay in REH was associated with reduced ADL capacity after one year 
(30).  
The present study has confirmed the overall findings from a systematic review 
(23) that REH does not impact upon hospital readmission rates. The relationship 
between readmissions and longer term outcomes is complex for hip fracture 
patients. One Italian study reported ongoing higher mortality beyond 180 days 
for readmitted patients, but this finding was not tested in multivariate analysis 
(31). A study in Genova found that the predictors for readmission within one year 
of  fracture were comorbidity and low functional status at original discharge (32), 
factors which are themselves associated with higher mortality . 
The evidence for any superior clinical benefit from delivery of REH in hospital 
units compared to use of alternative models, including home-based programs, is 
also weak. More than 30 years ago Swedish researchers (33) noted that prolonged 
hospitalisation, whether in orthopaedic or rehabilitation units, was associated 
with reduced capacity for subsequent independence. They advocated for early 
hospital discharge and consideration of rehabilitation as a domiciliary program. 
At the same time a Danish team (34) identified substantially lower costs but 
equivalent outcomes for patients rehabilitated in convalescent hospitals with 
physical therapy services, compared with similar patients treated in specialist 
REH hospitals. 
A small Australian trial of domiciliary vs hospital-based REH for previously 
independent patients showed no differences in measures of physical function at 
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12 months. Importantly, carer burden was reduced for patients treated at home 
(35). Another Australian program (HIPFIT) provided 12 months of high-intensity 
resistance training coupled with evidence-based treatment of other issues relevant 
to frailty, in a multidisciplinary outpatient program supervised by a geriatrician. 
Although study numbers were small - 62 participants, 62 controls - significant 
reduction in mortality and nursing home occupation after 12 months was achieved 
(18). In 2007, a study in Tuscany (17) showed that REH models for hip fracture 
ranging from admitted care to domiciliary programs, with an 18-fold cost 
variation, produced very similar 6-month mortality rates.  
Despite the weak evidence for sustained benefits from hospital-based REH, the 
age-standardised rates of  hospital-based REH (for all conditions) increased in 
Australia from 18 to 32 per 1000 persons aged ≥ 65 years between 1998-99 and 
2011-12 (2, 3). Evidence for a similar increase in ambulatory programs is lacking. 
Of almost 50000 episodes of REH for orthopaedic fractures (all types) reported 
to the Australasian Rehabilitation Outcomes Collaboration (AROC) from 2012 
to 2014 inclusive, only 2.4 % were in ambulatory settings (36).   
The assessment of “potential to benefit” which is integral to the process of 
selection for admission into REH appears to identify factors associated with better 
survival. In this analysis of community patients, referral to REH was associated 
with prolonged survival benefit. Perhaps surprisingly, given that REH programs 
are directed toward improvement of functional capacities, no impact was found 
upon longer-term dependence upon RAC, or use of community support services, 
even though there were lower rates of identified dementia in the REH group.  
The principal strengths of this study lie in the substantial patient numbers, the 
comprehensive dataset and most importantly the facility for linkage of hospital, 
aged care and mortality data. The potential for coding errors in administrative 
data is acknowledged, but acceptable coding accuracy for hip fracture in database 
records has been confirmed (37), further enhanced by the additional inputs 
through episode linkage (38). Under-reporting of some comorbidities is highly 
probable, particularly as the look-back period, confined to the “study-year” was 
of necessity brief for some patients. However this would be at least as  likely to 
add to the validity of any identified associations as  otherwise.  
The study would have been strengthened by access to data describing physical 
function status such as with Functional Independence Measure (FIM) scores and 
also by information on carer and social context at both the commencement of 
rehabilitation and at specified follow-up intervals. Associations between both of 
these items and short-term mortality and functional gain following REH are well 
established (39, 40). The study data contained no details of differences in the 
admission criteria, processes or intensity of the REH programs delivered by the 
various public and private hospitals. The reasons why individual patients were 
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not selected for REH could not be discerned from the study databases. It is 
appreciated that patients can be either too able or too frail to meet REH admission 
criteria, the similarities in patient characteristics between the REH and non-REH 
groups would suggest that neither reason was sufficiently prominent to bias the 
study findings. 
It is acknowledged that the DVA population is atypical, being several years older 
than the general hip fracture population in Australia (29), and having a higher 
proportion of males. Where comparable data sets are available, mostly relating to 
acute hospital care, utilisation data are very similar (25, 29), and patient age has 
only minor impact upon hospital stay and costs in the population presented here 
(25). However the findings and conclusions should be generalised with caution, 
unless compared in age-gender specific analyses. 
Database studies, with restricted capacity for describing clinical details, have an 
important role in presenting broad descriptions  of  process and outcomes for large 
patient populations. As with this study, important questions of efficacy and cost-
efficiency may be posed, which call for analyses based upon studies with access 
to deeper levels of both clinical and administrative detail. 
In summary, this paper has found, in a large series of elderly, community-dwelling 
Australians, post-fracture rehabilitation in hospital was associated with lower 
mortality for up to two years. There were no consistently significant effects 
attributable to REH upon hospital readmission rates, proportions of survivors who 
required support in Aged Care facilities, in the total days in RAC for the first post-
fracture year, or in the proportions of patients living without defined community 
services. Hospital-based REH added substantially to the duration and cost of the 
index hospital admission and prolonged stay in rehabilitation units was associated 
with poorer long-term outcomes. Given that hospital-based REH is resource 
intensive, and the cited evidence that non-hospital REH programs provide  
equivalent long-term outcomes, it is suggested that community-based programs 
be further considered for hip fracture patients. 
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Table V5-A. Patient characteristics of 1724 community-dwelling 
patients by rehabilitation selection  
 Rehabilitation 
(N=1050) 
No Rehabilitation 
(N=674) 
 
 N Per cent N Per cent P  
Males 383 36.5 245 36.4 0.96 
Mean age (years)  86.0  85.8 0.45 
Age group     0.004 
≥ 90 226 21.5 151 22.4  
85–89 471 44.9 302 44.8  
80–84 289 27.5 152 22.6  
< 80 64 6.1 69 10.2  
Fracture type     0.10 
Cervical 413 39.3 255 37.8  
Trochanteric 459 43.7 277 41.1  
Subtrochanteric 37 3.5 38 5.6  
Other 141 13.4 104 15.4  
Surgery  88.9  84.9 0.02 
Quan score     0.12 
≥ 3 132 12.6 106 15.7  
1–2 312 29.7 205 30.4  
0 606 57.7 414 53.9  
Low mortality risk 1 174 16.6 104 15.4 0.53 
Comorbidities 
Cancer 83 7.9 42 6.2 0.19 
Cardiac failure 132 12.6 67 9.9 0.09 
Dementia 101 9.6 152 22.6 <0.001 
Diabetes 44 4.2 33 4.9 0.17 
Cardiac ischaemia  106 10.0 57 8.5 0.25 
Renal failure 136 13.0 82 12.2 0.63 
Respiratory disease 92 8.8 41 6.1 0.13 
Stroke 62 5.9 37 5.5 0.72 
Complications 
Anaemia 83 7.9 53 7.9 0.46 
Delirium 92 8.8 41 6.1 0.04 
Pressure ulcer 87 8.3 46 6.8 0.27 
Respiratory infection 122 11.6 76 11.3 0.83 
Urinary infection  112 10.7 82 12.2 0.34 
1  Relative low mortality risk: Females aged < 85 years, comorbidity = 0 
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Table V5-B. Hospital utilisation data: 1724 community patients with hip 
fractures 
 Rehabilitation (N=1050) No rehabilitation (N=674) 
 Patients Days 95% CI Patients Days 95% CI 
P 
Mean length of stay : index hospital admission 1 
 Acute phase 1050 11.8 (11.3-12.3) 674 17.5 (16.3-18.7) <0.001 
 Rehabilitation 1050 25.1 (24.2-26.0) - – – – 
 Other episodes 273 20.7 (18.4-23.0) 238 30.5 (27.1-34.1) <0.001 
 Total 2 1050 42.4  (40.9-43.9) 674 28.3 (26.1-30.5) <0.001 
Readmissions within 365 days of index admission 
Patients 3 (%) 633  60.3 (57.3-63.3) 374  55.6 (51.8-59.4) 0.05 
Mean Days 4 1050 14.5 (12.6-16.4) 674 17.1 (13.5-20.6) 0.11 
Days > 30 5 (%) 182  28.8 (25.3-32.3) 112  29.9 (25.3-34.5) 0.69 
Mean total hospital costs  
$AUD 
 
95% CI $ AUD 95% CI 
 
Index admission 40439 (39338-41640) 26242 (24913-27571) <0.001 
Readmissions 14170 (12566-15774) 14729 (12373-17085) 0.06 
Total 54595 (52685-56505) 40970 (22492- 30022) <0.001 
1 LOS data for rehabilitation patients from Ireland et al. BMC Health Services Research 2015, 15:17 
doi:10.1186/s12913-015-0697-3 (Table V2-B).                                                                                                                                                           
2 Total LOS = Acute + Rehabilitation + pro-rata for Other episodes                                                         
3 Patients who had at least one hospital readmission  
4 Days = sum of LOS for all readmission episodes / all patients 
5 Mean days as for 4  above 
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Table V5-C. Outcome rates by rehabilitation status in 1724 acute phase 
survivors after hip fracture 
  Univariable analyses 
 Interval 1 With rehabilitation N=1050 Without  rehabilitation N=674 
 N Per cent (95 % CI) N Per cent 95 %CI P 
Death 
90 days 49 4.7 (3.4–6.0) 72 10.7 (8.4–13.0) <0.001 
One year 160 15.2 (13.0–17.4) 155 23.0 (19.8–26.2) <0.001 
Two years 275 26.2 (23.5–28.9) 251 37.2 (33.5–40.9) <0.001 
RAC resident 
At 90 days 150 15.0 2 (12.8–17.2) 114 18.9 (15.8–22.0) 0.04 
At one year 192 21.6 (18.9–24.3) 120 23.1 (19.5–26.7) 0.50 
At two years 148 19.1 (16.3–21.9) 79 18.7 (15.0–22.4) 0.95 
Independent living 3 
At 90 days 592 56.3 2 (53.3–59.3) 404 59.9 2 (56.2–63.6) 0.14 
At one year 438 41.7 (38.7–44.7) 313 46.4 (42.6–50.2) 0.054 
At two years 396 37.7 (34.8–40.6) 271 40.2 (36.5–43.9) 0.30 
       
Multivariable 4 analyses: Outcome risk for rehabilitation patients 
Interval 1 Death RAC Resident Independent living 3 
 OR 6 95% CI P OR 95% CI P OR 95% CI P 
90 days 0.40 (0.3–0.6) <0.001 0.89 (0.7–1.2) 0.42 0.87 (0.7–1.1) 0.19 
One year 0.61 (0.5–0.8) <0.001 1.09 (0.8–1.4) 0.52 0.46 (0.4–0.6) 0.002 
Two years 0.59 (0.5–0.7) 0.003 1.22 (0.9–1.6) 0.18 0.87 (0.7–1.1) 0.20 
 
1 Interval= Time since index hospital admission 
2 Per cent survivors at specified time point: 150/(1050 – 49) = 15.0 per cent at 90 days 
3 Not deceased, not in RAC, not receiving community nursing or veterans’ home care 
4 Adjusted for sex, age-group, comorbidity  
5 OR = Odds Ratio for given outcome for REH vs non-REH  
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Table V5-D. One-year outcomes by length of stay in acute care and 
rehabilitation for 1050 patients receiving rehabilitation 
 Death Residential aged care Independent living 1 
 Per cent 95 % CI Per cent 95 % CI Per cent 95 % CI 
Acute care LOS 
< 10 days 12.0 (9.1–14.9) 17.9 2 (14.2–21.6) 72.3 (68.3–76.3) 
10 –14 days 15.7 (11.7–19.7) 22.6 (17.6–27.6) 65.2 (60.0–70.4) 
≥ 15 days  20.2 (15.3–25.1) 31.1 (24.8–37.9) 55.0 (48.1–61.1) 
P 0.004 0.017 <0.001 
Rehabilitation LOS 
< 21 days 13.5 (10.4–16.6) 16.3 (12.7–19.9) 72.4 (68.3–75.5) 
21–34 days 15.3 (11.7–18.9) 22.4 (17.9–27.0) 65.7 (60.9–60.5) 
≥ 35 days 19.2 (13.8–24.6) 32.3 (25.2–39.4) 54.7 (47.9–61.5) 
P 0.16 <0.001 <0.001 
Multivarible 3 for Acute LOS  
         
 OR 4 95 % CI OR 95 % CI OR 95 % CI 
< 10 days referent referent referent 
10 –14 days 1.47 (0.96-2.24) 1.09 (0.73-1.64) 0.79 (0.58-1.05) 
≥ 15 days  1.60 (1.04- 2.45) 1.93 (1.30- 2.88) 0.66 (0.48-0.91) 
P 0.066 0.003 0.030 
Multivariable 3 for Rehabilitation LOS 
< 21 days referent – referent – referent – 
21–34 days 1.07 (0.72-1.59 1.34. (0.92-1.97) 0.79 (0.59-1.04) 
≥ 35 days 1.28 (0.81-2.03) 2.21 (1.44-3.43) 0.60 (0.42-0.86) 
P 0.57 0.002 0.015 
1 Neither deceased ,resident in RAC nor receiving community services 
2 Per cent of survivors at 365 days 
3 Adjusted for sex, age group, comorbidity                                                                                                   
4 OR = Odds Ratio for given outcome for REH vs non-REH  
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Section VI. Overview of results with additional findings  
In this section the principal findings of the various studies within this thesis are 
reviewed and summarised. Some additional original research findings are 
included where relevant to better illustrate the complexity of the data and to add 
further context to the published material in Section V.  All additional material 
presented in this section is drawn from the original study databases by methods 
described for the individual research studies in Section V.                   
 VI (1). Length of Stay 
Research studies 1 and 2 have identified the total burden of hospital stay for the 
initial management of hip fracture, the varied composition of that stay and the 
factors associated with shorter or longer time from admission to final discharge. 
These findings address the requirements of Objectives 1 and 2 in Section IV(1). 
The mean acute phase LOS for unlinked episodes in this study was 11.1 days 
(median 10 days): 11.4 days for men and 10.9 days for women. There was a small 
increase of slightly more than one day in mean LOS with increasing age between 
70 and 85 years, which was significant for women, but not for men. Patients aged 
90 years or older had shorter acute LOS than did octogenarians. 
Episode linkage for acute care showed that 22 per cent of patients had multiple 
acute episodes coded to hip fracture, with eight patients having four such 
continuous episodes. When additional acute phase episodes for the same patient 
were combined, the mean LOS was 20 per cent higher at 13.4 days than the 
unlinked value. 
Total LOS for hip fracture is the sum of all hospital time for acute fracture 
management, rehabilitation and care for other reasons, the latter group ranging 
from management of surgical complications, to issues arising from pre-existent 
comorbidity to subacute care while completing discharge arrangements. Only 41 
per cent of patients were discharged from hospital after a single episode while the 
other 59 per cent of patients averaged 2.8 episodes each. The most complex 
hospitalisation involved eight episodes of care in five different hospitals. The 
variety of episode combinations and eventual LOS demonstrates the clinical 
complexity of this patient population.  The mean total LOS identified in Research 
Study 1 was 30.8 days with a median of 26 days. The range was 1-310 days. 
Almost 7 per cent of patients were in hospital for 10 weeks or longer. 
Composition of total hospital stay 
Research Study 2 found that 43 per cent of total stay occurred in the initial acute 
phase. Rehabilitation as admitted care accounted for a further 37 per cent, and the 
remaining 20 per cent was on account of other episodes comprised of acute care 
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for complications and comorbidities, and subacute care for other reasons. There 
were 1352 episodes of in-hospital rehabilitation for 1172 patients (46 per cent) 
and 652 patients (26 per cent) had 780 other episodes as defined. Referral to 
rehabilitation occurred in 57 per cent of community patients and 17 per cent of 
RAC patients (P<0.001) and other episodes were identified for 30 per cent of 
community patients and 20 per cent of patients from RAC (P<0.001). 
There were 780 episodes for 652 patients for reasons other than acute fracture 
management or rehabilitation. This group was not separately analysed in Study 
2. These patients did not differ from the whole sample with regard to age or sex 
distribution.   Immediate and longer-term outcomes for this group are described 
in the review of Research Study 3 (page 129). 
Determinants of LOS 
Patients who were admitted from RAC or from the community had widely 
different episode distributions and resultant total LOS values of 18.8 days and 
35.4 days respectively (Table V2-B). An extensive list of factors which increase 
acute LOS for community and RAC patients are shown in Study 2, Table V2-C. 
The profiles of associations with altered LOS differed markedly between 
Community and RAC patients, as demonstrated in Study 2, Tables V2-C and V2-
D. For RAC patients, neither acute nor total LOS was impacted by any comorbid 
condition, but transfers to rehabilitation or intensive care were associated with 
much greater increases than for community patients (Tables V2- C, D). 
For the combined study sample, total LOS for patients referred for rehabilitation 
was 20 days longer than that of other patients. Total LOS for patients requiring 
other episodes was 49 days, even though the proportion referred to rehabilitation 
within this was not significantly high (48 per cent vs 45 per cent, P = 0.31). When 
the length of “other” episodes was seven days or longer (478 patients), mean total 
LOS was 56 days. 
Table VI-1 shows the associations with both acute phase and total LOS for the 
complete study population. The mean values for LOS increments are the 
exponentials of outputs from multivariable negative binomial regression models. 
Increases of greater than 2 days in the acute phase were associated with, in 
descending order, wound infection, skin (pressure) ulcer, urine infection, chest 
infection and referral to intensive care.  For total LOS, increases of greater than 
3 days were associated with referral to rehabilitation, transfers to unspecified 
facilities, skin ulceration, wound infection, urinary infection, Parkinson’s disease, 
subtrochanteric fracture and age between 85 and 89 years. 
Death in hospital was the only factor associated with a substantial decrease in 
either acute or total LOS for the complete population. It was evident from the data 
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of Table VI-1 that individual comorbidities play only a minor role in determining 
LOS. There was a small but significant increase in acute LOS for patients with 
multiple comorbidities (Quan score ≥ 2), of 0.9 extra days (P = 0.03), but no 
significant difference in respect of total LOS (P = 0.32). Complications exerted a 
much greater influence upon both acute and total LOS, especially pressure ulcers, 
and urinary tract or surgical site infections (Research Study 2). By far the 
strongest overall determinants of hospital stay were pre-admission residential 
status and referral for rehabilitation. The requirement for other hospital episodes 
other than acute phase and rehabilitation was a third major determinant. 
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Table VI-1. Factors significantly associated with acute and total LOS 
after hip fracture 
 Acute LOS : Baseline1 = 10.6 days Total LOS: Baseline = 13.7 days 
 Increment2 (95% CI) P Increment (95% CI) P 
Age-group  0.04  < 0.001 
< 80 referent  referent  
80-84 0.4 (-0.8, 1.9)  2.5 (0.6–4.6)  
85-89 1.0 (-0.3, 2.4)  3.4 (1.5–5.5)  
≥ 90 0.0 (-1.2, 1.3)  1.4 (-0.3, 3.4)  
Fracture Type –   
Cervical  referent  referent  
Trochanteric –  1.6 (0.7–2.5)  
Subtrochanteric –  3.5 (1.3–6.0)  
Unspecified  –  3.8 (2.5–5.3)  
Separation mode  < 0.001  < 0.001 
Usual residence  referent    
New RAC transfer 1.5 (0.4–2.7)  0.0 (-0.9, 0.9)  
Other transfer   6.2 (4.1–8.5)  
Death -1.3 (-2.7, -0.2)  -2.9 (-3.9, -1.8)  
Rehabilitation – – 12.5 (11.0–14.1)  
Surgery 1.3 (0.4–2.2) 0.003 –  
Intensive care 2.2 (0.9–3.6) 0.001 3.0 (1.3–4.9) 0.001 
Comorbidities 
Dementia – – -1.2 (-2.0, -0.3) 0.008 
Diabetes – – 2.1 (0.7–3.6) 0.002 
Parkinson's disease – – 3.9 (1.3–6.9) 0.001 
Cardiac failure 1.8 (0.8–2.8) < 0.001 – – 
Cerebrovascular 1.4 (0.1–2.8) 0.03 – – 
Complications 
Anaemia – – 1.5 (0.3–2.7) 0.001 
Delirium 1.6 (0.5–2.9) 0.006 2.6 (1.1–4.2) < 0.001 
Pressure Ulcer 4.9 (3.4–6.6) < 0.001 5.3 ( 3.9–6.8) < 0.001 
Chest infection 2.2 (0.9–3.6) < 0.001 2.2 (0.9–3.7) < 0.001 
Urinary infection 2.5 (1.5–3.6 ) <0.001 4.0 (2.7–5.3) < 0.001 
Wound infection 5.6 (2.1–10.2) < 0.001 5.0 (2.0–7.9) < 0.001 
1 Baseline = LOS for female <80 years with cervical fracture: no surgery, 
 rehabilitation, intensive care, comorbidity, complications: separated to 
 usual residence 
2  Mean additional days above baseline value    
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VI (2). Costs of hospital treatment 
The charges raised by hospitals for accommodation, theatre, prostheses and for 
any package arrangements with DVA were identified in Study 1, Table V1-B. The 
mean cost for the complete period of acute phase care was very close to 
$AUD15,000 and for total stay was just above $26,000. In subsequent work 
comparing DVA costs in the different states, additional fees for health practitioner 
services during hospitalisation (Study 4) raised the mean total cost of the index 
hospitalisation to slightly above $31,000. While formal cost analyses and 
projections are outside the expertise of this Thesis, the current cost for total 
hospital management would be in excess of $45,000 if annual inflation of 5 per 
cent was applied, as quoted for public hospital spending 2008 to 2015.[78] 
Determinants of hospital cost 
These are displayed in Table VI-2.The mean cost increments above defined 
baselines were derived by the same method as for LOS values (Table VI-1). As 
may be expected the factors associated with the greatest cost increases were 
similar to those responsible for increased LOS. The major cost increases were 
associated with transfers to rehabilitation, intensive care, surgical treatment and 
surgical site infection. Co-incident Parkinson’s disease and complicating pressure 
ulcer are the next most substantial cost factors. Effecting discharge to other than 
pre-admission accommodation increased expense. Subtrochanteric fractures were 
more costly for RAC but not community patients, otherwise sex, age group and 
fracture type are not substantial determinants of hospital cost. Patients with 
multiple comorbidities (Quan ≥ 2) had only slightly greater total costs than those 
with single or zero comorbid conditions ($32000 vs $30630, P=0.037). 
In unadjusted data, determinant factors for cost had a strongly cumulative effect. 
RAC patients treated non-surgically, without rehabilitation, who did not acquire 
a pressure ulcer and return to RAC (n=66) had a mean cost of $10,010. 
Community patients treated surgically, referred to rehabilitation, had a 
complicating pressure ulcer and are discharged to RAC (n=38) have a mean cost 
of $54,027. 
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Table VI-2. Factors significantly associated with cost for total hospital 
stay after hip fracture 
 All Patients (N=2552) Community (N=1844) RAC  (N=708) 
Baseline Cost1 $AUD 13195 $AUD 15217 $AUD 10459 
 Increment  (95% CI)2 Increment (95% CI) Increment (95% CI) 
Age-group  
< 80 referent referent referent 
80-84 718 (-409, 1946) – – 
85-89 1509 (368–2747) – – 
≥ 90 413 (-692, 1616) – – 
Fracture Type  
Cervical referent referent referent 
Trochanteric -530 (-1052, 13) – -949 (-1614, -234) 
Subtrochanteric 2827 (1293–4520) – 3528 (1110–6450) 
Unspecified 503 (-263, 1314) – 180 (-808, 1270) 
Separation mode 
Usual residence  referent referent referent 
New RAC transfer 295 (-296, 913) 3179 (2154–4262) N/A 
Other transfer 3291 (2041–4647) 3365 (1932–4919) 4282 (871–8721) 
Death -220 (-1066, 683) 173 (-1034, 1485) 276 (-690, 1336) 
Rehabilitation 9265 (8359–10210) 9382 (8241–19579) 7197 (5708–8821) 
Surgery 5765 (4751–6837) 5036 (3853–6291) 9230 (7379–11272) 
Intensive Care 5360 (4023–6837) 5454 93781–7276) 4869 (2731–7373) 
Comorbidities  
Cardiac failure – 1157 (67–2325) – 
Diabetes 1296 (409–2234) 1266 (73–2552) – 
Parkinson’s 2525 (872–4371) 3548 (1121–6338) – 
Cerebrovascular 1577 (482–2759) 259 (697–3974)  
Complications  
Anaemia 1682 (893–2516) 1643 (570–2786) 1520 (498–2638) 
Delirium 2364 (1395–3399) 2187 ( 873–3609) 1917 (697–3369) 
Pressure ulcer 3232 92369–4142) 3824 92646–5081) 2095 (975–3327) 
Chest infection 1237 9357–2174) 1423 (179–2768) – 
Urinary infection 2417 91639–3235) 2338 (1304–3436) 2862 (1724–4108) 
Wound infection 4942 (3336–6703) 5254 (3295–7421) 3936 (1090–7483) 
1 Baseline = LOS for female <80 years with cervical fracture: no surgery, 
 rehabilitation, intensive care, comorbidity or complications: separated to usual 
 residence 
2 Additional cost above baseline value 
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VI (3). Outcomes at hospital separation. 
The identified outcome measures were for death, transfer to RAC, transfer 
between or within hospitals and discharge to residence other than RAC. In the 
mean interval of 19.7 days between the end of the (unlinked) acute phase and 
final discharge the profile of these separations changed markedly as shown in 
Research Study 1, Table V1-D, and in Figure VI-1. The high proportion of 
transfers into other hospital episodes after the acute phase (50.9 per cent) were 
almost all reclassified at final discharge, when a small number of further transfers 
were to unidentified facilities. Only 23 per cent of patients were discharged 
directly from the acute phase to private homes. At final discharge 58 per cent of 
patients were initially assigned separation code 9 (“to usual residence”). This was 
reduced to 44 per cent after linkage with RAC data caused all but 14 of code 9 
separations for RAC patients to be reclassified as returning to residential aged 
care. Among community patients 60 per cent returned to non-institutional living. 
 
 
Figure VI-1. Separations from unlinked acute episodes and at final 
discharge 
Overall, men were less likely to be transferred to RAC than women (34.9 per cent 
vs 39.6 per cent (P=0.02)). Mortality rates at final hospital discharge were higher 
for men (16.9 per cent vs 7.6 per cent). 
At final discharge 60 per cent of community patients returned to private 
accommodation, 9.5 per cent had died and 21 per cent were transferred to RAC 
(although almost half of these were short term residents only). Small proportions 
were discharged to other health facilities to unidentified locations. Among RAC 
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patients, 80 per cent (97 per cent of hospital survivors) returned to RAC, 15 per 
cent died in hospital and 14 patients returned to non-institutional living. The 
different separation profiles are shown in Figure VI-2. 
 
 
Figure VI-2. Outcomes at final discharge for RAC and community patients 
VI (4). Mortality 
Research Study 3 addressed mortality rates and the factors associated with greater 
or lesser survival at intervals from 3 months to two years after hip fracture. 
Comparative mortality rates between hip fracture patients and a standard DVA 
population for 4 years after fracture have also been calculated. These results were 
in response to the requirements of Objective 4. 
The data presented for the DVA  study  population in 2008-09 showed 30-day 
mortality of 11 per cent, one-year mortality of 34 per cent, 47 per cent at two 
years and only one-third of patients surviving 4 years. Within these overall data 
there was wide diversity in mortality. At all listed time points the mortality rate 
for males was significantly higher (P <0.001). Admission from RAC and multiple 
comorbidities (Quan score ≥ 2) also increased the risk of death. The very large 
combined impact of these predictors is shown in Figure VI-3. Women aged below 
85 years from the community and with no recorded comorbidity had one-year 
mortality of 10 per cent, while the rate for men aged 85 years or older from RAC 
with multiple comorbidities was 89 per cent. 
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Figure VI-3. Mortality rates by sex and risk status 1                                                          
1  RAC patients aged ≥ 85 years with multiple comorbidities are high risk group for mortality  
 
Predictors of mortality 
In multivariate models the profiles of significant predictors varied across time 
(Research Study 3, Table V3-C). In the first 30 days, the mortality rate was 
approximately doubled by male sex, older age and admission into intensive care, 
and patients from RAC had a 50 per cent greater risk of dying. Patients selected 
for surgical treatment or rehabilitation were much less likely to die in this period. 
Cardiac failure, non-AMI ischaemic heart disease and renal disease all increased 
mortality risk by approximately 50 per cent. 
Between 30 days and one year, RAC patients were three times more likely to die 
than were community patients. Male sex and age over 80 years continued to 
carried increasingly high risk. (Study 3, Table V-3-C). Admission into intensive 
care, comorbid cardiac failure and renal disease continued to impart a higher risk 
as earlier. Patients with cerebrovascular disease, cancer and pressure ulcers prior 
to or at the time of hip fracture had increased risk of death between 30 days and 
one year after fracture. Rehabilitation continued to be associated with lower 
mortality, but the lower mortality among patients treated surgically was no longer 
evident. Patients who had additional or ‘other’ episodes within the index 
admission had similar mortality rates at one year and two years to those of the 
rest of the study population, even though comorbidity measured by mean Quan 
scores was higher in this sub-group. 
Direct transfer of community patients from hospital to RAC (new RAC transfer) 
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was also associated with higher mortality after 30 days (Study 3, Table V3-C). At 
90 days, 36 of 391 such patients (9.2 per cent) had died and at the end of one year 
26.1 per cent had died. Corresponding values for community patients discharged 
elsewhere were 2.7 % and 12.1 per cent (P<0.001). 
In the second year following hip fracture, 335 patients died (20% of 12-month 
survivors). Males were 40 % more likely to die, and risk for those aged 90 years 
or older was nearly three times that for persons younger than 80 years. Patients 
from RAC were more than three times more likely to die. Diabetes with 
complications, cardiac failure, cancer and dementia were, in descending order, 
associated with increased mortality, the latter having borderline significance 
(Research Study 3, Table V3-C). 
The higher mortality for RAC patients is again illustrated in Figure V3-A, which 
shows survival curves for four identified risk groups. Females from the 
community had one-year mortality of 19 per cent while 72 per cent of males from 
RAC had died. The addition of extra variables for age and comorbidity further 
widened this disparity. Of 216 community females aged below 85 years and with 
no comorbidities, 10 per cent were dead at one year, compared with 89 per cent 
of RAC males aged 85 years or older with two or more comorbidities. 
Table V3-D in Study 3 shows mortality rates for males and females standardised 
against the DVA TPOP for each of the four years following fracture. Comparison 
rates are higher for all four years, being substantially higher in year 1, then 
essentially stable. Males and females had similar ratios. Higher than expected 
mortality was sustained into the fourth year after fracture for all patients except 
for males aged 90 years or older. 
VI (5). Hospital readmission 
Hospital readmission within one year of the index fracture occurred in 52 per cent 
of 2269 patients who survived the initial hospitalisation (RAC patients 47 per 
cent, community patients 53 per cent). Total readmission episodes were 4499 (2.0 
per patient) for a total of 31,069 bed-days (13.7 per patient). Further details are 
summarised in Table VI-3. 
Readmission rates were significantly higher for community patients than for RAC 
patients (60.4 per cent vs 44.6 per cent, P < 0.001). Lower rates for RAC patients 
were partly offset by their shorter average survival time within the first year (220 
vs 299 days). Among community patients who survived the acute phase of the 
index admission, patients referred to REH had marginally higher readmission 
rates as shown in Research Study 5, (60.3% vs 55.6 %, p=0.05).  Readmission 
status was not a significant variable in regression models for the three defined 
outcomes for REH against non-REH patients. Within each subgroup, higher two-
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year mortality for readmitted REH patients (31% vs 18 %, P<0.001) was the only 
instance in which readmission was significantly associated with outcomes. For 
all causes of readmission, occupied bed days and costs per capita were not 
different for REH and non-REH patients (Table V2-B). There were 635 
readmission episodes coded as rehabilitation within the first year, for 239 
patients. Of these 580 episodes and 199 patients came from the REH group. 
 
Table VI-3. Hospital readmissions within one year for 2269 survivors 
of initial hospitalisation for hip fracture 
 All 
(N=2269) 
Community 
(N=1668) 
RAC 
(N=601) 
 
Readmitted patients 1276 1008 268  
Per cent survivors 56 60 45  
 
Episodes 
 
4499 
 
3913 
 
586 
 
Per patient 2.0 2.3 1.0  
Per readmitted patient 3.5 3.9 2.2  
 
Bed-days 
 
31069 
 
27174 
 
3895 
 
Per patient 13.7 16.3 6.5  
Per readmitted patient 24.3 27.0 14.5  
 
VI (6). Association between resource outlay and patient outcomes: 
comparative data for Australian States 
This relationship was examined in Research Study 4, by comparing hospital stay 
and costs in the different states of Australia with one year outcomes for death and 
measures of independent living. The results of this study address the requirements 
for Objective 5. For the purposes of this analysis, data in respect of the Australian 
Capital Territory was combined with that for New South Wales and Northern 
Territory data with that for South Australia. The patient demographics, 
proportions of patients treated surgically and of those with significant 
comorbidity were not significantly different between the six populations.  
Hospital services and costs 
As shown in Study 4, Table V4-A, the proportions of patients referred to intensive 
care and rehabilitation units varied significantly across Australia. Both of these 
services are associated with significant and substantial cost increments in the data 
for this thesis (Table VI-2). The range for identified intensive care admission rates 
was from zero to 14 per cent (P<0.001), and for rehabilitation between 32 per 
cent and 50 per cent (P=0.003). Mean acute phase LOS was between 9 and 15 
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days (P<0.001) and total LOS was between 25 and 36 days (P<0.001). Both the 
frequency and duration of rehabilitation episodes varied widely and significantly 
(Study 4, Figure V4-A).  The sum of costs for hospital accommodation, theatre, 
prosthesis and package fees negotiated by DVA with individual providers, plus 
charges for medical, allied health, and diagnostic services, ranged from $24,052 
to $36,247, a spread of more than 50 per cent around the mean of $31,028 (Figure 
V4-A). 
Post-hospital services 
Data were collated for episodes of service by community nursing and by Veterans’ 
Home Care, the latter providing a basket of personal and domestic services and 
also both institutional and in-home respite. The density of service provision and 
the currency of services at the end of the one year follow-up were identified. The 
total days in RAC after hospital discharge and the number of surviving patients 
who were RAC residents at year’s end were also tabled for community patients. 
Again the differences in provision of these items differed substantially and 
significantly among the states. 
Outcome measures 
Rates for mortality, current RAC residency and a defined level of independence 
were compared at one year from the index hospital admission in both univariate 
and multivariate models adjusted for sex, age group comorbidity weight, pre-
fracture RAC status, rehabilitation during initial hospitalisation and receipt of 
nursing and/or VHC services in the post-hospital period. Patients who were alive, 
not in RAC and not currently receiving nursing or VHC services were deemed to 
be living independently. In multivariable models there were no significant 
differences in rates of defined outcomes between Australian states. Mortality 
varied from 31 per cent to 41 per cent (P=0.71), RAC residency was between 32 
and 38 per cent (P= 0.56) and defined   independence between 33 to 39 per cent 
(P=0.20). The same state recorded the most favourable values for all three 
outcome measures, being also the state with the lowest cost for initial 
hospitalisation. (TablesV4-A,C) 
VI (7). Association of in-hospital rehabilitation with short-term and long-
term outcomes in community patients. 
Research Study no. 5 compared hospital resource outlay and one-year rates of 
mortality, RAC residency and defined independence for community patients with 
and without evidence for in-hospital rehabilitation (REH) during the index 
hospitalisation. This analysis addressed the requirements of Objective 6. 
The population for this study comprised 1724 community patients who survived 
the acute phase of hospital care of which 1050 received REH. The characteristics 
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of patients REH and non-REH patients were not significantly different with 
respect to age, sex and comorbidity weight as shown in Table V5-A. Patients with 
comorbid dementia and those with subtrochanteric fractures were under-
represented in the REH group, while patients treated surgically, and with 
complicating anaemia, urinary and surgical site infections were more frequently 
referred to REH. 
Comparative hospital utilisation data are shown in Table V5-B. REH patients had 
shorter time in the acute phase, and only half as many days per capita in 'other' 
episodes. These results were overshadowed by the 26,312 days in rehabilitation 
(mean LOS=25.1 days) for REH patients. As a result the mean total LOS was 
14.1 days longer for REH patients  (42.4 vs 28.3 days, P<0.001). Total hospital 
cost was higher for REH patients by $14,197 ($40,439 vs $26,242, P<0.001).  
At final discharge from the index hospitalisation, the distribution of immediate 
outcomes was significantly different between REH and non-REH patients as 
shown in Table VI-4 below. The difference in mortality would remain significant 
throughout the two year follow-up period as shown in Study V, Table V5-C. The 
significantly higher proportion of non-REH patients discharged to RAC did not 
maintain significance at or beyond 90 days from the index admission. There was 
a trend towards lower rates for defined independence for REH patients, but this 
only attained significance at one year. (Table V5-C). 
 
Table VI-4. Separations from index hospitalisation by rehabilitation 
selection 
Outcome Rehabilitation patients Non-rehabilitation patients P 
 
 Per cent 95 % CI Per cent 95 % CI  
 
Died 2.6 1.6–3.6 5.2 3.5–6.9 0.004  
RAC transfer 19.1 16.7–21.5 28.0 24.6–31.4 0.007  
Home 72.1 70.4–75.8 49.9 46.1–53.7 <0.001  
Other 5.1 3.8–6.4 16.9 14.1–19.7 <0.001  
 
The number of days in RAC and the number and costs of hospital readmissions 
over the first year were examined as indirect assessments of health or functional 
status. Total time in RAC was 68.3 days per capita for REH patients and 71.5 
days for non-REH patients. The proportions of patients readmitted at some stage 
during the first post-fracture year, and the proportion of total readmission 
episodes were not significantly different. Non-REH patient had a higher mean 
number of admitted days (17.9 vs 14.8, p=0.003) but the mean cost of readmission 
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did not differ ($14,156 vs $14,728, p=0.17). When costs were compared in a 
multivariable model adjusted for sex, age group, comorbidity, and length of 
survival, the same lack of significance (p=0.17) was found. 
The proportions of patients who were resident in RAC after 90 days were not 
different in either unadjusted or multivariate models. Similarly, there was no 
significant difference in rates of patients who were alive, not in RAC and not 
receiving community services in unadjusted analyses; in multivariate models 
there were significantly fewer independent non-REH patients at one year but not 
at two years. 
VI-8. Australian trends for prevalence and incidence of hip fracture 
At present there is no precise method for identifying annual numbers of hip 
fractures and hence the incidence in the general Australian population. The 
material presented in Section III (1-5) of this Thesis addresses these questions in 
response to the requirements of Objective 7. 
Between 1993-94 and 2012-13 hospital episodes for hip fracture increased by 63 
per cent from 14,200 to 23,600. Application of the DVA-derived episode: patient 
ratio of 1.25 as described in Section III (Table III-4) resulted in a total of 21,266 
episodes in 2008-09, representing 17,012 hip fracture patients. By 2012-13 these 
numbers had risen to 23,600 and 18,600 respectively. Men comprised 29 per cent 
of patients and just under 50 per cent of all patients were aged 85 years or older. 
Age specific incidence for nearly all age-sex groups fell across the period from 
1998-99 to 2012-13, with the age-standardised rate being reduced by 16 per cent 
for women and by 8 per cent for men. In the four years since 2008-09, there was 
a suggestion that incidence rates were stabilising except for persons aged 75-79 
years.  
A caseload projection to the year 2051, applied a further reduction in age-specific 
incidence, commensurate with that described for the period 1998-99 to 2012-13, 
to the mid-range demographic projections of the ABS. [63] The resulting estimate 
was for 50,000 patients, of whom 34 per cent would be males and patients aged 
85 years or older would comprise 60 per cent. (Table III-6) 
Hospital utilisation 
Since 1993-94 the mean LOS for episodes coded to hip fracture fell from 17.3 
days for men and women to 10.2 days for men and 9.7 days for women. These 
reductions were seen for all age-groups (Table III-3). It was not possible in these 
AIHW datasets to sum the LOS data for all episodes which comprise hospital care 
for hip fracture to identify any trends in the total hospital resource burden. Given 
that almost 50 per cent of hip fracture patients are referred for hospital based 
rehabilitation (Table V2-B), it was pertinent that LOS for rehabilitation (all 
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reasons) also fell by approximately 25 per cent between 1998-99 and 2012-13 
(Table III-4). 
VI-9. Data linkage and assessment of complex conditions 
The new findings within this Thesis are entirely due to the capacity for patient-
level linkage within DVA databases. The defining of the total burden of the index 
hospitalisation in both bed-days and costs required concatenation of line-by-line 
data items identified to the same patient. The same processes were necessarily 
applied to generate the descriptions of separation status at eventual discharge and 
to patient outcomes  following discharge. The many and complex predictive 
factors for all of these elements were rarely if ever available within a single 
database.  
The identification of the many patients who were RAC residents at the time of 
fracture provided particular insights. Not only was the index hospitalisation 
shorter, and less costly for these patients, but  values for ongoing survival, 
independence and post-hospital costs were all significantly below of those for 
community patients. 
 
Section VII. Context and Discussion  
In this section the key objectives and findings of this Thesis are discussed in the 
context of the recent Australian and international literature.  
 VII-1. Length of Stay 
The DVA-based finding of 11.1 days for length of the acute phase matched the 
result reported by AIHW for all Australia in 2008-09, as did the difference of 0.5 
days between men and women.[1] At the time of collating the figures (2011) there 
were no comparable data within Australia and few international comparisons in 
respect of total hospital LOS for hip fracture. Values ranging from 17 to 44 days 
were reported [37,79,80,81] but the definition or composition of “hospital care” 
also varied widely, especially with respect to whether rehabilitation was included 
in the initial hospital stay or provided elsewhere. 
Values for total LOS have varied enormously over time and between different 
health systems. Sixty years ago, the accepted  practice of delaying weight-bearing 
until there was evidence of bony union meant 3 to 9 months of bed rest and then 
further delays to achieve discharge.[21] In 1980, patients in Dundee, Scotland 
had an average LOS of 26 days for men and 36 days for women (two outlier 
values excluded).[32]  At the same time, a population-based study of hip fracture 
patients in Denmark reported mean total LOS in the acute setting of 24 days.[23] 
In 2001-2005 more than one quarter of English patients were in hospital for at 
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least 32 days [82] and mean total LOS in Scotland was 36 days in 2007,[69] both 
results being inclusive of rehabilitation. In the United States, where rehabilitation 
is mostly provided outside the hospital system, separation from the acute hospital 
setting usually occurs within one week. [70] 
Contemporary data report mean total LOS of 29 days in New South Wales,[84] 
20 days for English hospitals reporting to the NHFD [85] and 17 days in 
Sweden.[37] Progress towards more efficient hospital management is being 
achieved in many locations, but again the variable definition of 'hospital care', 
particularly with regard to rehabilitation, means that comparisons must be drawn 
with caution. 
Determinants of LOS 
The lack of a substantial age-related trend for LOS as evident in Table V1-1, is 
unusual for hospital patients. In two large British studies of primary total hip 
replacement for arthritis, LOS for patients older than 80 years was 30-40 per cent 
higher than that for patients in their seventies. [86,87] It would seem that the event 
of hip fracture defines a certain degree of frailty (and possibly biological age) 
which may itself determine care requirements, independent of chronological age. 
The different hospital trajectory for hip fracture patients admitted from aged care 
institutions has been recognised for 40 years. A Danish study in 1980 reported 
total hospital time of 22.7 days for a sample of 518 patients, which included 134 
patients from nursing homes with LOS of only 7 days. [88] Thirty years later a 
Swedish study reported total hospital stay of 7.5 days for RAC patients and 33.6 
days for patients admitted from their own homes.[4] This Thesis found 35.4 days 
and 18.8 days respectively.  
Whether or not post-fracture rehabilitation is included in the measure of hospital 
stay is another defining element. The data of Study 2, Table V2-B make this 
explicit for the Australian situation, where rehabilitation is almost exclusively 
performed in hospital. The European experience [69, 81, 82] finds  that stay in an 
acute hospital phase is 40 per cent or less of  'total institutionalised days'. The 
contemporary English data shows 20 hospital days, inclusive of 
rehabilitation,[85] while in the United States, fewer than 10 acute hospital days 
are followed, in at least 60 per cent of instances, by up to six weeks in various 
post-acute facilities.[70] 
In the past 20 years a variety of orthogeriatric models have been trialled, and are 
now widely recognised as contributing to best practice for hip fracture.[57,58] 
Although the factors used to assess efficacy of these multidisciplinary models are 
far from standardised, [89] acute phase  LOS is frequently reduced. [67,90]  A 
systematic review[89] found that for 13 studies which appeared to measure total 
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hospital stay, this value was in the range 23-28 days for co-managed patients and 
27-33 days for patients managed otherwise. In 5 of 13 individual studies there 
was a significant reduction in total LOS.[89]  A recent study of nearly 10,000 
patients in New South Wales produced an apparently contrary result, reporting 
mean acute LOS of 12.9 days and total LOS of 30.1 days for patients within 
orthogeriatric services and 11.2 days and 28.7 days respectively for patients 
treated otherwise.[84] 
The understanding of hospital LOS for hip fracture, and particularly the 
comparison between different care systems, requires knowledge of many 
predictors. Prior RAC residency, referral to rehabilitation, complication rates, 
post-acute destination and the model of care delivery are all key drivers of both 
acute and total LOS. 
 VII-2. Mortality 
Both early and later mortality rates after hip fracture increase with increasing age 
and are higher for men. [91,92] Using adjustment factors  for age and sex based 
on published studies, [92,93] the one year mortality of 33.9 per cent reported in 
Research Study 3 of this Thesis reduces to 29.3 per cent for a more representative 
Australian hip fracture sample with mean age 83 years and with 27 per cent of 
males.[1] While age and sex are evidently of high significance, the 1979 
statement that they are the exclusive determinants of mortality after hip fracture 
[23] is no longer supported. 
Early mortality 
The wide range of variation in definitions of hospital care and therefore its 
duration, results in equally wide variations in mortality rates at the point of 
discharge. The futility of comparing in-hospital mortality rates  between series 
with widely different LOS was evidenced by Jensen in 1979.[23] In the United 
States, a series with mean acute LOS of 4.6 days had in-hospital mortality of 1.6 
per cent.[94]  In a major Australian hospital, median LOS was 7.7 days and 
hospital mortality was 4.3 per cent.[95] Conversely, a large English sample found 
14.3 per cent deaths where median total LOS was 20 days and one-quarter of 
patients stayed more than 5 weeks.[83] It has therefore become conventional to 
report 30-day mortality as a comparable measure of hospital performance. 
The 30-day mortality reported from regional or single hospital studies in Australia 
are commensurate with international findings within the range of 5 per cent to 10 
per cent. [59,84,96] Prior to this Thesis there had been no description of mortality 
rates based upon a nation-wide sample. 
Many studies report only patients who have been treated surgically. [84,97,98] 
This excludes patients who are judged too frail to undergo surgery and therefore 
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may have an inferior prognosis. The databases for this Thesis showed that 13 per 
cent of non-operated patients were dead by 7 days after admission and that 30-
day mortality for this group was 22 per cent, or more than twice the rate for other 
patients. A recently published  database study in Japan found more than 400 per 
cent greater in-hospital mortality (mean LOS =38 days) among patients treated 
without surgery.[99] Unoperated hip fracture patients in English hospitals at the 
start of this century had 30-day mortality of 30 per cent, the rate for operated 
patients being less than 8 per cent.[83] 
Patients admitted from RAC have higher short-term mortality. At a Sydney 
hospital, 12 of 104 RAC patients (12 per cent, compared with 6 per cent of other 
patients (p=0.04) had died within 30 days.[100] The data for Research Study 3 in 
this Thesis showed a hazard ratio of 1.5 (95% CI 1.2-1.9) for RAC patients in 
respect of 30-day mortality, with nearly 21 per cent of patients having died by 
this time. 
The various formats of orthogeriatric care for hip fracture almost universally 
reduce short-term mortality. In an orthopaedic service in Genoa, Italy 
introduction of shared care did not alter LOS but reduced in-hospital mortality to 
4.8 per cent compared with 9.9 per cent. [101,102] Analysis of almost 10,000 hip 
fracture patients in New South Wales found 30-day mortality of 6.5 per cent in 
hospitals providing an orthogeriatric program and 8.1 per cent in those which did 
not.[84]  
However the establishment of the Geriatric Fracture Center in Rochester, while 
reducing LOS and complication rates, did not impact 30-day mortality.[103] A 
meta-analysis of 4637 patients in 9 settings[104] similarly failed to demonstrate 
reduction in short-term mortality. As stated in Research Studies 3 and 5 the data 
available to this Thesis provided nothing by which to distinguish orthogeriatric 
care from other formats of care delivery. 
Mortality at 30 days after hip fracture has declined steadily over the past 10 years. 
The English NHS data for 2001-2004 reported 9.7 per cent mortality at 30 days. 
[83] Within the same large sample, with the top quartile for total LOS being above 
32 days, in-hospital mortality was 14.3 per cent. [83] In 2013, after six years of 
increasing compliance with best-practice guidelines,[24] the 30-day mortality 
reported in the NHFD was 8.1 per cent. [85] A referral hospital in Newcastle, 
NSW has seen 30-day mortality reduced by 50 per cent to 8.2 per cent between 
2002 and 2011, even though multidisciplinary acute care was not universal. [96] 
In South Australia 30-day mortality fell approximately 20 per cent to 8.1 per cent 
between 2002-03 and 2007-08. [59] 
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One-year mortality 
The one-year crude mortality in the study population (34 per cent) was high by 
world standards, but the age-sex adjusted value of 29 per cent, was similar to that 
for many European series. [59,82,91] Another Australian study also found one-
year mortality of 29 per cent in a series with 25 per cent males and 44 per cent of 
patients age ≥ 85 years. [105] An American study of 43,165 Veterans’ Health 
Administration beneficiaries found 32.2 per mortality after one year: the mean 
age was 80 years, with 20 per cent of subjects aged 85 years or older and patients 
under 65 years excluded: 87 per cent of subjects were men. [106] By contrast a 
report from South Korea found one-year mortality of 16.6 per cent in a population 
of mean age 75 years, inclusive of those aged 50-64 years and with only 15 per 
cent aged 85 years or older. Men comprised 30 per cent of this latter study which 
was confined to patients who were treated surgically. [107] These disparities in 
reported mortality rates have been declared chiefly due to differences in patient 
demographics and inclusion / exclusion criteria of such dimensions that meta-
analyses of mortality rates were declared to be impractical. [108] 
A Norwegian orthogeriatric service reported 46 per cent one-year mortality for 
RAC patients compared with 14 per cent for community patients,[92] and 
corresponding values from a unit in Holland were 45 per cent and 17 per 
cent.[109] In this Thesis pre-fracture RAC residency was the most powerful 
predictor of mortality after the first 30 days (Table V3-C). 
Excess mortality 
A number of studies have demonstrated that mortality after hip fracture exceeds 
expected rates based on patients’ age and sex.[ 41,110] The excessive mortality 
is greatest in the first few months after injury, but continues for at least 10 years, 
and is more evident for men and for younger patients.[111,112] Excessive 
mortality from hip fracture also results among residents of aged care institutions,  
although the effect is not detectable beyond 9 months.[113,114] This Thesis found 
excessive mortality rates of slowly declining dimensions to the end of four years, 
excepting for males aged 90 years or older (Table V4-D) 
VII-3. Service provision, resource outlays and patient outcomes 
Hospital expenditure 
The question of whether more or different resource outlays in the initial hospital 
treatment would equate with different medium term outcomes was examined in 
Research Study 4. The Australia-wide database available to this Thesis provided 
the opportunity to compare practice and outcomes for six different state 
jurisdictions. As presented in (Figure V-1) and summarised in Section VI (6), 
there were differences in the order of 50 per cent in acute and total LOS, rates of 
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rehabilitation referral and total hospital costs. Patient characteristics were not 
significantly different between the states, but apart from the proportion receiving 
surgical treatment, unadjusted rates for all other listed in-hospital and post-
hospital services showed significant differences. 
One-year outcomes showed no significant differences in either unadjusted or 
adjusted models in respect of mortality, residence in RAC or in a defined 
measurement of independence. 
A number of studies of hospital services have shown that higher expenditure is 
associated with lower mortality at the point of discharge and at one year, and also 
lower 30-day readmission rates.[115,116,117] However, calculations based upon 
data within two national databases in Britain suggest that subsequent mortality is 
not related to LOS (often a surrogate for cost) for the primary hospital admission. 
[69,85] The data presented in Research Study 4 would appear to strongly support 
the latter view, that higher resource outlays do not equate to improved clinical 
outcomes, especially in the longer term.  
Orthogeriatric programs 
The extensive research into the efficacy of various forms of orthogeriatric care 
shows that in most, but not all cases, acute hospital stay is reduced, there are fewer 
complications and in-hospital or 30-day mortality is also improved, but outcomes 
beyond 6 months are not affected. [102, 104,118,119]  Isolated reports found 
significant reduction in one-year mortality [101] and functional gains sustained 
at one-year follow-up. [120] A large database study in New South Wales found 
orthogeriatric care associated with lower 30-day mortality but with no substantial 
impact upon overall hospital stay, and presumably costs.[84] A non-randomised 
cost-utility study of 3114 patients in a single hospital in Israel,[120] found that 
comprehensive orthogeriatric care reduced initial hospital costs by 30 per cent, 
while achieving lower one-year mortality rates (14.8 per cent vs 17.3 per cent, 
P=0.016). This Thesis, while acknowledging the advantages of multispecialty 
management for at least the acute phase of hospital care, possessed no data which 
could identify orthogeriatric practice.  
VII-4. Rehabilitation: costs and outcomes 
The results of Research Study 5 point to substantially increased costs in the order 
of $14,000 for Australian patients who have rehabilitation as admitted hospital 
patients after hip fracture. Costs attributable to rehabilitation in Ontario, Canada 
were between $CAN 5000-$6000 in 2010 dollars. [7] Death, failure to return 
home and hospital readmission are the accepted markers for defining better or 
worse outcomes, especially in database studies.[121] In this Thesis the provision 
of community support services over the first post-fracture year was also 
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documented. Mortality rates were lower for rehabilitation patients at 90-days and 
one year, although the causes of this are not clearly attributable to the 
interventions provided. There were no significant differences with regard to 
defined markers for independent living (Table V5-C).  Several systematic reviews 
covering a wide range of rehabilitation programs [121,122] have not provided 
convincing evidence of sustained functional benefits. Alternative modes of 
delivery of rehabilitation: day-hospital, hospital outpatient or domiciliary are 
variably reported as producing similar outcomes to those for hospital patients. 
[123,124,125] An analysis of Medicare (USA) data for 2002-03 showed that in-
hospital rehabilitation after hip fracture carried a cost impost of more than 
$US7000 over rehabilitation in skilled nursing facilities. The mortality at 120 
days was lower for hospital patients but the two patient groups had differing risk 
factor profiles.[123] A study of hip fracture patients in Tuscany found 10-fold 
differences in cost between inpatient and outpatient rehabilitation, but 
comparable 6-month mortality rates.[124] An intensive home-based program in 
Sydney showed improvement in both survival and rates of independent living 
after one year.[125] The findings of these international studies would appear to 
support the conclusions of Research Study 5 that hospital-based REH, while 
costly, does not infer lasting advantages with respect to patient independence. 
VII-5. Incidence, prevalence and projections 
This Thesis calculated the number of hip fractures in Australia in 2008-09 as 
17,012, being the number of uniquely identified patients hospitalised for the first 
time in 2008-09 with a principal diagnosis of hip fracture. The various 
adjustments to NHMD records to compensate for double counting [40, 53, 54, 
62] appear to have both excluded some legitimate hip fracture patients while 
accepting a degree of double counting. 
The requirement for an associated code for relevant surgery excludes hip fracture 
patients who are treated without operation. In the DVA study population this 
represented 13 per cent of cases: other studies identified a proportion of non-
operated patients between 3 per cent and 13 per cent. [73,99] It is also apparent 
that such patients may be regarded as too frail for surgery or have died prior to 
operation. In both instances their exclusion may bias the reported results in favour 
of better outcomes, particularly for in-hospital mortality. [83] 
The exclusion of patients whose first episode coded to hip fracture also indicates 
an inter-hospital or inter-service transfer may also exclude patients who fracture 
while already in hospital for an episode coded to another condition. There is good 
evidence [126,127] that these patients have significantly worse outcomes. The 
requirement for associated code for a low impact fall would have excluded nearly 
18 per cent of the study population for this Thesis. It would appear that accurate 
case finding from an administrative database is dependent upon a unique patient 
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identifier. One Australian estimate of hip fracture prevalence [62] almost exactly 
matched the finding of this study by both excluding patients without coded falls   
but including some instances of readmission. 
The importance of establishing an accurate base population becomes paramount 
when attempting to plan future service demands. By the middle of this century 
the hip fracture caseload is projected to at least double and possibly treble the 
current dimension. [128] 
Potential inaccuracies which apply to data derived from comparatively small 
regional study populations and from existing national databases are discussed. In 
particular the latter, reporting numbers of hospital episodes coded as hip fractures 
are known to include multiple entries for a substantial proportion of patients. 
While the dimension of this error would appear to range between 20 and 30 per 
cent, [38,40] systematic audits of databases for large populations against patient-
identified datasets do not appear to have been published. 
In 1999, an estimate of 60,000 hip fractures in Australia by 2051 was based upon 
the projections for the Australian population then current, together with the 
expectation that the rising trend in age-specific incidence for hip fracture would 
continue. Since then the incidence of hip fracture has fallen substantially across 
the age-range, and the projected population to 2051 has increased by 50 per cent 
above 1999 projections, to 38 million. [63] Two calculations, one based upon 
continuation of 18-year trends in age-standardised incidence and the other using 
projections of age-sex specific rates, produce estimates of between 38,000 and 
50,000 hip fractures (Table III-6). 
A recent set of calculations for New South Wales [128] using both static and 
reducing age-specific incidence rates would suggest that the lower of these 
estimates is more likely. By any measure, the proportion of patients aged 85 years 
and older will increase by at least 10 per cent. Substantial downward trends in 
hospital LOS (acute episodes) for hip fracture, and also for (all cause) admitted 
days for rehabilitation may mitigate but not eliminate a rising cost burden. [78] 
VII-6. Strengths and limitations 
This Thesis was based upon linked administrative databases provided by DVA for 
a patient sample which included one-seventh of the Australian hip fracture 
population in the study year.  How accurate and complete were the data, and how 
representative was the sample? 
Databases were compiled within DVA from data submitted by the various state 
health services for the purpose of billing surveillance. Patient identity and service 
items were cross-checked against billing and other Departmental records. These 
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features accord with higher data quality in administrative databases. [129] While 
the accuracy of diagnostic coding within administrative data is far from absolute, 
the sensitivity of coding for hip fracture was 95 per cent in an audit of ICD-10-
AM data in Victoria. [49] This was the highest level of sensitivity for any 
diagnosis other than cancer of the breast or lung, a level that was confirmed by 
the systematic review of Hudson. [51] 
Databases are generally unsuitable for identifying prevalence or incidence of 
medical conditions on a population basis. Hip fracture, for which hospital 
admission is essentially universal in Australia, is one condition for which this 
reservation does not apply. Across the world, as referenced throughout this work, 
administrative databases suitably adjusted to minimise double counting of 
patients, are accepted as the source for estimating caseloads and incidence rates. 
[23, 37, 41] 
The levels of ascertainment for comorbid diagnoses and complications within 
administrative databases fall well short of those extracted from clinical records 
or direct clinical observation. Little is known about levels of accuracy of 
secondary or comorbid diagnoses. Rates of ascertainment for key comorbidities 
compare favourably with those in other database studies. [83, 91] The likelihood 
of under-reporting has the effect that the impact of any particular comorbidity as 
a predictor variable may also be under-represented, but is unlikely to have been 
exaggerated. 
As with other administrative data, there are no clinical details which can identify 
physiological markers for disease severity. Neither was there any specific 
information describing physical or cognitive functionality, such as assessed by 
the 21-point Functional Independence Measure (FIM). Such assessment ratings 
have been shown to be useful in assessing risk status for undesired outcomes such 
as death, long and expensive hospitalisation, or entry into residential aged care. 
While sharing these limitations, the DVA databases available to these studies 
possessed additional strengths, including a very extensive list of demographic, 
clinical service and administrative descriptors. The particular and unique strength 
of the DVA databases was the capacity to link all other health service data with 
hospital data. Linkage with data describing periods of residence in aged care 
facilities, with data for hospital and community-based services following the 
initial (index) hospital admission and with date of death provided a 
comprehensive description of hip fracture management and its aftermath. Such 
detail is usually possible only for much smaller studies in which personal contact 
with patients or their clinical records can be maintained across time.  
In some instances, these linkages could identify surrogates for frailty or 
functional state, derived from the density and timing of provided services, such 
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as community nursing and Veterans' Home Care together with hospital 
readmissions and time in RAC facilities. Pharmaceutical dispensing and 
provision of mobility and other aids to physical function could also have assisted 
to create a profile of patient needs 
The study population of veterans and war widows was atypical of the Australian 
demographic for hip fracture patients. The mean age of both men and women was 
higher by at least 3 years and the proportion of men was greater by 10 per cent 
than in 'non-DVA' patients at the time. As noted when discussing projection 
models for hip fracture incidence and service demands, the DVA demographic in 
this study population was very similar to that which is expected for the national 
population some thirty years hence. 
More than 90 per cent of subjects were in receipt of the DVA Gold Card, a close 
equivalent of private health insurance. This status, together with access to some 
enhanced services provided and even promoted by DVA may have resulted in 
atypical treatment experiences and potentially different outcomes. Where service 
utilisation could be directly compared with that of non-DVA patients, as in 
comparisons of episodes for acute care, there was little or no apparent difference 
in rates of service, length of stay or costs.  Care has been taken to report results 
according to suitable age-sex groupings which are therefore comparable with 
matching demographic groups within non-DVA populations. Age-standardised 
data are also reported where appropriate. However caution has been exercised in 
extrapolating findings to the general population. 
VII-7. Opportunities and priorities for ongoing research initiatives 
Additional analyses of the current datasets 
The datasets and linkage processes of this thesis provide scope for a number of 
further analyses. Two studies are currently being performed. 
(i)  An additional linkage has been obtained with data collected by the 
Australasian Rehabilitation Outcomes Collaboration (AROC). A study is being 
performed together with AROC for a sub-sample of patients from Study V for 
whom Functional Independence Measure (FIM) scores have been provided.  
This study will examine the associations of physical functional status on 
admission into REH, and the rate and extent of functional gains during hospital-
based REH, with hospital LOS, costs and patient outcomes over the ensuing year.   
(ii) Additional data describing hospital services for the full study population for 
up to 2 years post-fracture. Readmission rates and the features associated with 
more frequent readmissions are to be analysed.  
146 
 
(ii) General priorities and initiatives 
(a)Complete the progress toward data linkage at a national level, with databases 
incorporating a de-identified but universally accepted patient identifier.  
Database linkage is central to the work of this thesis. Research Study 1 describes 
the differences in both utilisation and outcome findings between analyses of 
unlinked episode data and those from linkage of patient-level data both within 
and between individual datasets. The dimensions of these differences are such as 
to make the findings from unlinked data not only incomplete but misleading. The 
linkage between hospital and RAC datasets in provided important new insights 
into the issues examined in Research Studies no. 2, 3, 4 and 5. 
The potential value of nationally integrated reporting of core health data has been 
recognised for several decades. Agencies such as AIHW and ABS provide 
summarised reports and are able to provide a range of patient-specific or service-
specific reports upon special requests which carry appropriate Ethics Committee 
approvals. The number of such individual requests is increasing.  
In 20 years of personal experience on Commonwealth Ethics Committees there 
has not been a single significant breach of privacy due to the current practices of 
record and database linkage. The creation of a National Health Identifier for all 
citizens and the application of this key to all records of provided services 
generated by the disparate jurisdictions in Australia would enormously increase 
access to information which is highly relevant to the planning for and delivery of 
patient care. 
 (b). Establish consensus around the demographic, clinical and service delivery 
data to be recognised in all reports of hip fracture management and outcomes.  
At several stages of this Thesis, in particular the work of Research Studies no.3 
(mortality) and no.5 (rehabilitation outcomes), the lack of consistency in study 
design has frustrated attempts to definitively compare different systems of care 
delivery. The inconsistencies in definition of study populations, of patient care 
settings and selection of dependent and predictor variables is of such extent that 
most if not all attempts at meta-analyses provide very few, if any, definitive 
conclusions. The development and application of “best-practice” guidelines in 
both Europe and Australasia, should provide opportunities for such consensus. 
(c). Identify and validate the underlying causes of the decline in hip fracture 
incidence in Australia, as elsewhere. (What are we doing right?) 
Section III, parts 3 and 4 traced the trends in age-specific hip fracture incidence 
for the past 20 years of available records in Australia. The dire predictions for an 
epidemic of osteoporotic fractures, and hip fractures in particular, due to rapid 
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demographic changes do not appear to be happening. A diversity of interventions 
in diagnosis and treatment may be contributing as suggested by numerous single-
issue studies. 
 Even the most clinically focussed interrogation of population-based databases 
can only generate further questions as to the causes of identified movements in 
overall process or outcome results. Studies based upon audits of patient records 
are required to supply the answers.  
(d). Further evaluate efficacy of multidisciplinary models in the acute care 
phase of hospital management and, if validated, promote rapid introduction of 
same. 
The clinical complexities of hip fracture patients are displayed in detail in 
Research Studies no.2 and no.3. Protocol-based multi-specialty (orthogeriatric) 
management programs in the acute hospital setting are created to address this 
complexity. Short-term efficiencies and improved patient outcomes are 
frequently but not universally demonstrated for orthogeriatric care, while there is 
weaker evidence for more sustained benefits. The logical arguments in favour of 
multidisciplinary care and the many reports of positive outcomes suggest that the 
potential value of such programs be more systematically evaluated. 
(e). Evaluate alternatives to hospital-based rehabilitation following hip 
fracture, for which Australia has a very high proportional use. 
Research Studies no.2 and no.5 in particular identify the resource burdens of in-
hospital rehabilitation. Australia in particular has a very low proportion of post-
acute care for hip fracture delivered in ambulatory settings as a direct alternative 
to subacute hospital management. The apparent high differential cost of ongoing 
hospital care should, especially in the current Australian environment, promote 
further examination of non-hospital alternatives, many of which have equivalent 
outcomes for some patient groups. 
(f). Translate the clinical experience and research data for hip fracture 
management for other chronic and complex conditions in the elderly. 
The protocols of database linkage illustrated in this thesis could be similarly 
applied for the management of stroke, chronic cardiac failure, obstructive lung 
disease, less aggressive malignancies, arthritides and other chronic conditions 
with large patient populations and frequent, diverse health interventions.  
VII-8.  Conclusions 
Despite declining age-specific incidence over the past 15 years, rapid 
demographic changes mean that numbers of hip fractures in Australia continue to 
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increase.  
There is a high level of heterogeneity among hip fracture patients. Differentiation 
by age, sex, pre-fracture accommodation, selection for rehabilitation, 
comorbidity and geography can identify very large differences in treatment costs 
and outcomes, including an 8-fold difference in one-year mortality rates.  
There is similar diversity in protocols used to describe key data, such as an 
accurate count of hip fracture patients, immediate and ongoing treatment costs 
and outcomes over time. Consensus on the criteria for core elements, such as age-
range, comorbidity measures, and exclusion factors, at national and preferably 
international levels, would greatly enhance the information dividend. 
The linkage of population-based datasets has demonstrable value to identify key 
elements of the hip fracture population and to monitor the efficacy of 
interventions.  
Database analyses, while lacking some important clinical detail, also pose many 
potentially significant questions, which can and should provoke targeted 
examinations in studies with direct access to clinical records. 
Some predictors for inferior outcomes are potentially reversible and others may 
be mitigated by specific management programs. Orthogeriatric or other 
multidisciplinary models appear to be effective in improving short-term 
outcomes. Lasting benefits to patients and the wider community remain to be 
confirmed. 
The management of hip fracture in Australia remains hospital-centric. Frequent 
or prolonged hospital episodes are likely to have negative consequences for the 
ongoing welfare of frail and elderly persons. Preliminary evidence suggests that 
hospital time could be reduced, and alternatives to admitted care could be 
selectively introduced without detriment to patient outcomes. 
The methodologies of this Thesis are applicable to the study of a number of other 
chronic conditions. Hip fracture is, after all “the quintessential geriatric illness”. 
[130]   
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